data_2kcg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kcg _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.488 0 N-CA-C 113.917 0.327 . . . . 0.0 113.917 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.3 mm -96.36 125.79 46.28 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 117.329 0.565 . . . . 0.0 110.719 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 51.7 Cg_exo -56.9 131.97 48.79 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.428 2.086 . . . . 0.0 112.426 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 59.8 m -70.78 -10.3 59.2 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.483 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.91 -32.64 7.28 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.039 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.651 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 99.2 mt-10 -80.33 139.65 36.5 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.51 0.671 . . . . 0.0 110.207 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 5.4 m -109.75 135.42 50.69 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.892 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -101.77 50.45 0.85 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.447 0.642 . . . . 0.0 109.742 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.524 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 31.2 t -62.66 -50.12 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.727 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -125.4 -41.55 2.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.49 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.432 HG13 ' HD2' ' A' ' 12' ' ' PRO . 10.9 tt -117.21 134.95 23.01 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.294 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HD2' HG13 ' A' ' 11' ' ' ILE . 11.7 Cg_endo -59.16 148.86 83.81 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.629 2.22 . . . . 0.0 112.493 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.651 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 22.4 m -63.83 138.05 58.31 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.526 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.3 pt -77.22 -36.85 24.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.623 ' O ' HG12 ' A' ' 18' ' ' ILE . 19.4 m -83.12 16.75 2.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.946 0.403 . . . . 0.0 111.389 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.878 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 23.6 p -64.94 -27.72 69.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.937 0.398 . . . . 0.0 110.897 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.82 -21.56 29.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 15' ' ' SER . 23.7 pt -76.83 -6.41 8.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.872 0.367 . . . . 0.0 111.126 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.5 33.4 1.32 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.374 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.878 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 83.6 m -99.81 139.87 34.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.971 0.415 . . . . 0.0 110.717 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 21.7 t -119.21 137.5 53.6 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.565 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 51.5 t -73.49 122.04 21.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.943 0.402 . . . . 0.0 110.919 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -142.55 122.04 13.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.12 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m 57.03 36.82 28.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.576 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.524 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 16.0 mttp 68.03 21.21 8.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.588 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 42.5 t -137.73 131.02 42.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 93.0 m -83.56 126.8 33.19 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 122.039 -0.413 . . . . 0.0 110.784 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 3.8 m-85 -115.7 154.88 28.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.084 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.645 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 61.6 ttt-85 -137.59 112.43 8.95 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.6 t30 . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.738 -178.387 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.41 0 CA-C-O 120.145 -0.253 . . . . 0.0 113.649 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.7 mt -95.23 123.86 55.59 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 117.33 0.565 . . . . 0.0 110.683 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.66 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.6 Cg_exo -56.57 131.18 44.13 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 122.363 2.042 . . . . 0.0 112.486 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 57.3 m -72.96 -9.24 58.51 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.367 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.63 -33.08 6.32 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.785 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.436 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 49.9 mt-10 -74.68 140.83 44.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.6 0.714 . . . . 0.0 110.634 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -111.96 129.49 56.17 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.684 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -91.47 52.72 2.13 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.369 0.604 . . . . 0.0 110.202 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.566 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 48.1 t -67.13 -59.52 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.694 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 55.1 m95 -93.91 -51.04 5.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.07 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pp -131.14 161.64 60.5 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.069 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.42 146.24 61.69 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.797 2.331 . . . . 0.0 112.089 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.436 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 11.9 m -66.12 144.53 56.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.283 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -74.82 -27.79 20.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.021 0.439 . . . . 0.0 110.343 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.659 ' O ' HG12 ' A' ' 18' ' ' ILE . 10.1 p -67.46 -11.17 57.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.816 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.592 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 19.3 m -53.26 -32.46 48.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 111.469 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.15 71.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.659 HG12 ' O ' ' A' ' 15' ' ' SER . 27.0 pt -89.74 5.45 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.54 -20.22 4.41 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.656 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 72.4 m -66.17 148.24 52.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.232 0.539 . . . . 0.0 111.05 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 p -143.45 133.06 23.65 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.49 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.9 t -64.32 123.65 19.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.93 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -144.72 115.61 7.82 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.5 m 56.7 38.81 29.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.179 0.514 . . . . 0.0 110.471 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.566 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 5.5 mptp? 70.26 13.27 7.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.092 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.65 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 20.1 t -129.71 129.24 66.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.5 m -83.48 124.83 31.1 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 122.001 -0.437 . . . . 0.0 111.067 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.66 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 6.0 m-85 -114.99 150.57 35.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.997 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.799 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 60.3 ttt180 -129.59 111.78 13.06 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 121.339 0.59 . . . . 0.0 110.139 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.51 0 N-CA-C 114.261 0.464 . . . . 0.0 114.261 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mm -95.43 123.31 56.98 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 117.57 0.685 . . . . 0.0 110.758 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.625 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.6 Cg_exo -57.39 130.11 37.46 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 122.505 2.137 . . . . 0.0 112.655 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.875 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 56.8 m -73.54 -8.26 55.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.273 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.55 -30.76 7.88 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.641 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.662 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 94.5 mt-10 -75.08 138.64 42.26 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.471 0.653 . . . . 0.0 110.037 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -113.55 131.45 56.08 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.784 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.1 p -94.78 45.3 1.11 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.594 0.712 . . . . 0.0 109.865 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.709 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 48.2 t -70.88 -55.0 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.888 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -103.91 -44.89 4.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.015 0.436 . . . . 0.0 110.909 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.542 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.2 tt -133.63 138.98 32.31 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.196 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.542 ' HD2' HG13 ' A' ' 11' ' ' ILE . 9.5 Cg_endo -54.14 146.65 47.98 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.914 2.409 . . . . 0.0 112.744 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.662 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 5.4 m -67.86 144.74 55.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.745 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.9 tt -75.41 -34.98 31.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.154 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.404 ' HA ' HD11 ' A' ' 18' ' ' ILE . 66.3 m -71.16 -3.51 20.48 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.67 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.6 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 74.1 m -60.99 -35.18 76.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.756 0.313 . . . . 0.0 110.52 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.28 -28.54 69.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.176 0.512 . . . . 0.0 110.771 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.404 HD11 ' HA ' ' A' ' 15' ' ' SER . 2.8 mp -72.8 -26.6 23.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.247 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.422 ' HA3' ' NE ' ' A' ' 29' ' ' ARG . . . 148.21 -9.99 1.14 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.053 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.6 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 59.3 m -66.52 133.19 49.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.251 0.548 . . . . 0.0 110.663 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 13.8 m -110.41 136.58 49.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.959 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.9 t -74.47 117.31 16.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.793 0.33 . . . . 0.0 110.644 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.609 ' HD3' ' CE1' ' A' ' 28' ' ' TYR . 13.4 tttt -135.79 117.83 15.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.1 m 57.05 35.55 26.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.346 0.594 . . . . 0.0 109.963 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.709 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 59.1 mttm 68.21 20.41 8.85 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.668 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.576 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.2 t -129.85 125.94 61.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 85.3 m -85.25 122.64 29.72 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.016 0.436 . . . . 0.0 111.701 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.625 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 2.9 m-85 -113.36 151.05 31.77 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.68 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.875 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER -127.3 106.09 8.98 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.5 t30 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.093 -178.599 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.419 0 CA-C-O 120.184 -0.231 . . . . 0.0 113.659 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.2 mt -92.25 121.05 67.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 117.177 0.488 . . . . 0.0 110.667 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.602 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 50.6 Cg_exo -55.98 129.16 33.43 Favored 'Trans proline' 0 CA--C 1.52 -0.222 0 C-N-CA 122.486 2.124 . . . . 0.0 112.782 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.809 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 79.5 m -74.11 -1.98 22.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.496 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.33 -30.92 5.69 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 83.3 mt-10 -61.53 138.29 58.28 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.471 0.653 . . . . 0.0 110.357 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 m -117.48 125.6 51.17 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.592 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.2 p -93.54 46.8 1.21 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.652 0.739 . . . . 0.0 110.322 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.5 t -74.66 -38.96 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.703 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -130.06 -50.63 1.12 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.966 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -103.63 144.07 27.93 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.854 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.86 164.29 36.0 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.641 2.227 . . . . 0.0 112.422 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 16' ' ' SER . 3.5 m -54.79 125.88 21.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.483 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.0 pt -76.88 -38.39 28.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.477 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 10.5 m -90.77 32.9 0.95 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.104 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 2.4 p -60.59 -47.27 86.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.849 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.94 -22.44 66.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.046 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.5 mm -75.94 -26.89 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.584 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.56 -6.77 2.19 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.307 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 15' ' ' SER . 56.5 m -77.08 134.06 38.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.389 0.614 . . . . 0.0 111.275 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.3 m -127.57 136.31 51.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.652 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.7 t -68.81 127.19 32.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.895 0.378 . . . . 0.0 111.601 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -149.91 120.45 7.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.709 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m 58.33 36.7 25.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.854 0.359 . . . . 0.0 110.604 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt 69.4 15.06 8.44 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.404 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.43 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 38.2 t -131.92 130.05 61.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 68.8 m -84.2 124.36 31.09 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 122.151 -0.343 . . . . 0.0 110.762 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.602 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 3.2 m-85 -112.34 153.76 26.75 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.626 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.809 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.6 ttm180 -128.85 108.92 10.83 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 121.381 0.61 . . . . 0.0 109.975 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.436 0 N-CA-C 113.835 0.294 . . . . 0.0 113.835 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.4 mt -94.39 123.53 58.28 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 117.357 0.579 . . . . 0.0 110.699 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.588 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 50.6 Cg_exo -56.12 131.97 49.09 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.431 2.088 . . . . 0.0 112.397 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 74.2 m -71.88 -8.31 53.59 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.75 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.05 -32.53 6.78 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.98 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.629 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 99.7 mt-10 -79.99 140.92 36.4 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.471 0.653 . . . . 0.0 110.011 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.8 m -111.91 135.11 52.97 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.707 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -98.57 51.01 0.99 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.483 0.658 . . . . 0.0 109.719 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.54 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 44.3 t -63.96 -49.69 80.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.639 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -116.23 -48.61 2.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.719 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.92 153.14 50.94 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.64 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -66.71 146.02 77.39 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.557 2.172 . . . . 0.0 111.653 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.629 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 6.2 m -67.81 148.27 51.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.346 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.2 mm -74.0 -37.59 47.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.285 0.564 . . . . 0.0 110.006 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.437 ' HA ' HD12 ' A' ' 18' ' ' ILE . 65.1 p -63.96 -12.37 36.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.061 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.767 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 13.0 m -56.59 -38.37 71.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.665 0.269 . . . . 0.0 111.094 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.34 -24.15 67.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.826 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 15' ' ' SER . 3.2 mp -79.73 -39.59 20.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.4 0.619 . . . . 0.0 110.224 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . 157.68 36.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.534 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.767 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 77.2 m -112.36 142.14 45.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.035 0.445 . . . . 0.0 110.573 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 m -119.53 133.45 55.67 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.013 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.4 t -70.54 121.86 18.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.349 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.1 tttp -140.09 117.14 11.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.241 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m 55.99 39.27 30.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.924 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.54 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 18.1 mttp 70.21 15.56 7.49 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.011 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.613 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.8 t -132.59 128.97 58.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 87.8 m -83.73 128.23 34.38 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.989 -0.445 . . . . 0.0 110.884 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.613 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 5.9 m-85 -117.67 155.49 29.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.248 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.678 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 30.6 ttm180 -135.98 109.12 7.73 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.3 t30 . . . . . 0 C--N 1.327 -0.406 0 CA-C-O 121.507 0.67 . . . . 0.0 109.902 -178.58 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.449 0 N-CA-C 113.885 0.314 . . . . 0.0 113.885 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm -96.51 123.22 55.11 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 117.546 0.673 . . . . 0.0 110.723 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.659 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 50.7 Cg_exo -56.52 132.2 50.37 Favored 'Trans proline' 0 CA--C 1.517 -0.367 0 C-N-CA 122.474 2.116 . . . . 0.0 112.611 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.742 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 60.7 m -73.99 -10.89 60.1 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.272 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.0 -32.71 6.79 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.93 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -73.03 139.53 46.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.525 0.679 . . . . 0.0 110.516 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.5 m -107.48 130.35 54.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.873 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.3 p -100.54 47.84 0.92 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.166 0.508 . . . . 0.0 110.501 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.8 t -73.59 -48.85 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.77 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -101.02 -49.5 4.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.031 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.63 153.36 81.5 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.653 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -66.75 147.3 80.97 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.7 2.266 . . . . 0.0 111.813 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.2 m -66.94 149.28 50.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.512 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.5 mt -72.03 -35.62 54.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.375 0.607 . . . . 0.0 109.836 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.7 p -69.23 -3.25 13.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.477 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 31.3 m -56.5 -39.48 73.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.0 0.428 . . . . 0.0 110.679 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.74 -22.3 64.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.1 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.3 mm -78.71 -28.04 14.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.764 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 151.73 -16.42 0.83 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.836 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 16' ' ' SER . 76.0 m -67.88 139.74 56.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.372 0.606 . . . . 0.0 111.213 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.448 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 6.3 m -122.21 131.46 53.95 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.941 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.1 t -66.53 124.34 22.52 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.22 0.325 . . . . 0.0 110.334 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.448 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.6 mttm -142.64 115.57 8.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.099 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 53.8 m 55.37 38.38 30.23 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.441 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.553 ' NZ ' ' HB2' ' A' ' 25' ' ' LYS . 8.3 mtmp? 74.95 13.89 3.28 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.727 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.639 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.3 t -133.44 128.72 55.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 90.6 m -83.1 125.55 31.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.849 0.357 . . . . 0.0 110.965 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.659 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 5.8 m-85 -115.55 151.37 35.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.819 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.742 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 27.7 ttm180 -130.95 110.41 11.24 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 121.457 0.646 . . . . 0.0 110.089 -178.756 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 114.038 0.375 . . . . 0.0 114.038 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.4 mm -100.46 123.78 45.03 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 117.339 0.569 . . . . 0.0 110.74 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.68 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.3 Cg_exo -55.47 133.38 57.74 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.539 2.16 . . . . 0.0 112.472 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 35.2 m -76.53 -5.79 49.09 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.511 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.11 -32.83 5.83 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.689 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.47 145.15 39.42 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.464 0.65 . . . . 0.0 110.734 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.3 m -119.02 132.57 56.06 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.049 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -89.77 58.08 4.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.639 0.733 . . . . 0.0 109.706 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.649 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 22.5 t -63.72 -48.67 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.319 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -130.7 -40.63 1.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.779 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.6 pt -116.88 155.18 49.48 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.032 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -70.67 145.82 52.9 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.837 2.358 . . . . 0.0 111.755 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.5 m -69.99 147.3 50.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.17 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 15' ' ' SER . 10.6 tp -71.82 -34.73 52.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.965 0.412 . . . . 0.0 110.352 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.5 ' N ' HG23 ' A' ' 14' ' ' ILE . 14.3 m -66.72 -14.83 63.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.251 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.705 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 70.2 m -59.67 -32.79 70.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.717 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.96 -25.47 66.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mp -81.3 -46.7 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.304 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.53 34.05 0.02 OUTLIER Glycine 0 C--N 1.319 -0.414 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.086 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.705 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 72.3 m -108.59 143.31 37.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.12 0.486 . . . . 0.0 110.683 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 12.3 p -121.91 137.26 54.86 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.518 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -71.25 115.16 10.08 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -133.76 115.83 15.01 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.8 m 57.34 37.61 28.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.043 0.449 . . . . 0.0 110.695 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.649 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 14.5 ttmm 71.9 12.07 6.16 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.53 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.695 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 18.1 t -127.94 129.81 69.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 21' ' ' SER . 97.3 m -82.11 124.79 30.17 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 122.051 -0.405 . . . . 0.0 111.062 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.695 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 5.4 m-85 -116.51 151.12 36.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.799 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.541 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 31.7 ttp85 -128.89 118.19 22.27 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.441 ' OD1' ' HG2' ' A' ' 29' ' ' ARG . 5.0 p-10 . . . . . 0 N--CA 1.469 0.504 0 O-C-N 123.954 0.784 . . . . 0.0 111.783 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.396 0 CA-C-O 120.177 -0.235 . . . . 0.0 113.484 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.9 mt -94.2 121.96 62.63 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 117.224 0.512 . . . . 0.0 110.551 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.683 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.3 Cg_exo -56.14 129.9 37.34 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.39 2.06 . . . . 0.0 112.64 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.795 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 76.5 m -74.09 -4.86 38.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.236 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.09 -27.39 8.37 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.494 ' OE1' ' HB2' ' A' ' 15' ' ' SER . 32.3 mt-10 -68.0 138.97 56.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.523 0.677 . . . . 0.0 110.873 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -111.74 125.17 53.7 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.441 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.1 p -98.68 43.79 1.05 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.288 0.566 . . . . 0.0 110.215 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 1.069 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 38.9 t -73.12 -51.18 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.112 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.631 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 3.8 m-90 -97.28 -51.02 4.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.156 0.503 . . . . 0.0 110.902 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.1 pt -130.95 156.12 80.54 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.688 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.35 146.7 81.44 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.642 2.228 . . . . 0.0 111.916 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 6' ' ' GLU . 24.1 m -66.97 146.44 54.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.72 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.41 HD13 HG22 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -75.31 -35.04 32.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.006 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.494 ' HB2' ' OE1' ' A' ' 6' ' ' GLU . 11.1 m -76.38 5.1 7.66 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.436 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 36.1 m -58.8 -41.02 85.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 110.611 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.51 -24.98 67.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.227 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.0 mt -76.18 -25.72 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.951 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.13 -13.71 0.73 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.057 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 56.6 m -71.67 139.03 49.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.362 0.601 . . . . 0.0 111.289 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.472 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 7.7 m -125.0 130.76 53.01 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.729 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.0 t -65.19 120.78 13.36 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.245 0.341 . . . . 0.0 110.395 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.7 mttm -141.44 115.94 9.56 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 47.1 m 56.2 39.59 30.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 111.026 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 1.069 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 46.4 mmtm 71.63 12.43 6.4 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.167 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.635 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.4 t -130.89 128.22 62.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 86.5 m -83.62 122.9 29.2 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.965 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.683 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 4.5 m-85 -111.5 151.09 29.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.907 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.795 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.0 ttm180 -128.45 112.06 13.96 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.393 0.616 . . . . 0.0 110.071 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.36 0 CA-C-O 120.337 -0.146 . . . . 0.0 113.436 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -98.86 128.37 32.62 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 117.114 0.457 . . . . 0.0 110.618 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.672 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 47.9 Cg_exo -58.37 130.89 39.75 Favored 'Trans proline' 0 CA--C 1.517 -0.36 0 C-N-CA 122.312 2.008 . . . . 0.0 112.155 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 52.8 m -73.59 -6.29 45.66 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.69 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.5 -31.84 7.09 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.647 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.617 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 98.8 mt-10 -77.76 138.91 39.27 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.457 0.646 . . . . 0.0 109.839 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 m -117.42 134.78 54.45 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.914 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -96.17 46.35 1.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.229 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.912 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 39.9 t -66.4 -42.53 90.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.84 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -127.35 -46.73 1.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.339 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.7 tp -117.33 136.72 23.55 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.761 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.85 148.62 91.69 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.296 1.997 . . . . 0.0 111.826 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.617 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 4.3 m -69.15 147.08 51.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.951 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.4 mp -77.18 -37.67 26.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.581 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.1 t -68.02 -7.4 28.75 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.364 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.571 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 69.2 m -59.27 -37.72 78.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.755 0.312 . . . . 0.0 110.928 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.21 -25.49 67.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.178 0.513 . . . . 0.0 111.098 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.24 -25.47 16.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.617 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.15 -16.5 0.79 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.874 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 57.5 m -66.18 138.98 58.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.405 0.622 . . . . 0.0 111.489 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 p -121.71 135.21 54.95 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.101 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.7 t -66.43 123.31 19.64 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.984 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -138.17 113.81 9.71 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 m 56.27 38.78 30.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.432 0.634 . . . . 0.0 110.303 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.912 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 72.6 mttt 68.33 20.0 8.81 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.164 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.661 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.6 t -132.08 127.24 57.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 89.0 m -84.94 123.18 30.22 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.109 0.481 . . . . 0.0 111.777 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.672 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 2.9 m-85 -116.05 150.88 36.57 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.816 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.715 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 44.7 ttt-85 -135.34 121.03 19.51 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.324 -178.191 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 113.875 0.31 . . . . 0.0 113.875 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.8 mm -95.63 125.18 50.27 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 117.352 0.576 . . . . 0.0 110.661 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.61 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.9 Cg_exo -57.14 131.24 44.01 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 C-N-CA 122.424 2.082 . . . . 0.0 112.494 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.811 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 69.9 m -72.89 -10.42 59.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.333 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.27 -33.05 6.78 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.867 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -75.07 141.18 43.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.519 0.676 . . . . 0.0 110.251 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 m -116.07 130.55 56.86 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.417 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.25 48.38 1.16 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.041 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.942 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 39.2 t -65.3 -40.82 89.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.545 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -132.82 -47.12 0.87 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.336 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.484 HD13 ' HD2' ' A' ' 12' ' ' PRO . 6.5 tp -110.84 134.91 20.83 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.91 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.484 ' HD2' HD13 ' A' ' 11' ' ' ILE . 20.8 Cg_exo -63.95 147.47 91.93 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.334 2.022 . . . . 0.0 111.643 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.2 m -63.96 145.48 55.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.408 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.485 ' H ' HD11 ' A' ' 14' ' ' ILE . 3.7 mp -75.31 -43.88 42.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.967 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.727 ' O ' HG12 ' A' ' 18' ' ' ILE . 8.3 m -76.32 15.43 0.59 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.064 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.737 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 18.6 p -63.89 -39.01 93.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.233 0.54 . . . . 0.0 110.595 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.99 -28.06 67.39 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.727 HG12 ' O ' ' A' ' 15' ' ' SER . 11.4 pt -78.65 -3.62 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.99 -17.94 3.83 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.006 -1.093 . . . . 0.0 113.36 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.737 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 57.3 m -66.6 131.62 46.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.467 0.651 . . . . 0.0 111.314 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 15.2 m -117.5 137.0 52.84 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.932 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -72.82 120.28 18.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.964 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.613 ' HD3' ' CE1' ' A' ' 28' ' ' TYR . 6.9 tttt -139.53 119.57 13.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.1 m 57.84 35.76 25.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.26 0.552 . . . . 0.0 109.923 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.942 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 73.2 mttt 66.61 23.51 10.32 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.562 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.606 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 24.6 t -134.73 127.23 48.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 94.0 m -83.85 123.1 29.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.983 0.421 . . . . 0.0 111.449 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.613 ' CE1' ' HD3' ' A' ' 23' ' ' LYS . 3.9 m-85 -113.78 152.45 30.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.674 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.811 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 57.8 ttt180 -130.48 110.72 11.67 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.0 m120 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.58 -178.771 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.358 0 CA-C-O 120.32 -0.156 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.3 124.19 50.01 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 117.068 0.434 . . . . 0.0 110.334 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.65 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 50.7 Cg_exo -56.31 132.18 50.3 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.418 2.079 . . . . 0.0 112.491 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.582 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 80.5 m -72.61 -10.46 59.82 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.21 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.03 -32.03 7.57 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.849 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.683 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 97.3 mt-10 -78.25 138.24 38.52 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.592 0.71 . . . . 0.0 110.455 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 m -107.94 134.33 51.01 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.151 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.514 ' O ' ' HD2' ' A' ' 25' ' ' LYS . 1.7 p -101.0 37.88 1.66 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.237 0.542 . . . . 0.0 110.117 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.628 ' HB ' ' CE3' ' A' ' 10' ' ' TRP . 39.5 t -64.35 -52.4 56.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.999 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.628 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 3.8 m-90 -96.71 -55.55 2.86 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.175 0.512 . . . . 0.0 110.434 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 23.4 pt -125.96 156.59 71.41 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.301 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.85 147.31 89.39 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.55 2.167 . . . . 0.0 111.997 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.683 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 27.6 m -65.1 142.35 58.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.701 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.2 pt -77.05 -35.65 23.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.98 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 50.4 m -79.75 12.17 2.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.834 0.349 . . . . 0.0 111.606 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.877 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 19.4 p -60.95 -36.01 78.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.768 0.318 . . . . 0.0 110.964 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.6 -23.25 62.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.473 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 60.9 mt -70.86 -25.8 26.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.652 0.739 . . . . 0.0 110.289 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.95 31.84 0.29 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.661 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.877 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 60.0 m -103.34 137.46 41.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.192 0.52 . . . . 0.0 110.765 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.472 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 11.2 m -119.48 134.09 55.38 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.053 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.1 t -67.74 120.08 13.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.19 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.4 mttm -139.72 115.58 10.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 t 58.35 36.64 25.66 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.36 0.6 . . . . 0.0 109.854 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.514 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 28.6 mmtp 68.49 19.79 8.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.797 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.663 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 22.6 t -132.91 128.05 56.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 90.8 m -83.61 121.87 27.83 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.89 0.376 . . . . 0.0 111.357 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.663 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 5.0 m-85 -112.38 152.58 28.45 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.025 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.582 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 49.4 ttp85 -133.84 113.59 12.42 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 121.301 0.572 . . . . 0.0 109.952 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 N-CA-C 113.808 0.283 . . . . 0.0 113.808 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.29 124.0 52.87 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 117.36 0.58 . . . . 0.0 110.759 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.663 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.6 Cg_exo -57.34 130.67 40.42 Favored 'Trans proline' 0 CA--C 1.516 -0.38 0 C-N-CA 122.415 2.076 . . . . 0.0 112.471 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.763 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 72.6 m -72.94 -9.7 59.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.319 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.28 -32.89 6.64 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.582 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -73.09 140.61 47.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.503 0.668 . . . . 0.0 110.507 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -114.47 130.77 56.75 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.842 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.8 48.78 1.38 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.378 0.608 . . . . 0.0 110.126 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.537 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 45.1 t -64.69 -57.25 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.924 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 59.2 m95 -102.8 -47.82 4.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.091 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.84 158.88 69.06 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.25 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -68.21 147.14 72.03 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.795 2.33 . . . . 0.0 111.997 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.6 m -64.82 151.97 44.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.93 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 14' ' ' ILE . 13.9 tt -75.8 -38.48 37.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.426 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 m -76.6 9.75 2.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.741 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 22.9 p -59.19 -49.25 78.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.896 0.379 . . . . 0.0 110.906 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.7 -22.54 67.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.471 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.8 mt -75.07 -24.52 17.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.614 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.75 -14.99 0.92 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.208 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 36.4 m -74.15 132.6 42.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.461 0.648 . . . . 0.0 111.592 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 14.6 m -115.18 136.63 52.91 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.959 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 51.7 t -70.61 120.16 15.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.836 0.351 . . . . 0.0 110.564 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -139.73 118.52 12.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.966 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.8 m 56.64 36.68 28.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.141 0.495 . . . . 0.0 110.334 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER 69.52 17.63 7.93 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.956 -179.423 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.616 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 24.7 t -132.82 129.44 58.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 89.1 m -83.7 122.27 28.4 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.042 0.449 . . . . 0.0 111.336 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.663 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 4.4 m-85 -112.8 152.21 29.45 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.608 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.763 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 66.2 ttt180 -130.87 111.68 12.32 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.9 m120 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.707 -178.886 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.43 0 N-CA-C 113.882 0.313 . . . . 0.0 113.882 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.5 mm -96.68 126.58 42.63 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 117.307 0.554 . . . . 0.0 110.864 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.606 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.6 Cg_exo -57.33 130.45 39.33 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.403 2.069 . . . . 0.0 112.366 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 34.8 m -72.25 -8.42 54.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.558 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.1 -30.97 8.19 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.189 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -74.59 142.21 44.66 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.511 0.672 . . . . 0.0 110.672 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 m -109.59 128.81 55.48 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.01 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -94.38 48.12 1.22 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.11 0.481 . . . . 0.0 110.713 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.21 -57.3 5.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.493 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -98.64 -37.22 9.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.724 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.555 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.0 tt -146.21 138.96 14.06 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.339 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.555 ' HD2' HG13 ' A' ' 11' ' ' ILE . 8.3 Cg_endo -53.59 144.57 51.81 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.88 2.386 . . . . 0.0 112.779 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.2 m -65.4 147.35 53.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.832 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mm -73.04 -38.76 56.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.115 0.484 . . . . 0.0 110.303 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.545 ' O ' HG12 ' A' ' 18' ' ' ILE . 6.8 m -68.7 -4.55 16.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.227 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.679 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 15.6 m -58.1 -35.33 71.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.105 0.479 . . . . 0.0 110.638 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.69 -32.62 74.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.573 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 15' ' ' SER . 27.1 pt -86.74 5.9 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.78 -18.52 4.55 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 119.634 -1.27 . . . . 0.0 114.538 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.679 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 83.6 m -67.71 139.68 56.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.618 0.709 . . . . 0.0 111.803 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.0 m -125.1 135.38 52.63 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.747 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.3 t -69.74 125.08 25.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.093 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -146.6 119.42 8.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.132 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.606 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 10.8 m 56.85 39.61 29.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.967 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 24' ' ' SER . 8.7 ptpt 70.98 9.19 6.73 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.446 1.098 . . . . 0.0 112.038 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 t -128.39 130.43 69.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.209 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 91.5 m -83.72 127.2 33.61 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 122.189 -0.319 . . . . 0.0 110.738 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.606 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 2.9 m-85 -115.37 153.2 31.44 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.646 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 62.4 ttt-85 -136.09 115.49 12.67 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.724 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.342 0 CA-C-O 120.369 -0.128 . . . . 0.0 113.294 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.4 mm -96.37 125.64 46.83 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 117.026 0.413 . . . . 0.0 110.384 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.649 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.6 Cg_exo -57.15 132.64 52.54 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.353 2.035 . . . . 0.0 112.358 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 72.5 m -72.11 -7.84 51.26 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.562 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.33 -31.38 8.1 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.246 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -79.69 141.04 36.79 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.693 0.759 . . . . 0.0 111.038 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 m -107.74 129.55 55.03 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.0 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -99.92 51.03 0.91 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.56 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.57 -45.53 77.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.803 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -117.57 -48.56 2.59 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.952 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.6 pt -117.85 151.26 48.49 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.837 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.3 146.11 68.15 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.664 2.243 . . . . 0.0 111.661 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 10.0 m -66.55 148.41 51.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.488 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.437 HD13 ' H ' ' A' ' 14' ' ' ILE . 3.3 mp -71.92 -43.11 68.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.298 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.4 p -68.03 -3.13 9.17 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.847 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 18.3 m -57.99 -40.81 81.62 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.708 0.289 . . . . 0.0 110.609 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.02 67.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.607 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.8 mt -76.74 -37.14 27.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.408 0.623 . . . . 0.0 110.284 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . 155.42 33.36 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.704 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.847 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 83.9 m -109.92 138.67 45.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.17 0.509 . . . . 0.0 110.605 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.8 m -118.97 117.74 29.62 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.923 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 32.8 t -62.9 137.79 58.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.848 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -166.83 128.92 1.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.096 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.647 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 9.4 t 57.29 41.9 25.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 24' ' ' SER . 0.9 OUTLIER 62.6 16.06 8.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.777 1.231 . . . . 0.0 112.413 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.665 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.3 t -134.29 130.76 54.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.147 0.498 . . . . 0.0 110.995 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 89.5 m -84.14 128.1 34.34 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.102 178.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.665 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 6.6 m-85 -119.01 153.75 34.18 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.794 0.331 . . . . 0.0 110.173 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.594 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 29.5 ttm180 -134.61 114.8 13.14 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.654 -178.708 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.406 0 CA-C-O 120.174 -0.237 . . . . 0.0 113.678 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.2 mm -96.49 124.46 50.85 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 117.31 0.555 . . . . 0.0 110.585 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.659 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.4 Cg_exo -56.98 130.39 39.54 Favored 'Trans proline' 0 CA--C 1.516 -0.392 0 C-N-CA 122.405 2.07 . . . . 0.0 112.51 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.775 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 76.0 m -73.46 -8.49 56.12 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.4 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.33 -28.44 8.95 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.588 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.702 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 94.4 mt-10 -74.69 137.3 42.05 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.535 0.683 . . . . 0.0 109.957 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.2 m -108.92 131.8 54.67 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.681 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.0 p -99.41 45.02 1.0 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.581 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.611 ' HB ' ' CE3' ' A' ' 10' ' ' TRP . 21.6 t -76.3 -52.1 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.145 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.611 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 5.1 m-90 -93.74 -49.23 5.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.305 0.574 . . . . 0.0 110.935 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.444 HD12 HG21 ' A' ' 11' ' ' ILE . 17.0 pt -136.23 159.41 70.94 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.018 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -63.74 146.88 92.56 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.392 2.062 . . . . 0.0 111.637 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.702 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 36.5 m -66.33 149.86 49.73 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.797 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.448 ' H ' HD11 ' A' ' 14' ' ' ILE . 4.2 mp -72.69 -41.05 62.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.969 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -73.14 5.44 3.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 31.4 m -60.5 -41.66 94.77 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.945 0.402 . . . . 0.0 110.512 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.78 -25.8 67.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.281 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.5 mt -74.91 -25.36 18.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.009 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.18 -8.86 1.09 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.101 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 40.7 m -73.92 136.04 43.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.339 0.59 . . . . 0.0 111.147 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.482 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 5.7 m -118.71 131.09 56.14 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.681 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.1 t -64.91 121.52 14.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.275 0.36 . . . . 0.0 110.227 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.5 mttm -141.08 113.0 7.75 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.563 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 48.8 m 54.31 45.76 26.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.305 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 24' ' ' SER . 1.2 pttm 71.33 4.87 5.23 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.838 1.255 . . . . 0.0 112.518 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.615 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.1 t -125.35 127.91 72.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 120.856 0.36 . . . . 0.0 110.324 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 91.8 m -83.95 120.93 26.7 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.815 0.34 . . . . 0.0 110.827 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.659 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 5.0 m-85 -109.42 151.78 26.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.143 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.775 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.6 ttm180 -130.31 113.65 14.65 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-O 121.317 0.58 . . . . 0.0 110.159 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.401 0 N-CA-C 113.828 0.291 . . . . 0.0 113.828 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.2 mm -95.85 126.9 43.15 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 117.266 0.533 . . . . 0.0 110.709 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.656 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.6 Cg_exo -57.09 132.73 53.24 Favored 'Trans proline' 0 CA--C 1.518 -0.323 0 C-N-CA 122.48 2.12 . . . . 0.0 112.458 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.555 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 74.4 m -74.11 -9.12 58.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.281 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.36 -31.58 7.89 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.637 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.663 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 95.0 mt-10 -76.6 139.64 40.72 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.456 0.646 . . . . 0.0 110.094 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.1 m -114.95 133.55 55.92 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.001 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -97.73 51.22 1.06 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.816 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.844 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 36.8 t -62.84 -40.0 87.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.03 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -128.82 -49.48 1.24 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.088 0.471 . . . . 0.0 110.383 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.23 153.29 46.42 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.408 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -65.78 147.8 85.91 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.559 2.173 . . . . 0.0 111.648 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.663 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 8.3 m -69.44 150.12 47.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.417 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 mm -70.03 -41.41 79.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.274 0.559 . . . . 0.0 109.892 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.486 ' HA ' HD12 ' A' ' 18' ' ' ILE . 68.0 m -69.17 -6.76 30.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.878 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 74.2 m -62.67 -35.43 79.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.927 0.394 . . . . 0.0 110.287 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.2 -24.32 65.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.698 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.5 ' N ' HD13 ' A' ' 18' ' ' ILE . 2.7 mp -78.7 -34.23 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.395 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.48 -14.25 0.18 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.311 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 46.3 m -66.35 133.02 49.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.492 0.663 . . . . 0.0 111.414 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.4 m -107.29 135.38 48.89 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.16 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.0 t -73.31 118.86 16.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 0.0 110.723 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -132.16 118.4 19.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 p 49.97 42.2 24.17 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.643 0.735 . . . . 0.0 111.087 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.844 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 74.4 mttt 67.87 20.97 9.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.544 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.627 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.6 t -133.39 126.18 51.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 93.4 m -83.87 124.56 31.1 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.989 0.423 . . . . 0.0 111.661 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.656 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 3.9 m-85 -115.5 154.42 29.36 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.883 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.555 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 48.8 ttp85 -138.16 114.83 10.57 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.8 t30 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.504 -178.164 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.305 0 CA-C-O 120.309 -0.162 . . . . 0.0 113.382 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.1 mt -95.3 123.99 55.05 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 117.014 0.407 . . . . 0.0 110.425 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.682 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.2 Cg_exo -57.22 132.46 51.28 Favored 'Trans proline' 0 CA--C 1.516 -0.411 0 C-N-CA 122.3 2.0 . . . . 0.0 112.063 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 90.0 m -74.3 -6.53 48.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.518 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.74 -28.83 9.38 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.78 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.676 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 94.8 mt-10 -77.38 136.4 38.42 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.593 0.711 . . . . 0.0 110.149 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.5 m -109.45 132.13 54.42 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.659 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 p -103.45 51.36 0.79 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.048 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.52 HG13 ' HD2' ' A' ' 25' ' ' LYS . 40.5 t -65.86 -41.89 90.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.957 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -124.1 -49.5 1.83 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.524 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.7 pt -112.8 150.83 43.39 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.69 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -66.41 147.71 83.12 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.648 2.232 . . . . 0.0 111.636 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.676 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 8.8 m -69.94 149.53 47.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.338 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.9 mm -70.55 -41.57 78.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.149 0.499 . . . . 0.0 110.152 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.471 ' HA ' HD12 ' A' ' 18' ' ' ILE . 70.2 m -70.76 -3.51 19.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.024 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 75.3 m -63.02 -35.84 81.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.926 0.393 . . . . 0.0 110.337 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.64 -22.61 64.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.732 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.471 HD12 ' HA ' ' A' ' 15' ' ' SER . 2.6 mp -79.59 -34.07 15.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.4 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.82 -16.76 0.19 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.18 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 16' ' ' SER . 34.8 m -65.12 131.28 46.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.549 0.69 . . . . 0.0 111.244 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.401 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 2.6 m -104.49 127.19 52.14 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.13 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.7 t -72.37 128.67 36.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.45 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.419 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 12.4 ptpt -158.19 127.58 5.79 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m 58.82 33.77 23.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.115 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.52 ' HD2' HG13 ' A' ' 9' ' ' VAL . 51.6 mtmt 69.57 17.67 7.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.567 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.705 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 17.5 t -135.4 129.41 49.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.043 0.449 . . . . 0.0 110.053 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 84.9 m -86.81 122.88 31.3 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.921 0.391 . . . . 0.0 111.044 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.705 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 3.5 m-85 -114.39 153.37 29.98 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.939 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.465 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 41.6 ttp85 -137.02 114.31 10.84 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.7 t30 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.602 -178.257 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.465 0 N-CA-C 114.178 0.431 . . . . 0.0 114.178 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -94.43 121.95 62.25 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 117.569 0.685 . . . . 0.0 110.883 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 50.3 Cg_exo -56.29 131.42 45.69 Favored 'Trans proline' 0 CA--C 1.518 -0.307 0 C-N-CA 122.523 2.149 . . . . 0.0 112.717 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 70.1 m -71.62 -11.26 60.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.467 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.65 -31.19 8.4 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.063 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -75.45 140.17 42.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.5 0.667 . . . . 0.0 110.322 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 m -106.73 130.47 54.44 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.144 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -96.75 49.29 1.08 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.117 0.484 . . . . 0.0 110.752 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 25' ' ' LYS . 22.0 t -80.29 -59.9 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.405 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -91.83 -36.29 13.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.418 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.416 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.4 tt -149.31 140.96 14.65 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.854 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.416 ' HD2' HG13 ' A' ' 11' ' ' ILE . 37.9 Cg_exo -57.58 147.69 77.66 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.346 2.03 . . . . 0.0 112.0 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.7 m -64.84 148.73 50.78 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.1 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 mm -74.68 -40.16 47.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.354 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.439 ' O ' HG12 ' A' ' 18' ' ' ILE . 55.9 p -70.99 0.87 6.49 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.778 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 16.1 m -60.91 -35.61 77.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.252 0.549 . . . . 0.0 110.614 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.33 -29.71 70.97 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.45 HD12 HG23 ' A' ' 18' ' ' ILE . 38.7 pt -92.42 7.41 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.05 -25.0 2.68 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 119.214 -1.47 . . . . 0.0 114.536 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.778 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 69.9 m -68.25 142.68 55.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.5 0.667 . . . . 0.0 111.842 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 3.4 p -129.86 133.85 47.16 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.963 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 t -70.38 124.08 23.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.866 0.365 . . . . 0.0 111.317 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -148.56 121.28 8.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.857 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.692 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 11.2 m 55.22 47.23 22.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.692 ' HG3' ' O ' ' A' ' 24' ' ' SER . 0.0 OUTLIER 57.9 15.66 3.21 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.206 1.402 . . . . 0.0 112.754 -178.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.6 t -130.55 130.06 64.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.035 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 99.6 m -83.56 128.01 34.19 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 122.08 -0.388 . . . . 0.0 110.681 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 4.2 m-85 -113.98 154.08 28.23 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.95 0.405 . . . . 0.0 110.222 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.762 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 29.8 ttm180 -132.22 103.94 6.5 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.674 -178.353 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 120.447 -0.085 . . . . 0.0 113.257 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.5 mt -94.5 122.19 61.6 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.864 0.332 . . . . 0.0 110.433 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.614 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.2 Cg_exo -55.06 133.05 55.92 Favored 'Trans proline' 0 CA--C 1.519 -0.247 0 C-N-CA 122.478 2.119 . . . . 0.0 112.448 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.672 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 71.0 m -76.64 -2.46 32.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.463 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.17 -31.54 6.26 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 48.5 mt-10 -65.47 141.73 58.39 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.551 0.691 . . . . 0.0 111.07 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -117.57 125.61 51.11 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.603 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.8 p -96.94 45.52 1.05 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.391 0.615 . . . . 0.0 110.864 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.61 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 36.5 t -67.66 -52.94 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.655 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -114.82 -48.08 2.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.256 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 27.5 pt -108.28 143.71 27.97 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.127 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.08 164.31 34.68 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.645 2.23 . . . . 0.0 112.487 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.591 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 1.5 m -58.53 130.01 44.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.34 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.5 tt -86.63 -32.02 6.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.7 m -86.06 21.75 1.91 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.341 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.591 ' OG ' ' HB2' ' A' ' 13' ' ' CYS . 68.9 m -54.41 -36.19 63.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.98 0.419 . . . . 0.0 111.092 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.77 -25.84 67.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.526 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.442 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 5.9 mm -86.92 38.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.145 0.497 . . . . 0.0 110.63 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.05 30.61 74.1 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.775 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 98.8 m -106.72 146.66 30.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.88 0.371 . . . . 0.0 110.359 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.3 t -148.43 141.07 24.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.342 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.3 t -67.64 125.31 25.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.092 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -144.68 115.67 7.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.886 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.6 m 57.13 41.68 26.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.186 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.61 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 1.2 tptt 72.26 7.61 5.73 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.059 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.744 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.2 t -130.44 131.1 65.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 43.2 m -79.34 128.62 33.56 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.744 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 11.5 m-85 -121.43 155.84 34.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.102 0.477 . . . . 0.0 110.812 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.672 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 38.8 ttp180 -131.71 112.83 12.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.2 p30 . . . . . 0 N--CA 1.473 0.691 0 O-C-N 124.145 0.903 . . . . 0.0 111.993 -178.228 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 CA-C-O 120.256 -0.191 . . . . 0.0 113.403 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.2 mm -96.55 124.31 51.23 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 117.15 0.475 . . . . 0.0 110.469 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.645 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.4 Cg_exo -56.54 131.7 47.27 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 122.41 2.073 . . . . 0.0 112.493 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 91.7 m -71.87 -8.47 54.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.338 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.01 -30.85 8.34 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.696 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.64 137.53 40.79 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.682 0.753 . . . . 0.0 110.548 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -110.25 129.47 55.72 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.52 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 p -97.79 47.51 1.01 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.177 0.513 . . . . 0.0 110.254 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 1.03 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 44.1 t -66.92 -52.38 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.071 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -105.45 -49.55 3.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.5 pt -125.69 148.37 61.78 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.72 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.12 150.42 88.68 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.592 2.195 . . . . 0.0 112.738 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.9 m -67.27 150.48 48.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.606 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.4 pt -77.68 -38.38 25.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.618 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.8 m -79.11 12.15 2.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.849 0.357 . . . . 0.0 111.706 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.578 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 52.6 p -66.77 -44.92 80.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.163 0.506 . . . . 0.0 110.745 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.68 -26.19 65.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.547 HG13 HH22 ' A' ' 29' ' ' ARG . 18.8 pt -93.6 10.85 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.2 -31.04 2.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 119.191 -1.48 . . . . 0.0 115.138 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.578 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 56.0 m -68.68 130.73 43.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.805 0.803 . . . . 0.0 111.48 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.426 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 3.7 m -111.39 125.47 53.9 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.182 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 25.9 t -71.24 126.91 30.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.523 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 21' ' ' SER . 12.5 ptpt -157.86 128.92 6.55 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m 58.78 34.62 23.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.052 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 1.03 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 46.9 mmtm 69.68 15.47 8.09 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.82 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.686 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 20.2 t -135.19 130.82 51.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.431 . . . . 0.0 110.351 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 98.1 m -85.48 122.6 29.84 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.852 0.358 . . . . 0.0 110.621 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.686 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 6.0 m-85 -111.95 154.23 25.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.481 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.578 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 52.0 ttm-85 -131.4 111.45 11.84 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.964 -179.409 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.488 0 N-CA-C 113.917 0.327 . . . . 0.0 113.917 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.3 mm -96.36 125.79 46.28 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 117.329 0.565 . . . . 0.0 110.719 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 51.7 Cg_exo -56.9 131.97 48.79 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.428 2.086 . . . . 0.0 112.426 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 59.8 m -70.78 -10.3 59.2 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.483 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.91 -32.64 7.28 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.039 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.651 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 99.2 mt-10 -80.33 139.65 36.5 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.51 0.671 . . . . 0.0 110.207 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 5.4 m -109.75 135.42 50.69 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.892 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -101.77 50.45 0.85 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.447 0.642 . . . . 0.0 109.742 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.524 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 31.2 t -62.66 -50.12 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.727 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -125.4 -41.55 2.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.49 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.432 HG13 ' HD2' ' A' ' 12' ' ' PRO . 10.9 tt -117.21 134.95 23.01 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.294 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HD2' HG13 ' A' ' 11' ' ' ILE . 11.7 Cg_endo -59.16 148.86 83.81 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.629 2.22 . . . . 0.0 112.493 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.651 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 22.4 m -63.83 138.05 58.31 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.526 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.3 pt -77.22 -36.85 24.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.623 ' O ' HG12 ' A' ' 18' ' ' ILE . 19.4 m -83.12 16.75 2.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.946 0.403 . . . . 0.0 111.389 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.878 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 23.6 p -64.94 -27.72 69.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.937 0.398 . . . . 0.0 110.897 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.82 -21.56 29.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 15' ' ' SER . 23.7 pt -76.83 -6.41 8.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.872 0.367 . . . . 0.0 111.126 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.5 33.4 1.32 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.374 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.878 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 83.6 m -99.81 139.87 34.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.971 0.415 . . . . 0.0 110.717 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 21.7 t -119.21 137.5 53.6 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.565 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 51.5 t -73.49 122.04 21.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.943 0.402 . . . . 0.0 110.919 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -142.55 122.04 13.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.12 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m 57.03 36.82 28.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.576 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.524 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 16.0 mttp 68.03 21.21 8.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.588 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 42.5 t -137.73 131.02 42.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 93.0 m -83.56 126.8 33.19 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 122.039 -0.413 . . . . 0.0 110.784 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 3.8 m-85 -115.7 154.88 28.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.084 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.645 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 61.6 ttt-85 -137.59 112.43 8.95 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.6 t30 . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.738 -178.387 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.41 0 CA-C-O 120.145 -0.253 . . . . 0.0 113.649 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.7 mt -95.23 123.86 55.59 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 117.33 0.565 . . . . 0.0 110.683 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.66 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.6 Cg_exo -56.57 131.18 44.13 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 122.363 2.042 . . . . 0.0 112.486 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 57.3 m -72.96 -9.24 58.51 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.367 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.63 -33.08 6.32 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.785 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.436 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 49.9 mt-10 -74.68 140.83 44.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.6 0.714 . . . . 0.0 110.634 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -111.96 129.49 56.17 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.684 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -91.47 52.72 2.13 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.369 0.604 . . . . 0.0 110.202 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.566 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 48.1 t -67.13 -59.52 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.694 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 55.1 m95 -93.91 -51.04 5.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.07 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pp -131.14 161.64 60.5 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.069 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.42 146.24 61.69 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.797 2.331 . . . . 0.0 112.089 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.436 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 11.9 m -66.12 144.53 56.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.283 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -74.82 -27.79 20.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.021 0.439 . . . . 0.0 110.343 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.659 ' O ' HG12 ' A' ' 18' ' ' ILE . 10.1 p -67.46 -11.17 57.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.816 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.592 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 19.3 m -53.26 -32.46 48.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 111.469 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.15 71.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.659 HG12 ' O ' ' A' ' 15' ' ' SER . 27.0 pt -89.74 5.45 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.54 -20.22 4.41 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.656 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 72.4 m -66.17 148.24 52.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.232 0.539 . . . . 0.0 111.05 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 p -143.45 133.06 23.65 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.49 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.9 t -64.32 123.65 19.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.93 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -144.72 115.61 7.82 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.5 m 56.7 38.81 29.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.179 0.514 . . . . 0.0 110.471 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.566 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 5.5 mptp? 70.26 13.27 7.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.092 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.65 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 20.1 t -129.71 129.24 66.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.5 m -83.48 124.83 31.1 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 122.001 -0.437 . . . . 0.0 111.067 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.66 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 6.0 m-85 -114.99 150.57 35.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.997 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.799 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 60.3 ttt180 -129.59 111.78 13.06 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 121.339 0.59 . . . . 0.0 110.139 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.51 0 N-CA-C 114.261 0.464 . . . . 0.0 114.261 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mm -95.43 123.31 56.98 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 117.57 0.685 . . . . 0.0 110.758 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.625 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.6 Cg_exo -57.39 130.11 37.46 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 122.505 2.137 . . . . 0.0 112.655 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.875 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 56.8 m -73.54 -8.26 55.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.273 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.55 -30.76 7.88 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.641 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.662 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 94.5 mt-10 -75.08 138.64 42.26 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.471 0.653 . . . . 0.0 110.037 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -113.55 131.45 56.08 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.784 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.1 p -94.78 45.3 1.11 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.594 0.712 . . . . 0.0 109.865 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.709 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 48.2 t -70.88 -55.0 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.888 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -103.91 -44.89 4.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.015 0.436 . . . . 0.0 110.909 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.542 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.2 tt -133.63 138.98 32.31 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.196 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.542 ' HD2' HG13 ' A' ' 11' ' ' ILE . 9.5 Cg_endo -54.14 146.65 47.98 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.914 2.409 . . . . 0.0 112.744 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.662 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 5.4 m -67.86 144.74 55.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.745 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.9 tt -75.41 -34.98 31.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.154 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.404 ' HA ' HD11 ' A' ' 18' ' ' ILE . 66.3 m -71.16 -3.51 20.48 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.67 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.6 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 74.1 m -60.99 -35.18 76.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.756 0.313 . . . . 0.0 110.52 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.28 -28.54 69.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.176 0.512 . . . . 0.0 110.771 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.404 HD11 ' HA ' ' A' ' 15' ' ' SER . 2.8 mp -72.8 -26.6 23.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.247 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.422 ' HA3' ' NE ' ' A' ' 29' ' ' ARG . . . 148.21 -9.99 1.14 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.053 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.6 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 59.3 m -66.52 133.19 49.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.251 0.548 . . . . 0.0 110.663 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 13.8 m -110.41 136.58 49.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.959 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.9 t -74.47 117.31 16.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.793 0.33 . . . . 0.0 110.644 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.609 ' HD3' ' CE1' ' A' ' 28' ' ' TYR . 13.4 tttt -135.79 117.83 15.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.1 m 57.05 35.55 26.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.346 0.594 . . . . 0.0 109.963 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.709 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 59.1 mttm 68.21 20.41 8.85 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.668 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.576 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.2 t -129.85 125.94 61.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 85.3 m -85.25 122.64 29.72 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.016 0.436 . . . . 0.0 111.701 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.625 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 2.9 m-85 -113.36 151.05 31.77 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.68 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.875 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER -127.3 106.09 8.98 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.5 t30 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.093 -178.599 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.419 0 CA-C-O 120.184 -0.231 . . . . 0.0 113.659 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.2 mt -92.25 121.05 67.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 117.177 0.488 . . . . 0.0 110.667 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.602 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 50.6 Cg_exo -55.98 129.16 33.43 Favored 'Trans proline' 0 CA--C 1.52 -0.222 0 C-N-CA 122.486 2.124 . . . . 0.0 112.782 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.809 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 79.5 m -74.11 -1.98 22.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.496 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.33 -30.92 5.69 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 83.3 mt-10 -61.53 138.29 58.28 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.471 0.653 . . . . 0.0 110.357 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 m -117.48 125.6 51.17 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.592 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.2 p -93.54 46.8 1.21 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.652 0.739 . . . . 0.0 110.322 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.5 t -74.66 -38.96 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.703 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -130.06 -50.63 1.12 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.966 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -103.63 144.07 27.93 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.854 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.86 164.29 36.0 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.641 2.227 . . . . 0.0 112.422 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 16' ' ' SER . 3.5 m -54.79 125.88 21.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.483 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.0 pt -76.88 -38.39 28.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.477 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 10.5 m -90.77 32.9 0.95 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.104 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 2.4 p -60.59 -47.27 86.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.849 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.94 -22.44 66.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.046 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.5 mm -75.94 -26.89 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.584 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.56 -6.77 2.19 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.307 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 15' ' ' SER . 56.5 m -77.08 134.06 38.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.389 0.614 . . . . 0.0 111.275 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.3 m -127.57 136.31 51.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.652 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.7 t -68.81 127.19 32.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.895 0.378 . . . . 0.0 111.601 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -149.91 120.45 7.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.709 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m 58.33 36.7 25.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.854 0.359 . . . . 0.0 110.604 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt 69.4 15.06 8.44 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.404 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.43 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 38.2 t -131.92 130.05 61.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 68.8 m -84.2 124.36 31.09 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 122.151 -0.343 . . . . 0.0 110.762 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.602 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 3.2 m-85 -112.34 153.76 26.75 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.626 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.809 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.6 ttm180 -128.85 108.92 10.83 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 121.381 0.61 . . . . 0.0 109.975 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.436 0 N-CA-C 113.835 0.294 . . . . 0.0 113.835 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.4 mt -94.39 123.53 58.28 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 117.357 0.579 . . . . 0.0 110.699 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.588 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 50.6 Cg_exo -56.12 131.97 49.09 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.431 2.088 . . . . 0.0 112.397 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 74.2 m -71.88 -8.31 53.59 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.75 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.05 -32.53 6.78 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.98 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.629 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 99.7 mt-10 -79.99 140.92 36.4 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.471 0.653 . . . . 0.0 110.011 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.8 m -111.91 135.11 52.97 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.707 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -98.57 51.01 0.99 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.483 0.658 . . . . 0.0 109.719 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.54 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 44.3 t -63.96 -49.69 80.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.639 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -116.23 -48.61 2.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.719 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.92 153.14 50.94 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.64 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -66.71 146.02 77.39 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.557 2.172 . . . . 0.0 111.653 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.629 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 6.2 m -67.81 148.27 51.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.346 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.2 mm -74.0 -37.59 47.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.285 0.564 . . . . 0.0 110.006 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.437 ' HA ' HD12 ' A' ' 18' ' ' ILE . 65.1 p -63.96 -12.37 36.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.061 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.767 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 13.0 m -56.59 -38.37 71.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.665 0.269 . . . . 0.0 111.094 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.34 -24.15 67.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.826 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 15' ' ' SER . 3.2 mp -79.73 -39.59 20.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.4 0.619 . . . . 0.0 110.224 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . 157.68 36.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.534 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.767 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 77.2 m -112.36 142.14 45.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.035 0.445 . . . . 0.0 110.573 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 m -119.53 133.45 55.67 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.013 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.4 t -70.54 121.86 18.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.349 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.1 tttp -140.09 117.14 11.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.241 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m 55.99 39.27 30.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.924 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.54 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 18.1 mttp 70.21 15.56 7.49 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.011 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.613 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.8 t -132.59 128.97 58.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 87.8 m -83.73 128.23 34.38 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.989 -0.445 . . . . 0.0 110.884 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.613 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 5.9 m-85 -117.67 155.49 29.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.248 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.678 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 30.6 ttm180 -135.98 109.12 7.73 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.3 t30 . . . . . 0 C--N 1.327 -0.406 0 CA-C-O 121.507 0.67 . . . . 0.0 109.902 -178.58 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.449 0 N-CA-C 113.885 0.314 . . . . 0.0 113.885 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm -96.51 123.22 55.11 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 117.546 0.673 . . . . 0.0 110.723 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.659 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 50.7 Cg_exo -56.52 132.2 50.37 Favored 'Trans proline' 0 CA--C 1.517 -0.367 0 C-N-CA 122.474 2.116 . . . . 0.0 112.611 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.742 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 60.7 m -73.99 -10.89 60.1 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.272 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.0 -32.71 6.79 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.93 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -73.03 139.53 46.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.525 0.679 . . . . 0.0 110.516 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.5 m -107.48 130.35 54.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.873 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.3 p -100.54 47.84 0.92 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.166 0.508 . . . . 0.0 110.501 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.8 t -73.59 -48.85 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.77 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -101.02 -49.5 4.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.031 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.63 153.36 81.5 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.653 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -66.75 147.3 80.97 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.7 2.266 . . . . 0.0 111.813 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.2 m -66.94 149.28 50.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.512 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.5 mt -72.03 -35.62 54.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.375 0.607 . . . . 0.0 109.836 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.7 p -69.23 -3.25 13.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.477 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 31.3 m -56.5 -39.48 73.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.0 0.428 . . . . 0.0 110.679 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.74 -22.3 64.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.1 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.3 mm -78.71 -28.04 14.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.764 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 151.73 -16.42 0.83 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.836 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 16' ' ' SER . 76.0 m -67.88 139.74 56.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.372 0.606 . . . . 0.0 111.213 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.448 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 6.3 m -122.21 131.46 53.95 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.941 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.1 t -66.53 124.34 22.52 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.22 0.325 . . . . 0.0 110.334 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.448 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.6 mttm -142.64 115.57 8.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.099 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 53.8 m 55.37 38.38 30.23 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.441 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.553 ' NZ ' ' HB2' ' A' ' 25' ' ' LYS . 8.3 mtmp? 74.95 13.89 3.28 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.727 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.639 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.3 t -133.44 128.72 55.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 90.6 m -83.1 125.55 31.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.849 0.357 . . . . 0.0 110.965 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.659 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 5.8 m-85 -115.55 151.37 35.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.819 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.742 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 27.7 ttm180 -130.95 110.41 11.24 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 121.457 0.646 . . . . 0.0 110.089 -178.756 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 114.038 0.375 . . . . 0.0 114.038 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.4 mm -100.46 123.78 45.03 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 117.339 0.569 . . . . 0.0 110.74 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.68 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.3 Cg_exo -55.47 133.38 57.74 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.539 2.16 . . . . 0.0 112.472 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 35.2 m -76.53 -5.79 49.09 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.511 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.11 -32.83 5.83 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.689 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.47 145.15 39.42 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.464 0.65 . . . . 0.0 110.734 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.3 m -119.02 132.57 56.06 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.049 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -89.77 58.08 4.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.639 0.733 . . . . 0.0 109.706 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.649 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 22.5 t -63.72 -48.67 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.319 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -130.7 -40.63 1.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.779 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.6 pt -116.88 155.18 49.48 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.032 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -70.67 145.82 52.9 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.837 2.358 . . . . 0.0 111.755 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.5 m -69.99 147.3 50.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.17 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 15' ' ' SER . 10.6 tp -71.82 -34.73 52.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.965 0.412 . . . . 0.0 110.352 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.5 ' N ' HG23 ' A' ' 14' ' ' ILE . 14.3 m -66.72 -14.83 63.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.251 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.705 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 70.2 m -59.67 -32.79 70.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.717 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.96 -25.47 66.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mp -81.3 -46.7 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.304 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.53 34.05 0.02 OUTLIER Glycine 0 C--N 1.319 -0.414 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.086 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.705 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 72.3 m -108.59 143.31 37.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.12 0.486 . . . . 0.0 110.683 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 12.3 p -121.91 137.26 54.86 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.518 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -71.25 115.16 10.08 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -133.76 115.83 15.01 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.8 m 57.34 37.61 28.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.043 0.449 . . . . 0.0 110.695 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.649 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 14.5 ttmm 71.9 12.07 6.16 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.53 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.695 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 18.1 t -127.94 129.81 69.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 21' ' ' SER . 97.3 m -82.11 124.79 30.17 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 122.051 -0.405 . . . . 0.0 111.062 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.695 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 5.4 m-85 -116.51 151.12 36.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.799 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.541 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 31.7 ttp85 -128.89 118.19 22.27 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.441 ' OD1' ' HG2' ' A' ' 29' ' ' ARG . 5.0 p-10 . . . . . 0 N--CA 1.469 0.504 0 O-C-N 123.954 0.784 . . . . 0.0 111.783 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.396 0 CA-C-O 120.177 -0.235 . . . . 0.0 113.484 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.9 mt -94.2 121.96 62.63 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 117.224 0.512 . . . . 0.0 110.551 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.683 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.3 Cg_exo -56.14 129.9 37.34 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.39 2.06 . . . . 0.0 112.64 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.795 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 76.5 m -74.09 -4.86 38.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.236 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.09 -27.39 8.37 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.494 ' OE1' ' HB2' ' A' ' 15' ' ' SER . 32.3 mt-10 -68.0 138.97 56.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.523 0.677 . . . . 0.0 110.873 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -111.74 125.17 53.7 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.441 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.1 p -98.68 43.79 1.05 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.288 0.566 . . . . 0.0 110.215 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 1.069 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 38.9 t -73.12 -51.18 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.112 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.631 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 3.8 m-90 -97.28 -51.02 4.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.156 0.503 . . . . 0.0 110.902 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.1 pt -130.95 156.12 80.54 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.688 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.35 146.7 81.44 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.642 2.228 . . . . 0.0 111.916 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 6' ' ' GLU . 24.1 m -66.97 146.44 54.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.72 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.41 HD13 HG22 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -75.31 -35.04 32.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.006 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.494 ' HB2' ' OE1' ' A' ' 6' ' ' GLU . 11.1 m -76.38 5.1 7.66 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.436 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 36.1 m -58.8 -41.02 85.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 110.611 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.51 -24.98 67.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.227 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.0 mt -76.18 -25.72 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.951 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.13 -13.71 0.73 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.057 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 56.6 m -71.67 139.03 49.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.362 0.601 . . . . 0.0 111.289 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.472 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 7.7 m -125.0 130.76 53.01 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.729 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.0 t -65.19 120.78 13.36 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.245 0.341 . . . . 0.0 110.395 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.7 mttm -141.44 115.94 9.56 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 47.1 m 56.2 39.59 30.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 111.026 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 1.069 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 46.4 mmtm 71.63 12.43 6.4 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.167 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.635 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.4 t -130.89 128.22 62.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 86.5 m -83.62 122.9 29.2 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.965 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.683 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 4.5 m-85 -111.5 151.09 29.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.907 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.795 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.0 ttm180 -128.45 112.06 13.96 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.393 0.616 . . . . 0.0 110.071 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.36 0 CA-C-O 120.337 -0.146 . . . . 0.0 113.436 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -98.86 128.37 32.62 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 117.114 0.457 . . . . 0.0 110.618 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.672 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 47.9 Cg_exo -58.37 130.89 39.75 Favored 'Trans proline' 0 CA--C 1.517 -0.36 0 C-N-CA 122.312 2.008 . . . . 0.0 112.155 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 52.8 m -73.59 -6.29 45.66 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.69 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.5 -31.84 7.09 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.647 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.617 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 98.8 mt-10 -77.76 138.91 39.27 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.457 0.646 . . . . 0.0 109.839 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 m -117.42 134.78 54.45 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.914 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -96.17 46.35 1.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.229 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.912 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 39.9 t -66.4 -42.53 90.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.84 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -127.35 -46.73 1.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.339 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.7 tp -117.33 136.72 23.55 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.761 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.85 148.62 91.69 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.296 1.997 . . . . 0.0 111.826 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.617 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 4.3 m -69.15 147.08 51.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.951 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.4 mp -77.18 -37.67 26.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.581 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.1 t -68.02 -7.4 28.75 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.364 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.571 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 69.2 m -59.27 -37.72 78.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.755 0.312 . . . . 0.0 110.928 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.21 -25.49 67.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.178 0.513 . . . . 0.0 111.098 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.24 -25.47 16.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.617 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.15 -16.5 0.79 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.874 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 57.5 m -66.18 138.98 58.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.405 0.622 . . . . 0.0 111.489 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 p -121.71 135.21 54.95 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.101 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.7 t -66.43 123.31 19.64 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.984 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -138.17 113.81 9.71 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 m 56.27 38.78 30.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.432 0.634 . . . . 0.0 110.303 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.912 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 72.6 mttt 68.33 20.0 8.81 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.164 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.661 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.6 t -132.08 127.24 57.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 89.0 m -84.94 123.18 30.22 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.109 0.481 . . . . 0.0 111.777 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.672 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 2.9 m-85 -116.05 150.88 36.57 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.816 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.715 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 44.7 ttt-85 -135.34 121.03 19.51 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.324 -178.191 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 113.875 0.31 . . . . 0.0 113.875 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.8 mm -95.63 125.18 50.27 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 117.352 0.576 . . . . 0.0 110.661 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.61 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.9 Cg_exo -57.14 131.24 44.01 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 C-N-CA 122.424 2.082 . . . . 0.0 112.494 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.811 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 69.9 m -72.89 -10.42 59.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.333 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.27 -33.05 6.78 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.867 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -75.07 141.18 43.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.519 0.676 . . . . 0.0 110.251 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 m -116.07 130.55 56.86 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.417 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.25 48.38 1.16 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.041 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.942 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 39.2 t -65.3 -40.82 89.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.545 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -132.82 -47.12 0.87 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.336 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.484 HD13 ' HD2' ' A' ' 12' ' ' PRO . 6.5 tp -110.84 134.91 20.83 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.91 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.484 ' HD2' HD13 ' A' ' 11' ' ' ILE . 20.8 Cg_exo -63.95 147.47 91.93 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.334 2.022 . . . . 0.0 111.643 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.2 m -63.96 145.48 55.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.408 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.485 ' H ' HD11 ' A' ' 14' ' ' ILE . 3.7 mp -75.31 -43.88 42.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.967 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.727 ' O ' HG12 ' A' ' 18' ' ' ILE . 8.3 m -76.32 15.43 0.59 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.064 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.737 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 18.6 p -63.89 -39.01 93.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.233 0.54 . . . . 0.0 110.595 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.99 -28.06 67.39 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.727 HG12 ' O ' ' A' ' 15' ' ' SER . 11.4 pt -78.65 -3.62 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.99 -17.94 3.83 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.006 -1.093 . . . . 0.0 113.36 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.737 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 57.3 m -66.6 131.62 46.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.467 0.651 . . . . 0.0 111.314 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 15.2 m -117.5 137.0 52.84 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.932 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -72.82 120.28 18.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.964 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.613 ' HD3' ' CE1' ' A' ' 28' ' ' TYR . 6.9 tttt -139.53 119.57 13.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.1 m 57.84 35.76 25.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.26 0.552 . . . . 0.0 109.923 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.942 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 73.2 mttt 66.61 23.51 10.32 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.562 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.606 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 24.6 t -134.73 127.23 48.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 94.0 m -83.85 123.1 29.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.983 0.421 . . . . 0.0 111.449 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.613 ' CE1' ' HD3' ' A' ' 23' ' ' LYS . 3.9 m-85 -113.78 152.45 30.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.674 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.811 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 57.8 ttt180 -130.48 110.72 11.67 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.0 m120 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.58 -178.771 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.358 0 CA-C-O 120.32 -0.156 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.3 124.19 50.01 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 117.068 0.434 . . . . 0.0 110.334 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.65 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 50.7 Cg_exo -56.31 132.18 50.3 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.418 2.079 . . . . 0.0 112.491 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.582 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 80.5 m -72.61 -10.46 59.82 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.21 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.03 -32.03 7.57 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.849 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.683 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 97.3 mt-10 -78.25 138.24 38.52 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.592 0.71 . . . . 0.0 110.455 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 m -107.94 134.33 51.01 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.151 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.514 ' O ' ' HD2' ' A' ' 25' ' ' LYS . 1.7 p -101.0 37.88 1.66 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.237 0.542 . . . . 0.0 110.117 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.628 ' HB ' ' CE3' ' A' ' 10' ' ' TRP . 39.5 t -64.35 -52.4 56.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.999 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.628 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 3.8 m-90 -96.71 -55.55 2.86 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.175 0.512 . . . . 0.0 110.434 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 23.4 pt -125.96 156.59 71.41 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.301 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.85 147.31 89.39 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.55 2.167 . . . . 0.0 111.997 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.683 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 27.6 m -65.1 142.35 58.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.701 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.2 pt -77.05 -35.65 23.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.98 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 50.4 m -79.75 12.17 2.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.834 0.349 . . . . 0.0 111.606 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.877 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 19.4 p -60.95 -36.01 78.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.768 0.318 . . . . 0.0 110.964 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.6 -23.25 62.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.473 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 60.9 mt -70.86 -25.8 26.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.652 0.739 . . . . 0.0 110.289 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.95 31.84 0.29 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.661 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.877 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 60.0 m -103.34 137.46 41.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.192 0.52 . . . . 0.0 110.765 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.472 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 11.2 m -119.48 134.09 55.38 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.053 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.1 t -67.74 120.08 13.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.19 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.4 mttm -139.72 115.58 10.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 t 58.35 36.64 25.66 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.36 0.6 . . . . 0.0 109.854 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.514 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 28.6 mmtp 68.49 19.79 8.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.797 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.663 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 22.6 t -132.91 128.05 56.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 90.8 m -83.61 121.87 27.83 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.89 0.376 . . . . 0.0 111.357 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.663 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 5.0 m-85 -112.38 152.58 28.45 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.025 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.582 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 49.4 ttp85 -133.84 113.59 12.42 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 121.301 0.572 . . . . 0.0 109.952 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 N-CA-C 113.808 0.283 . . . . 0.0 113.808 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.29 124.0 52.87 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 117.36 0.58 . . . . 0.0 110.759 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.663 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.6 Cg_exo -57.34 130.67 40.42 Favored 'Trans proline' 0 CA--C 1.516 -0.38 0 C-N-CA 122.415 2.076 . . . . 0.0 112.471 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.763 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 72.6 m -72.94 -9.7 59.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.319 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.28 -32.89 6.64 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.582 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -73.09 140.61 47.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.503 0.668 . . . . 0.0 110.507 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -114.47 130.77 56.75 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.842 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.8 48.78 1.38 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.378 0.608 . . . . 0.0 110.126 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.537 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 45.1 t -64.69 -57.25 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.924 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 59.2 m95 -102.8 -47.82 4.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.091 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.84 158.88 69.06 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.25 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -68.21 147.14 72.03 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.795 2.33 . . . . 0.0 111.997 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.6 m -64.82 151.97 44.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.93 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 14' ' ' ILE . 13.9 tt -75.8 -38.48 37.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.426 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 m -76.6 9.75 2.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.741 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 22.9 p -59.19 -49.25 78.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.896 0.379 . . . . 0.0 110.906 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.7 -22.54 67.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.471 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.8 mt -75.07 -24.52 17.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.614 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.75 -14.99 0.92 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.208 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 36.4 m -74.15 132.6 42.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.461 0.648 . . . . 0.0 111.592 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 14.6 m -115.18 136.63 52.91 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.959 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 51.7 t -70.61 120.16 15.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.836 0.351 . . . . 0.0 110.564 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -139.73 118.52 12.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.966 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.8 m 56.64 36.68 28.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.141 0.495 . . . . 0.0 110.334 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER 69.52 17.63 7.93 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.956 -179.423 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.616 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 24.7 t -132.82 129.44 58.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 89.1 m -83.7 122.27 28.4 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.042 0.449 . . . . 0.0 111.336 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.663 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 4.4 m-85 -112.8 152.21 29.45 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.608 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.763 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 66.2 ttt180 -130.87 111.68 12.32 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.9 m120 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.707 -178.886 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.43 0 N-CA-C 113.882 0.313 . . . . 0.0 113.882 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.5 mm -96.68 126.58 42.63 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 117.307 0.554 . . . . 0.0 110.864 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.606 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.6 Cg_exo -57.33 130.45 39.33 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.403 2.069 . . . . 0.0 112.366 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 34.8 m -72.25 -8.42 54.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.558 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.1 -30.97 8.19 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.189 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -74.59 142.21 44.66 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.511 0.672 . . . . 0.0 110.672 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 m -109.59 128.81 55.48 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.01 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -94.38 48.12 1.22 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.11 0.481 . . . . 0.0 110.713 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.21 -57.3 5.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.493 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -98.64 -37.22 9.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.724 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.555 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.0 tt -146.21 138.96 14.06 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.339 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.555 ' HD2' HG13 ' A' ' 11' ' ' ILE . 8.3 Cg_endo -53.59 144.57 51.81 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.88 2.386 . . . . 0.0 112.779 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.2 m -65.4 147.35 53.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.832 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mm -73.04 -38.76 56.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.115 0.484 . . . . 0.0 110.303 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.545 ' O ' HG12 ' A' ' 18' ' ' ILE . 6.8 m -68.7 -4.55 16.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.227 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.679 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 15.6 m -58.1 -35.33 71.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.105 0.479 . . . . 0.0 110.638 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.69 -32.62 74.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.573 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 15' ' ' SER . 27.1 pt -86.74 5.9 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.78 -18.52 4.55 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 119.634 -1.27 . . . . 0.0 114.538 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.679 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 83.6 m -67.71 139.68 56.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.618 0.709 . . . . 0.0 111.803 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.0 m -125.1 135.38 52.63 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.747 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.3 t -69.74 125.08 25.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.093 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -146.6 119.42 8.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.132 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.606 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 10.8 m 56.85 39.61 29.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.967 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 24' ' ' SER . 8.7 ptpt 70.98 9.19 6.73 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.446 1.098 . . . . 0.0 112.038 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 t -128.39 130.43 69.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.209 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 91.5 m -83.72 127.2 33.61 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 122.189 -0.319 . . . . 0.0 110.738 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.606 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 2.9 m-85 -115.37 153.2 31.44 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.646 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 62.4 ttt-85 -136.09 115.49 12.67 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.724 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.342 0 CA-C-O 120.369 -0.128 . . . . 0.0 113.294 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.4 mm -96.37 125.64 46.83 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 117.026 0.413 . . . . 0.0 110.384 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.649 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.6 Cg_exo -57.15 132.64 52.54 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.353 2.035 . . . . 0.0 112.358 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 72.5 m -72.11 -7.84 51.26 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.562 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.33 -31.38 8.1 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.246 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -79.69 141.04 36.79 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.693 0.759 . . . . 0.0 111.038 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 m -107.74 129.55 55.03 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.0 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -99.92 51.03 0.91 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.56 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.57 -45.53 77.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.803 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -117.57 -48.56 2.59 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.952 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.6 pt -117.85 151.26 48.49 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.837 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.3 146.11 68.15 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.664 2.243 . . . . 0.0 111.661 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 10.0 m -66.55 148.41 51.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.488 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.437 HD13 ' H ' ' A' ' 14' ' ' ILE . 3.3 mp -71.92 -43.11 68.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.298 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.4 p -68.03 -3.13 9.17 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.847 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 18.3 m -57.99 -40.81 81.62 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.708 0.289 . . . . 0.0 110.609 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.02 67.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.607 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.8 mt -76.74 -37.14 27.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.408 0.623 . . . . 0.0 110.284 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . 155.42 33.36 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.704 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.847 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 83.9 m -109.92 138.67 45.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.17 0.509 . . . . 0.0 110.605 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.8 m -118.97 117.74 29.62 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.923 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 32.8 t -62.9 137.79 58.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.848 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -166.83 128.92 1.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.096 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.647 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 9.4 t 57.29 41.9 25.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 24' ' ' SER . 0.9 OUTLIER 62.6 16.06 8.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.777 1.231 . . . . 0.0 112.413 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.665 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.3 t -134.29 130.76 54.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.147 0.498 . . . . 0.0 110.995 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 89.5 m -84.14 128.1 34.34 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.102 178.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.665 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 6.6 m-85 -119.01 153.75 34.18 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.794 0.331 . . . . 0.0 110.173 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.594 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 29.5 ttm180 -134.61 114.8 13.14 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.654 -178.708 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.406 0 CA-C-O 120.174 -0.237 . . . . 0.0 113.678 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.2 mm -96.49 124.46 50.85 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 117.31 0.555 . . . . 0.0 110.585 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.659 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.4 Cg_exo -56.98 130.39 39.54 Favored 'Trans proline' 0 CA--C 1.516 -0.392 0 C-N-CA 122.405 2.07 . . . . 0.0 112.51 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.775 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 76.0 m -73.46 -8.49 56.12 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.4 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.33 -28.44 8.95 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.588 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.702 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 94.4 mt-10 -74.69 137.3 42.05 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.535 0.683 . . . . 0.0 109.957 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.2 m -108.92 131.8 54.67 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.681 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.0 p -99.41 45.02 1.0 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.581 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.611 ' HB ' ' CE3' ' A' ' 10' ' ' TRP . 21.6 t -76.3 -52.1 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.145 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.611 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 5.1 m-90 -93.74 -49.23 5.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.305 0.574 . . . . 0.0 110.935 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.444 HD12 HG21 ' A' ' 11' ' ' ILE . 17.0 pt -136.23 159.41 70.94 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.018 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -63.74 146.88 92.56 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.392 2.062 . . . . 0.0 111.637 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.702 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 36.5 m -66.33 149.86 49.73 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.797 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.448 ' H ' HD11 ' A' ' 14' ' ' ILE . 4.2 mp -72.69 -41.05 62.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.969 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -73.14 5.44 3.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 31.4 m -60.5 -41.66 94.77 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.945 0.402 . . . . 0.0 110.512 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.78 -25.8 67.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.281 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.5 mt -74.91 -25.36 18.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.009 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.18 -8.86 1.09 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.101 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 40.7 m -73.92 136.04 43.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.339 0.59 . . . . 0.0 111.147 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.482 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 5.7 m -118.71 131.09 56.14 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.681 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.1 t -64.91 121.52 14.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.275 0.36 . . . . 0.0 110.227 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.5 mttm -141.08 113.0 7.75 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.563 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 48.8 m 54.31 45.76 26.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.305 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 24' ' ' SER . 1.2 pttm 71.33 4.87 5.23 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.838 1.255 . . . . 0.0 112.518 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.615 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.1 t -125.35 127.91 72.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 120.856 0.36 . . . . 0.0 110.324 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 91.8 m -83.95 120.93 26.7 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.815 0.34 . . . . 0.0 110.827 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.659 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 5.0 m-85 -109.42 151.78 26.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.143 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.775 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.6 ttm180 -130.31 113.65 14.65 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-O 121.317 0.58 . . . . 0.0 110.159 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.401 0 N-CA-C 113.828 0.291 . . . . 0.0 113.828 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.2 mm -95.85 126.9 43.15 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 117.266 0.533 . . . . 0.0 110.709 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.656 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.6 Cg_exo -57.09 132.73 53.24 Favored 'Trans proline' 0 CA--C 1.518 -0.323 0 C-N-CA 122.48 2.12 . . . . 0.0 112.458 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.555 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 74.4 m -74.11 -9.12 58.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.281 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.36 -31.58 7.89 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.637 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.663 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 95.0 mt-10 -76.6 139.64 40.72 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.456 0.646 . . . . 0.0 110.094 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.1 m -114.95 133.55 55.92 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.001 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -97.73 51.22 1.06 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.816 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.844 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 36.8 t -62.84 -40.0 87.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.03 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -128.82 -49.48 1.24 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.088 0.471 . . . . 0.0 110.383 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.23 153.29 46.42 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.408 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -65.78 147.8 85.91 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.559 2.173 . . . . 0.0 111.648 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.663 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 8.3 m -69.44 150.12 47.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.417 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 mm -70.03 -41.41 79.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.274 0.559 . . . . 0.0 109.892 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.486 ' HA ' HD12 ' A' ' 18' ' ' ILE . 68.0 m -69.17 -6.76 30.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.878 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 74.2 m -62.67 -35.43 79.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.927 0.394 . . . . 0.0 110.287 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.2 -24.32 65.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.698 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.5 ' N ' HD13 ' A' ' 18' ' ' ILE . 2.7 mp -78.7 -34.23 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.395 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.48 -14.25 0.18 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.311 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 46.3 m -66.35 133.02 49.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.492 0.663 . . . . 0.0 111.414 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.4 m -107.29 135.38 48.89 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.16 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.0 t -73.31 118.86 16.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 0.0 110.723 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -132.16 118.4 19.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 p 49.97 42.2 24.17 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.643 0.735 . . . . 0.0 111.087 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.844 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 74.4 mttt 67.87 20.97 9.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.544 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.627 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.6 t -133.39 126.18 51.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 93.4 m -83.87 124.56 31.1 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.989 0.423 . . . . 0.0 111.661 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.656 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 3.9 m-85 -115.5 154.42 29.36 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.883 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.555 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 48.8 ttp85 -138.16 114.83 10.57 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.8 t30 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.504 -178.164 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.305 0 CA-C-O 120.309 -0.162 . . . . 0.0 113.382 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.1 mt -95.3 123.99 55.05 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 117.014 0.407 . . . . 0.0 110.425 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.682 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.2 Cg_exo -57.22 132.46 51.28 Favored 'Trans proline' 0 CA--C 1.516 -0.411 0 C-N-CA 122.3 2.0 . . . . 0.0 112.063 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 90.0 m -74.3 -6.53 48.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.518 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.74 -28.83 9.38 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.78 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.676 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 94.8 mt-10 -77.38 136.4 38.42 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.593 0.711 . . . . 0.0 110.149 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.5 m -109.45 132.13 54.42 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.659 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 p -103.45 51.36 0.79 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.048 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.52 HG13 ' HD2' ' A' ' 25' ' ' LYS . 40.5 t -65.86 -41.89 90.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.957 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -124.1 -49.5 1.83 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.524 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.7 pt -112.8 150.83 43.39 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.69 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -66.41 147.71 83.12 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.648 2.232 . . . . 0.0 111.636 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.676 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 8.8 m -69.94 149.53 47.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.338 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.9 mm -70.55 -41.57 78.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.149 0.499 . . . . 0.0 110.152 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.471 ' HA ' HD12 ' A' ' 18' ' ' ILE . 70.2 m -70.76 -3.51 19.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.024 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 75.3 m -63.02 -35.84 81.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.926 0.393 . . . . 0.0 110.337 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.64 -22.61 64.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.732 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.471 HD12 ' HA ' ' A' ' 15' ' ' SER . 2.6 mp -79.59 -34.07 15.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.4 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.82 -16.76 0.19 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.18 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 16' ' ' SER . 34.8 m -65.12 131.28 46.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.549 0.69 . . . . 0.0 111.244 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.401 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 2.6 m -104.49 127.19 52.14 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.13 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.7 t -72.37 128.67 36.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.45 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.419 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 12.4 ptpt -158.19 127.58 5.79 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m 58.82 33.77 23.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.115 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.52 ' HD2' HG13 ' A' ' 9' ' ' VAL . 51.6 mtmt 69.57 17.67 7.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.567 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.705 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 17.5 t -135.4 129.41 49.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.043 0.449 . . . . 0.0 110.053 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 84.9 m -86.81 122.88 31.3 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.921 0.391 . . . . 0.0 111.044 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.705 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 3.5 m-85 -114.39 153.37 29.98 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.939 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.465 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 41.6 ttp85 -137.02 114.31 10.84 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.7 t30 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.602 -178.257 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.465 0 N-CA-C 114.178 0.431 . . . . 0.0 114.178 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -94.43 121.95 62.25 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 117.569 0.685 . . . . 0.0 110.883 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 50.3 Cg_exo -56.29 131.42 45.69 Favored 'Trans proline' 0 CA--C 1.518 -0.307 0 C-N-CA 122.523 2.149 . . . . 0.0 112.717 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 70.1 m -71.62 -11.26 60.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.467 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.65 -31.19 8.4 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.063 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -75.45 140.17 42.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.5 0.667 . . . . 0.0 110.322 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 m -106.73 130.47 54.44 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.144 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -96.75 49.29 1.08 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.117 0.484 . . . . 0.0 110.752 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 25' ' ' LYS . 22.0 t -80.29 -59.9 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.405 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -91.83 -36.29 13.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.418 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.416 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.4 tt -149.31 140.96 14.65 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.854 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.416 ' HD2' HG13 ' A' ' 11' ' ' ILE . 37.9 Cg_exo -57.58 147.69 77.66 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.346 2.03 . . . . 0.0 112.0 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.7 m -64.84 148.73 50.78 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.1 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 mm -74.68 -40.16 47.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.354 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.439 ' O ' HG12 ' A' ' 18' ' ' ILE . 55.9 p -70.99 0.87 6.49 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.778 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 16.1 m -60.91 -35.61 77.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.252 0.549 . . . . 0.0 110.614 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.33 -29.71 70.97 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.45 HD12 HG23 ' A' ' 18' ' ' ILE . 38.7 pt -92.42 7.41 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.05 -25.0 2.68 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 119.214 -1.47 . . . . 0.0 114.536 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.778 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 69.9 m -68.25 142.68 55.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.5 0.667 . . . . 0.0 111.842 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 3.4 p -129.86 133.85 47.16 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.963 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 t -70.38 124.08 23.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.866 0.365 . . . . 0.0 111.317 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -148.56 121.28 8.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.857 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.692 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 11.2 m 55.22 47.23 22.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.692 ' HG3' ' O ' ' A' ' 24' ' ' SER . 0.0 OUTLIER 57.9 15.66 3.21 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.206 1.402 . . . . 0.0 112.754 -178.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.6 t -130.55 130.06 64.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.035 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 99.6 m -83.56 128.01 34.19 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 122.08 -0.388 . . . . 0.0 110.681 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 4.2 m-85 -113.98 154.08 28.23 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.95 0.405 . . . . 0.0 110.222 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.762 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 29.8 ttm180 -132.22 103.94 6.5 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.674 -178.353 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 120.447 -0.085 . . . . 0.0 113.257 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.5 mt -94.5 122.19 61.6 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.864 0.332 . . . . 0.0 110.433 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.614 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.2 Cg_exo -55.06 133.05 55.92 Favored 'Trans proline' 0 CA--C 1.519 -0.247 0 C-N-CA 122.478 2.119 . . . . 0.0 112.448 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.672 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 71.0 m -76.64 -2.46 32.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.463 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.17 -31.54 6.26 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 48.5 mt-10 -65.47 141.73 58.39 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.551 0.691 . . . . 0.0 111.07 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -117.57 125.61 51.11 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.603 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.8 p -96.94 45.52 1.05 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.391 0.615 . . . . 0.0 110.864 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.61 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 36.5 t -67.66 -52.94 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.655 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -114.82 -48.08 2.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.256 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 27.5 pt -108.28 143.71 27.97 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.127 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.08 164.31 34.68 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.645 2.23 . . . . 0.0 112.487 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.591 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 1.5 m -58.53 130.01 44.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.34 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.5 tt -86.63 -32.02 6.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.7 m -86.06 21.75 1.91 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.341 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.591 ' OG ' ' HB2' ' A' ' 13' ' ' CYS . 68.9 m -54.41 -36.19 63.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.98 0.419 . . . . 0.0 111.092 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.77 -25.84 67.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.526 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.442 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 5.9 mm -86.92 38.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.145 0.497 . . . . 0.0 110.63 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.05 30.61 74.1 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.775 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 98.8 m -106.72 146.66 30.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.88 0.371 . . . . 0.0 110.359 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.3 t -148.43 141.07 24.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.342 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.3 t -67.64 125.31 25.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.092 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -144.68 115.67 7.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.886 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.6 m 57.13 41.68 26.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.186 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.61 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 1.2 tptt 72.26 7.61 5.73 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.059 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.744 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.2 t -130.44 131.1 65.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 43.2 m -79.34 128.62 33.56 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.744 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 11.5 m-85 -121.43 155.84 34.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.102 0.477 . . . . 0.0 110.812 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.672 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 38.8 ttp180 -131.71 112.83 12.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.2 p30 . . . . . 0 N--CA 1.473 0.691 0 O-C-N 124.145 0.903 . . . . 0.0 111.993 -178.228 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 CA-C-O 120.256 -0.191 . . . . 0.0 113.403 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.2 mm -96.55 124.31 51.23 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 117.15 0.475 . . . . 0.0 110.469 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.645 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.4 Cg_exo -56.54 131.7 47.27 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 122.41 2.073 . . . . 0.0 112.493 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 91.7 m -71.87 -8.47 54.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.338 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.01 -30.85 8.34 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.696 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.64 137.53 40.79 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.682 0.753 . . . . 0.0 110.548 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -110.25 129.47 55.72 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.52 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 p -97.79 47.51 1.01 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.177 0.513 . . . . 0.0 110.254 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 1.03 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 44.1 t -66.92 -52.38 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.071 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -105.45 -49.55 3.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.5 pt -125.69 148.37 61.78 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.72 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.12 150.42 88.68 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.592 2.195 . . . . 0.0 112.738 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.9 m -67.27 150.48 48.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.606 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.4 pt -77.68 -38.38 25.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.618 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.8 m -79.11 12.15 2.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.849 0.357 . . . . 0.0 111.706 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.578 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 52.6 p -66.77 -44.92 80.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.163 0.506 . . . . 0.0 110.745 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.68 -26.19 65.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.547 HG13 HH22 ' A' ' 29' ' ' ARG . 18.8 pt -93.6 10.85 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.2 -31.04 2.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 119.191 -1.48 . . . . 0.0 115.138 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.578 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 56.0 m -68.68 130.73 43.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.805 0.803 . . . . 0.0 111.48 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.426 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 3.7 m -111.39 125.47 53.9 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.182 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 25.9 t -71.24 126.91 30.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.523 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 21' ' ' SER . 12.5 ptpt -157.86 128.92 6.55 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m 58.78 34.62 23.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.052 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 1.03 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 46.9 mmtm 69.68 15.47 8.09 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.82 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.686 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 20.2 t -135.19 130.82 51.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.431 . . . . 0.0 110.351 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 98.1 m -85.48 122.6 29.84 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.852 0.358 . . . . 0.0 110.621 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.686 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 6.0 m-85 -111.95 154.23 25.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.481 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.578 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 52.0 ttm-85 -131.4 111.45 11.84 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.964 -179.409 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.488 0 N-CA-C 113.917 0.327 . . . . 0.0 113.917 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.3 mm -96.36 125.79 46.28 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 117.329 0.565 . . . . 0.0 110.719 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 51.7 Cg_exo -56.9 131.97 48.79 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.428 2.086 . . . . 0.0 112.426 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.667 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 59.8 m -70.78 -10.3 59.2 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.483 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.91 -32.64 7.28 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.039 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.662 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 99.2 mt-10 -80.33 139.65 36.5 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.51 0.671 . . . . 0.0 110.207 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 5.4 m -109.75 135.42 50.69 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.892 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -101.77 50.45 0.85 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.447 0.642 . . . . 0.0 109.742 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.522 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 31.2 t -62.66 -50.12 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.727 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -125.4 -41.55 2.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.49 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.454 HG13 ' HD2' ' A' ' 12' ' ' PRO . 10.9 tt -117.21 134.95 23.01 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.294 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.454 ' HD2' HG13 ' A' ' 11' ' ' ILE . 11.7 Cg_endo -59.16 148.86 83.81 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.629 2.22 . . . . 0.0 112.493 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.662 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 22.4 m -63.83 138.05 58.31 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.526 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.3 pt -77.22 -36.85 24.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.623 ' O ' HG12 ' A' ' 18' ' ' ILE . 19.4 m -83.12 16.75 2.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.946 0.403 . . . . 0.0 111.389 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.893 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 23.6 p -64.94 -27.72 69.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.937 0.398 . . . . 0.0 110.897 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.82 -21.56 29.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 15' ' ' SER . 23.7 pt -76.83 -6.41 8.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.872 0.367 . . . . 0.0 111.126 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.5 33.4 1.32 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.374 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.893 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 83.6 m -99.81 139.87 34.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.971 0.415 . . . . 0.0 110.717 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 21.7 t -119.21 137.5 53.6 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.565 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 51.5 t -73.49 122.04 21.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.943 0.402 . . . . 0.0 110.919 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -142.55 122.04 13.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.12 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m 57.03 36.82 28.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.576 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 16.0 mttp 68.03 21.21 8.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.588 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 42.5 t -137.73 131.02 42.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 93.0 m -83.56 126.8 33.19 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 122.039 -0.413 . . . . 0.0 110.784 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.683 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 3.8 m-85 -115.7 154.88 28.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.084 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.667 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 61.6 ttt-85 -137.59 112.43 8.95 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.6 t30 . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.738 -178.387 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.41 0 CA-C-O 120.145 -0.253 . . . . 0.0 113.649 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.7 mt -95.23 123.86 55.59 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 117.33 0.565 . . . . 0.0 110.683 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.668 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.6 Cg_exo -56.57 131.18 44.13 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 122.363 2.042 . . . . 0.0 112.486 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.815 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 57.3 m -72.96 -9.24 58.51 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.367 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.63 -33.08 6.32 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.785 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.44 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 49.9 mt-10 -74.68 140.83 44.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.6 0.714 . . . . 0.0 110.634 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -111.96 129.49 56.17 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.684 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -91.47 52.72 2.13 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.369 0.604 . . . . 0.0 110.202 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.611 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 48.1 t -67.13 -59.52 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.694 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 55.1 m95 -93.91 -51.04 5.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.07 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pp -131.14 161.64 60.5 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.069 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.42 146.24 61.69 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.797 2.331 . . . . 0.0 112.089 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 11.9 m -66.12 144.53 56.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.283 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.741 HD13 ' H ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -74.82 -27.79 20.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.021 0.439 . . . . 0.0 110.343 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.68 ' O ' HG12 ' A' ' 18' ' ' ILE . 10.1 p -67.46 -11.17 57.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.816 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.621 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 19.3 m -53.26 -32.46 48.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 111.469 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.15 71.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.68 HG12 ' O ' ' A' ' 15' ' ' SER . 27.0 pt -89.74 5.45 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.54 -20.22 4.41 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.656 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.621 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 72.4 m -66.17 148.24 52.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.232 0.539 . . . . 0.0 111.05 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 p -143.45 133.06 23.65 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.49 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.9 t -64.32 123.65 19.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.93 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -144.72 115.61 7.82 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.5 m 56.7 38.81 29.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.179 0.514 . . . . 0.0 110.471 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.611 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 5.5 mptp? 70.26 13.27 7.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.092 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.652 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 20.1 t -129.71 129.24 66.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.5 m -83.48 124.83 31.1 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 122.001 -0.437 . . . . 0.0 111.067 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.668 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 6.0 m-85 -114.99 150.57 35.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.997 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.815 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 60.3 ttt180 -129.59 111.78 13.06 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 121.339 0.59 . . . . 0.0 110.139 -179.064 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.51 0 N-CA-C 114.261 0.464 . . . . 0.0 114.261 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mm -95.43 123.31 56.98 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 117.57 0.685 . . . . 0.0 110.758 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.673 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 52.6 Cg_exo -57.39 130.11 37.46 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 122.505 2.137 . . . . 0.0 112.655 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.88 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 56.8 m -73.54 -8.26 55.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.273 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.55 -30.76 7.88 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.641 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.684 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 94.5 mt-10 -75.08 138.64 42.26 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.471 0.653 . . . . 0.0 110.037 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -113.55 131.45 56.08 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.784 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.1 p -94.78 45.3 1.11 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.594 0.712 . . . . 0.0 109.865 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.704 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 48.2 t -70.88 -55.0 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.888 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -103.91 -44.89 4.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.015 0.436 . . . . 0.0 110.909 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.551 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.2 tt -133.63 138.98 32.31 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.196 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HD2' HG13 ' A' ' 11' ' ' ILE . 9.5 Cg_endo -54.14 146.65 47.98 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.914 2.409 . . . . 0.0 112.744 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.684 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 5.4 m -67.86 144.74 55.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.745 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.9 tt -75.41 -34.98 31.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.154 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.77 ' HA ' HD13 ' A' ' 18' ' ' ILE . 66.3 m -71.16 -3.51 20.48 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.67 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.611 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 74.1 m -60.99 -35.18 76.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.756 0.313 . . . . 0.0 110.52 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.28 -28.54 69.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.176 0.512 . . . . 0.0 110.771 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.77 HD13 ' HA ' ' A' ' 15' ' ' SER . 2.8 mp -72.8 -26.6 23.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.247 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.424 ' HA3' ' NE ' ' A' ' 29' ' ' ARG . . . 148.21 -9.99 1.14 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.053 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 59.3 m -66.52 133.19 49.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.251 0.548 . . . . 0.0 110.663 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 13.8 m -110.41 136.58 49.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.959 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.9 t -74.47 117.31 16.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.793 0.33 . . . . 0.0 110.644 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.618 ' HD3' ' CE1' ' A' ' 28' ' ' TYR . 13.4 tttt -135.79 117.83 15.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.1 m 57.05 35.55 26.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.346 0.594 . . . . 0.0 109.963 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.704 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 59.1 mttm 68.21 20.41 8.85 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.668 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.576 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.2 t -129.85 125.94 61.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 85.3 m -85.25 122.64 29.72 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.016 0.436 . . . . 0.0 111.701 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 2.9 m-85 -113.36 151.05 31.77 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.68 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.88 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER -127.3 106.09 8.98 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.44 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.5 t30 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.093 -178.599 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.419 0 CA-C-O 120.184 -0.231 . . . . 0.0 113.659 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.2 mt -92.25 121.05 67.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 117.177 0.488 . . . . 0.0 110.667 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.661 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 50.6 Cg_exo -55.98 129.16 33.43 Favored 'Trans proline' 0 CA--C 1.52 -0.222 0 C-N-CA 122.486 2.124 . . . . 0.0 112.782 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.828 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 79.5 m -74.11 -1.98 22.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.496 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.33 -30.92 5.69 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 83.3 mt-10 -61.53 138.29 58.28 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.471 0.653 . . . . 0.0 110.357 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 m -117.48 125.6 51.17 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.592 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.2 p -93.54 46.8 1.21 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.652 0.739 . . . . 0.0 110.322 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.414 HG22 ' HE2' ' A' ' 25' ' ' LYS . 49.5 t -74.66 -38.96 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.703 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -130.06 -50.63 1.12 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.966 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.827 ' H ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -103.63 144.07 27.93 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.854 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.86 164.29 36.0 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.641 2.227 . . . . 0.0 112.422 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 16' ' ' SER . 3.5 m -54.79 125.88 21.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.483 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.0 pt -76.88 -38.39 28.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.496 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 10.5 m -90.77 32.9 0.95 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.104 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.496 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 2.4 p -60.59 -47.27 86.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.849 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.94 -22.44 66.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.046 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.5 mm -75.94 -26.89 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.584 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.56 -6.77 2.19 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.307 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 15' ' ' SER . 56.5 m -77.08 134.06 38.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.389 0.614 . . . . 0.0 111.275 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 18.3 m -127.57 136.31 51.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.652 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.7 t -68.81 127.19 32.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.895 0.378 . . . . 0.0 111.601 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -149.91 120.45 7.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.709 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m 58.33 36.7 25.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.854 0.359 . . . . 0.0 110.604 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HE2' HG22 ' A' ' 9' ' ' VAL . 59.8 mtpt 69.4 15.06 8.44 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.404 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.43 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 38.2 t -131.92 130.05 61.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.565 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 68.8 m -84.2 124.36 31.09 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 122.151 -0.343 . . . . 0.0 110.762 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.661 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 3.2 m-85 -112.34 153.76 26.75 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.626 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.828 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.6 ttm180 -128.85 108.92 10.83 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 121.381 0.61 . . . . 0.0 109.975 -178.79 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.436 0 N-CA-C 113.835 0.294 . . . . 0.0 113.835 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.4 mt -94.39 123.53 58.28 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 117.357 0.579 . . . . 0.0 110.699 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.646 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 50.6 Cg_exo -56.12 131.97 49.09 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.431 2.088 . . . . 0.0 112.397 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 74.2 m -71.88 -8.31 53.59 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.75 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.05 -32.53 6.78 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.98 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.648 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 99.7 mt-10 -79.99 140.92 36.4 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.471 0.653 . . . . 0.0 110.011 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.8 m -111.91 135.11 52.97 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.707 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -98.57 51.01 0.99 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.483 0.658 . . . . 0.0 109.719 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.541 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 44.3 t -63.96 -49.69 80.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.639 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -116.23 -48.61 2.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.719 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.707 ' H ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -117.92 153.14 50.94 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.64 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -66.71 146.02 77.39 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.557 2.172 . . . . 0.0 111.653 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.648 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 6.2 m -67.81 148.27 51.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.346 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.2 mm -74.0 -37.59 47.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.285 0.564 . . . . 0.0 110.006 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.7 ' HA ' HD13 ' A' ' 18' ' ' ILE . 65.1 p -63.96 -12.37 36.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.061 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.772 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 13.0 m -56.59 -38.37 71.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.665 0.269 . . . . 0.0 111.094 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.34 -24.15 67.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.826 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.7 HD13 ' HA ' ' A' ' 15' ' ' SER . 3.2 mp -79.73 -39.59 20.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.4 0.619 . . . . 0.0 110.224 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . 157.68 36.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.534 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.772 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 77.2 m -112.36 142.14 45.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.035 0.445 . . . . 0.0 110.573 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 m -119.53 133.45 55.67 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.013 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.4 t -70.54 121.86 18.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.349 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.1 tttp -140.09 117.14 11.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.241 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m 55.99 39.27 30.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.924 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 18.1 mttp 70.21 15.56 7.49 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.011 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.618 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.8 t -132.59 128.97 58.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 87.8 m -83.73 128.23 34.38 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.989 -0.445 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.646 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 5.9 m-85 -117.67 155.49 29.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.248 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.701 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 30.6 ttm180 -135.98 109.12 7.73 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.3 t30 . . . . . 0 C--N 1.327 -0.406 0 CA-C-O 121.507 0.67 . . . . 0.0 109.902 -178.58 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.449 0 N-CA-C 113.885 0.314 . . . . 0.0 113.885 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm -96.51 123.22 55.11 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 117.546 0.673 . . . . 0.0 110.723 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.668 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 50.7 Cg_exo -56.52 132.2 50.37 Favored 'Trans proline' 0 CA--C 1.517 -0.367 0 C-N-CA 122.474 2.116 . . . . 0.0 112.611 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.761 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 60.7 m -73.99 -10.89 60.1 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.272 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.0 -32.71 6.79 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.93 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -73.03 139.53 46.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.525 0.679 . . . . 0.0 110.516 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.5 m -107.48 130.35 54.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.873 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.3 p -100.54 47.84 0.92 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.166 0.508 . . . . 0.0 110.501 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.644 HG22 ' HB3' ' A' ' 25' ' ' LYS . 42.8 t -73.59 -48.85 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.77 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -101.02 -49.5 4.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.031 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.63 153.36 81.5 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.653 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -66.75 147.3 80.97 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.7 2.266 . . . . 0.0 111.813 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.2 m -66.94 149.28 50.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.512 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.5 mt -72.03 -35.62 54.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.375 0.607 . . . . 0.0 109.836 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.7 p -69.23 -3.25 13.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.477 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 31.3 m -56.5 -39.48 73.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.0 0.428 . . . . 0.0 110.679 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.74 -22.3 64.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.1 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.3 mm -78.71 -28.04 14.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.764 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 151.73 -16.42 0.83 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.836 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 16' ' ' SER . 76.0 m -67.88 139.74 56.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.372 0.606 . . . . 0.0 111.213 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.465 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 6.3 m -122.21 131.46 53.95 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.941 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.1 t -66.53 124.34 22.52 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.22 0.325 . . . . 0.0 110.334 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.465 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.6 mttm -142.64 115.57 8.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.099 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 53.8 m 55.37 38.38 30.23 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.441 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.644 ' HB3' HG22 ' A' ' 9' ' ' VAL . 8.3 mtmp? 74.95 13.89 3.28 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.727 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.644 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.3 t -133.44 128.72 55.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 90.6 m -83.1 125.55 31.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.849 0.357 . . . . 0.0 110.965 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.668 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 5.8 m-85 -115.55 151.37 35.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.819 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.761 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 27.7 ttm180 -130.95 110.41 11.24 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 121.457 0.646 . . . . 0.0 110.089 -178.756 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 114.038 0.375 . . . . 0.0 114.038 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.4 mm -100.46 123.78 45.03 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 117.339 0.569 . . . . 0.0 110.74 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.687 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.3 Cg_exo -55.47 133.38 57.74 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.539 2.16 . . . . 0.0 112.472 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 35.2 m -76.53 -5.79 49.09 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.511 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.11 -32.83 5.83 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.689 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.504 ' OE2' HG22 ' A' ' 14' ' ' ILE . 48.5 mt-10 -76.47 145.15 39.42 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.464 0.65 . . . . 0.0 110.734 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.3 m -119.02 132.57 56.06 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.049 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -89.77 58.08 4.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.639 0.733 . . . . 0.0 109.706 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.637 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 22.5 t -63.72 -48.67 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.319 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -130.7 -40.63 1.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.779 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 26.6 pt -116.88 155.18 49.48 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.032 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 11' ' ' ILE . 8.0 Cg_exo -70.67 145.82 52.9 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.837 2.358 . . . . 0.0 111.755 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.5 m -69.99 147.3 50.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.17 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.504 HG22 ' OE2' ' A' ' 6' ' ' GLU . 10.6 tp -71.82 -34.73 52.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.965 0.412 . . . . 0.0 110.352 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.667 ' HA ' HD13 ' A' ' 18' ' ' ILE . 14.3 m -66.72 -14.83 63.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.251 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.714 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 70.2 m -59.67 -32.79 70.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.717 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.96 -25.47 66.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.667 HD13 ' HA ' ' A' ' 15' ' ' SER . 3.2 mp -81.3 -46.7 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.304 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.53 34.05 0.02 OUTLIER Glycine 0 C--N 1.319 -0.414 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.086 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.714 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 72.3 m -108.59 143.31 37.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.12 0.486 . . . . 0.0 110.683 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 12.3 p -121.91 137.26 54.86 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.518 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -71.25 115.16 10.08 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -133.76 115.83 15.01 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.8 m 57.34 37.61 28.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.043 0.449 . . . . 0.0 110.695 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.637 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 14.5 ttmm 71.9 12.07 6.16 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.53 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.699 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 18.1 t -127.94 129.81 69.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 97.3 m -82.11 124.79 30.17 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 122.051 -0.405 . . . . 0.0 111.062 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.699 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 5.4 m-85 -116.51 151.12 36.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.799 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.563 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 31.7 ttp85 -128.89 118.19 22.27 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.45 ' OD1' ' HG2' ' A' ' 29' ' ' ARG . 5.0 p-10 . . . . . 0 N--CA 1.469 0.504 0 O-C-N 123.954 0.784 . . . . 0.0 111.783 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.396 0 CA-C-O 120.177 -0.235 . . . . 0.0 113.484 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.9 mt -94.2 121.96 62.63 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 117.224 0.512 . . . . 0.0 110.551 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.694 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.3 Cg_exo -56.14 129.9 37.34 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.39 2.06 . . . . 0.0 112.64 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.812 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 76.5 m -74.09 -4.86 38.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.236 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.09 -27.39 8.37 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.487 ' OE1' ' HB2' ' A' ' 15' ' ' SER . 32.3 mt-10 -68.0 138.97 56.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.523 0.677 . . . . 0.0 110.873 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -111.74 125.17 53.7 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.441 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.1 p -98.68 43.79 1.05 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.288 0.566 . . . . 0.0 110.215 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.059 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 38.9 t -73.12 -51.18 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.112 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.642 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 3.8 m-90 -97.28 -51.02 4.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.156 0.503 . . . . 0.0 110.902 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.1 pt -130.95 156.12 80.54 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.688 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.35 146.7 81.44 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.642 2.228 . . . . 0.0 111.916 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 6' ' ' GLU . 24.1 m -66.97 146.44 54.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.72 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.817 HD13 ' H ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -75.31 -35.04 32.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.006 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.487 ' HB2' ' OE1' ' A' ' 6' ' ' GLU . 11.1 m -76.38 5.1 7.66 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.447 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 36.1 m -58.8 -41.02 85.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 110.611 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.51 -24.98 67.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.227 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.0 mt -76.18 -25.72 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.951 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.13 -13.71 0.73 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.057 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 56.6 m -71.67 139.03 49.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.362 0.601 . . . . 0.0 111.289 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.491 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 7.7 m -125.0 130.76 53.01 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.729 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.0 t -65.19 120.78 13.36 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.245 0.341 . . . . 0.0 110.395 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.7 mttm -141.44 115.94 9.56 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.1 m 56.2 39.59 30.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 111.026 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 1.059 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 46.4 mmtm 71.63 12.43 6.4 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.167 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.637 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.4 t -130.89 128.22 62.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 86.5 m -83.62 122.9 29.2 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.965 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.694 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 4.5 m-85 -111.5 151.09 29.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.907 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.812 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.0 ttm180 -128.45 112.06 13.96 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.393 0.616 . . . . 0.0 110.071 -179.06 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.36 0 CA-C-O 120.337 -0.146 . . . . 0.0 113.436 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -98.86 128.37 32.62 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 117.114 0.457 . . . . 0.0 110.618 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.68 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 47.9 Cg_exo -58.37 130.89 39.75 Favored 'Trans proline' 0 CA--C 1.517 -0.36 0 C-N-CA 122.312 2.008 . . . . 0.0 112.155 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.734 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 52.8 m -73.59 -6.29 45.66 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.69 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.5 -31.84 7.09 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.647 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.637 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 98.8 mt-10 -77.76 138.91 39.27 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.457 0.646 . . . . 0.0 109.839 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 m -117.42 134.78 54.45 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.914 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -96.17 46.35 1.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.229 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.925 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 39.9 t -66.4 -42.53 90.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.84 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -127.35 -46.73 1.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.339 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.7 tp -117.33 136.72 23.55 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.761 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.85 148.62 91.69 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.296 1.997 . . . . 0.0 111.826 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.637 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 4.3 m -69.15 147.08 51.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.951 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.428 ' H ' HD12 ' A' ' 14' ' ' ILE . 4.4 mp -77.18 -37.67 26.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.581 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.84 ' HA ' HD13 ' A' ' 18' ' ' ILE . 5.1 t -68.02 -7.4 28.75 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.364 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.579 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 69.2 m -59.27 -37.72 78.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.755 0.312 . . . . 0.0 110.928 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.21 -25.49 67.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.178 0.513 . . . . 0.0 111.098 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.84 HD13 ' HA ' ' A' ' 15' ' ' SER . 2.9 mp -76.24 -25.47 16.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.617 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.15 -16.5 0.79 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.874 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.579 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 57.5 m -66.18 138.98 58.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.405 0.622 . . . . 0.0 111.489 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 p -121.71 135.21 54.95 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.101 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.7 t -66.43 123.31 19.64 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.984 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -138.17 113.81 9.71 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 m 56.27 38.78 30.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.432 0.634 . . . . 0.0 110.303 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.925 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 72.6 mttt 68.33 20.0 8.81 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.164 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.667 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.6 t -132.08 127.24 57.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 89.0 m -84.94 123.18 30.22 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.109 0.481 . . . . 0.0 111.777 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.68 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 2.9 m-85 -116.05 150.88 36.57 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.816 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.734 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 44.7 ttt-85 -135.34 121.03 19.51 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.324 -178.191 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 113.875 0.31 . . . . 0.0 113.875 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.8 mm -95.63 125.18 50.27 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 117.352 0.576 . . . . 0.0 110.661 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 52.9 Cg_exo -57.14 131.24 44.01 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 C-N-CA 122.424 2.082 . . . . 0.0 112.494 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.83 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 69.9 m -72.89 -10.42 59.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.333 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.27 -33.05 6.78 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.867 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -75.07 141.18 43.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.519 0.676 . . . . 0.0 110.251 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 m -116.07 130.55 56.86 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.417 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.25 48.38 1.16 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.041 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.933 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 39.2 t -65.3 -40.82 89.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.545 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -132.82 -47.12 0.87 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.336 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.5 tp -110.84 134.91 20.83 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.91 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -63.95 147.47 91.93 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.334 2.022 . . . . 0.0 111.643 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.2 m -63.96 145.48 55.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.408 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mp -75.31 -43.88 42.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.967 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.74 ' O ' HG12 ' A' ' 18' ' ' ILE . 8.3 m -76.32 15.43 0.59 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.064 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.759 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 18.6 p -63.89 -39.01 93.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.233 0.54 . . . . 0.0 110.595 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.99 -28.06 67.39 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 15' ' ' SER . 11.4 pt -78.65 -3.62 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.99 -17.94 3.83 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.006 -1.093 . . . . 0.0 113.36 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.759 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 57.3 m -66.6 131.62 46.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.467 0.651 . . . . 0.0 111.314 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 15.2 m -117.5 137.0 52.84 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.932 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -72.82 120.28 18.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.964 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.625 ' HD3' ' CE1' ' A' ' 28' ' ' TYR . 6.9 tttt -139.53 119.57 13.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.1 m 57.84 35.76 25.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.26 0.552 . . . . 0.0 109.923 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.933 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 73.2 mttt 66.61 23.51 10.32 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.562 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.606 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 24.6 t -134.73 127.23 48.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.544 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 94.0 m -83.85 123.1 29.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.983 0.421 . . . . 0.0 111.449 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.669 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 3.9 m-85 -113.78 152.45 30.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.674 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.83 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 57.8 ttt180 -130.48 110.72 11.67 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.58 -178.771 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.358 0 CA-C-O 120.32 -0.156 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.3 124.19 50.01 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 117.068 0.434 . . . . 0.0 110.334 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.652 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 50.7 Cg_exo -56.31 132.18 50.3 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.418 2.079 . . . . 0.0 112.491 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 80.5 m -72.61 -10.46 59.82 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.21 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.03 -32.03 7.57 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.849 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.694 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 97.3 mt-10 -78.25 138.24 38.52 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.592 0.71 . . . . 0.0 110.455 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 m -107.94 134.33 51.01 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.151 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.532 ' O ' ' HD2' ' A' ' 25' ' ' LYS . 1.7 p -101.0 37.88 1.66 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.237 0.542 . . . . 0.0 110.117 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.637 ' HB ' ' CE3' ' A' ' 10' ' ' TRP . 39.5 t -64.35 -52.4 56.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.999 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.637 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 3.8 m-90 -96.71 -55.55 2.86 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.175 0.512 . . . . 0.0 110.434 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 23.4 pt -125.96 156.59 71.41 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.301 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.85 147.31 89.39 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.55 2.167 . . . . 0.0 111.997 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.694 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 27.6 m -65.1 142.35 58.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.701 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.2 pt -77.05 -35.65 23.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.98 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.49 ' HB3' HD12 ' A' ' 18' ' ' ILE . 50.4 m -79.75 12.17 2.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.834 0.349 . . . . 0.0 111.606 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.887 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 19.4 p -60.95 -36.01 78.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.768 0.318 . . . . 0.0 110.964 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.6 -23.25 62.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.473 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 15' ' ' SER . 60.9 mt -70.86 -25.8 26.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.652 0.739 . . . . 0.0 110.289 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.95 31.84 0.29 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.661 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.887 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 60.0 m -103.34 137.46 41.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.192 0.52 . . . . 0.0 110.765 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.487 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 11.2 m -119.48 134.09 55.38 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.053 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.1 t -67.74 120.08 13.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.19 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.4 mttm -139.72 115.58 10.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 t 58.35 36.64 25.66 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.36 0.6 . . . . 0.0 109.854 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.532 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 28.6 mmtp 68.49 19.79 8.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.797 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.666 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 22.6 t -132.91 128.05 56.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 90.8 m -83.61 121.87 27.83 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.89 0.376 . . . . 0.0 111.357 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.666 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 5.0 m-85 -112.38 152.58 28.45 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.025 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.603 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 49.4 ttp85 -133.84 113.59 12.42 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 121.301 0.572 . . . . 0.0 109.952 -179.147 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 N-CA-C 113.808 0.283 . . . . 0.0 113.808 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.29 124.0 52.87 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 117.36 0.58 . . . . 0.0 110.759 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.673 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.6 Cg_exo -57.34 130.67 40.42 Favored 'Trans proline' 0 CA--C 1.516 -0.38 0 C-N-CA 122.415 2.076 . . . . 0.0 112.471 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.784 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 72.6 m -72.94 -9.7 59.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.319 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.28 -32.89 6.64 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.582 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -73.09 140.61 47.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.503 0.668 . . . . 0.0 110.507 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -114.47 130.77 56.75 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.842 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.8 48.78 1.38 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.378 0.608 . . . . 0.0 110.126 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.585 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 45.1 t -64.69 -57.25 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.924 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 59.2 m95 -102.8 -47.82 4.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.091 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.84 158.88 69.06 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.25 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -68.21 147.14 72.03 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.795 2.33 . . . . 0.0 111.997 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.6 m -64.82 151.97 44.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.93 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 13.9 tt -75.8 -38.48 37.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.426 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 m -76.6 9.75 2.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.741 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 22.9 p -59.19 -49.25 78.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.896 0.379 . . . . 0.0 110.906 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.7 -22.54 67.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.471 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.8 mt -75.07 -24.52 17.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.614 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.75 -14.99 0.92 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.208 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 36.4 m -74.15 132.6 42.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.461 0.648 . . . . 0.0 111.592 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 14.6 m -115.18 136.63 52.91 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.959 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 51.7 t -70.61 120.16 15.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.836 0.351 . . . . 0.0 110.564 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -139.73 118.52 12.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.966 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.8 m 56.64 36.68 28.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.141 0.495 . . . . 0.0 110.334 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.585 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER 69.52 17.63 7.93 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.956 -179.423 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.618 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 24.7 t -132.82 129.44 58.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 89.1 m -83.7 122.27 28.4 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.042 0.449 . . . . 0.0 111.336 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.673 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 4.4 m-85 -112.8 152.21 29.45 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.608 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.784 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 66.2 ttt180 -130.87 111.68 12.32 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.707 -178.886 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.43 0 N-CA-C 113.882 0.313 . . . . 0.0 113.882 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.5 mm -96.68 126.58 42.63 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 117.307 0.554 . . . . 0.0 110.864 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.654 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 51.6 Cg_exo -57.33 130.45 39.33 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.403 2.069 . . . . 0.0 112.366 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.666 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 34.8 m -72.25 -8.42 54.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.558 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.1 -30.97 8.19 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.189 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -74.59 142.21 44.66 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.511 0.672 . . . . 0.0 110.672 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 m -109.59 128.81 55.48 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.01 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -94.38 48.12 1.22 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.11 0.481 . . . . 0.0 110.713 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.21 -57.3 5.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.493 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -98.64 -37.22 9.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.724 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.573 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.0 tt -146.21 138.96 14.06 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.339 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HD2' HG13 ' A' ' 11' ' ' ILE . 8.3 Cg_endo -53.59 144.57 51.81 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.88 2.386 . . . . 0.0 112.779 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.2 m -65.4 147.35 53.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.832 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mm -73.04 -38.76 56.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.115 0.484 . . . . 0.0 110.303 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.567 ' O ' HG12 ' A' ' 18' ' ' ILE . 6.8 m -68.7 -4.55 16.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.227 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.696 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 15.6 m -58.1 -35.33 71.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.105 0.479 . . . . 0.0 110.638 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.69 -32.62 74.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.573 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.567 HG12 ' O ' ' A' ' 15' ' ' SER . 27.1 pt -86.74 5.9 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.78 -18.52 4.55 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 119.634 -1.27 . . . . 0.0 114.538 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.696 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 83.6 m -67.71 139.68 56.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.618 0.709 . . . . 0.0 111.803 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.0 m -125.1 135.38 52.63 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.747 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.3 t -69.74 125.08 25.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.093 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -146.6 119.42 8.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.132 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.608 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 10.8 m 56.85 39.61 29.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.967 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 24' ' ' SER . 8.7 ptpt 70.98 9.19 6.73 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.446 1.098 . . . . 0.0 112.038 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 t -128.39 130.43 69.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.209 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 91.5 m -83.72 127.2 33.61 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 122.189 -0.319 . . . . 0.0 110.738 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 2.9 m-85 -115.37 153.2 31.44 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.666 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 62.4 ttt-85 -136.09 115.49 12.67 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.724 -178.771 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.342 0 CA-C-O 120.369 -0.128 . . . . 0.0 113.294 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.4 mm -96.37 125.64 46.83 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 117.026 0.413 . . . . 0.0 110.384 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.654 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.6 Cg_exo -57.15 132.64 52.54 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.353 2.035 . . . . 0.0 112.358 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 72.5 m -72.11 -7.84 51.26 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.562 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.33 -31.38 8.1 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.246 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -79.69 141.04 36.79 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.693 0.759 . . . . 0.0 111.038 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 m -107.74 129.55 55.03 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.0 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -99.92 51.03 0.91 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.56 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.57 -45.53 77.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.803 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -117.57 -48.56 2.59 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.952 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.6 pt -117.85 151.26 48.49 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.837 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.3 146.11 68.15 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.664 2.243 . . . . 0.0 111.661 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 10.0 m -66.55 148.41 51.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.488 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -71.92 -43.11 68.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.298 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.4 p -68.03 -3.13 9.17 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.866 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 18.3 m -57.99 -40.81 81.62 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.708 0.289 . . . . 0.0 110.609 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.02 67.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.607 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.8 mt -76.74 -37.14 27.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.408 0.623 . . . . 0.0 110.284 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . 155.42 33.36 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.704 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.866 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 83.9 m -109.92 138.67 45.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.17 0.509 . . . . 0.0 110.605 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.8 m -118.97 117.74 29.62 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.923 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 32.8 t -62.9 137.79 58.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.848 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -166.83 128.92 1.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.096 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.64 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 9.4 t 57.29 41.9 25.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 24' ' ' SER . 0.9 OUTLIER 62.6 16.06 8.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.777 1.231 . . . . 0.0 112.413 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.662 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.3 t -134.29 130.76 54.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.147 0.498 . . . . 0.0 110.995 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 89.5 m -84.14 128.1 34.34 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.102 178.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.662 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 6.6 m-85 -119.01 153.75 34.18 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.794 0.331 . . . . 0.0 110.173 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.615 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 29.5 ttm180 -134.61 114.8 13.14 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.654 -178.708 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.406 0 CA-C-O 120.174 -0.237 . . . . 0.0 113.678 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.2 mm -96.49 124.46 50.85 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 117.31 0.555 . . . . 0.0 110.585 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.67 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.4 Cg_exo -56.98 130.39 39.54 Favored 'Trans proline' 0 CA--C 1.516 -0.392 0 C-N-CA 122.405 2.07 . . . . 0.0 112.51 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.795 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 76.0 m -73.46 -8.49 56.12 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.4 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.33 -28.44 8.95 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.588 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.714 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 94.4 mt-10 -74.69 137.3 42.05 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.535 0.683 . . . . 0.0 109.957 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.2 m -108.92 131.8 54.67 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.681 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.0 p -99.41 45.02 1.0 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.581 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.621 ' HB ' ' CE3' ' A' ' 10' ' ' TRP . 21.6 t -76.3 -52.1 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.145 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.621 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 5.1 m-90 -93.74 -49.23 5.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.305 0.574 . . . . 0.0 110.935 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.0 pt -136.23 159.41 70.94 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.018 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -63.74 146.88 92.56 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.392 2.062 . . . . 0.0 111.637 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.714 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 36.5 m -66.33 149.86 49.73 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.797 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.453 ' H ' HD12 ' A' ' 14' ' ' ILE . 4.2 mp -72.69 -41.05 62.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.969 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -73.14 5.44 3.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 31.4 m -60.5 -41.66 94.77 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.945 0.402 . . . . 0.0 110.512 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.78 -25.8 67.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.281 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.5 mt -74.91 -25.36 18.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.009 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.18 -8.86 1.09 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.101 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 40.7 m -73.92 136.04 43.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.339 0.59 . . . . 0.0 111.147 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.497 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 5.7 m -118.71 131.09 56.14 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.681 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.1 t -64.91 121.52 14.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.275 0.36 . . . . 0.0 110.227 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.5 mttm -141.08 113.0 7.75 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.548 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 48.8 m 54.31 45.76 26.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.305 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 24' ' ' SER . 1.2 pttm 71.33 4.87 5.23 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.838 1.255 . . . . 0.0 112.518 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.62 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.1 t -125.35 127.91 72.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 120.856 0.36 . . . . 0.0 110.324 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 91.8 m -83.95 120.93 26.7 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.815 0.34 . . . . 0.0 110.827 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.67 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 5.0 m-85 -109.42 151.78 26.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.143 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.795 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.6 ttm180 -130.31 113.65 14.65 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 . . . . . 0 C--N 1.328 -0.36 0 CA-C-O 121.317 0.58 . . . . 0.0 110.159 -179.149 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.401 0 N-CA-C 113.828 0.291 . . . . 0.0 113.828 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 51.2 mm -95.85 126.9 43.15 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 117.266 0.533 . . . . 0.0 110.709 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.662 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.6 Cg_exo -57.09 132.73 53.24 Favored 'Trans proline' 0 CA--C 1.518 -0.323 0 C-N-CA 122.48 2.12 . . . . 0.0 112.458 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 74.4 m -74.11 -9.12 58.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.281 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.36 -31.58 7.89 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.637 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.684 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 95.0 mt-10 -76.6 139.64 40.72 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.456 0.646 . . . . 0.0 110.094 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.1 m -114.95 133.55 55.92 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.001 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -97.73 51.22 1.06 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.816 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.851 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 36.8 t -62.84 -40.0 87.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.03 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -128.82 -49.48 1.24 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.088 0.471 . . . . 0.0 110.383 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.744 ' H ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -114.23 153.29 46.42 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.408 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -65.78 147.8 85.91 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.559 2.173 . . . . 0.0 111.648 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.684 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 8.3 m -69.44 150.12 47.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.417 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 mm -70.03 -41.41 79.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.274 0.559 . . . . 0.0 109.892 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.801 ' HA ' HD13 ' A' ' 18' ' ' ILE . 68.0 m -69.17 -6.76 30.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.878 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 74.2 m -62.67 -35.43 79.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.927 0.394 . . . . 0.0 110.287 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.2 -24.32 65.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.698 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.801 HD13 ' HA ' ' A' ' 15' ' ' SER . 2.7 mp -78.7 -34.23 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.395 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.48 -14.25 0.18 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.311 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 46.3 m -66.35 133.02 49.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.492 0.663 . . . . 0.0 111.414 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 13.4 m -107.29 135.38 48.89 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.16 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.0 t -73.31 118.86 16.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 0.0 110.723 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -132.16 118.4 19.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 p 49.97 42.2 24.17 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.643 0.735 . . . . 0.0 111.087 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.851 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 74.4 mttt 67.87 20.97 9.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.544 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.624 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.6 t -133.39 126.18 51.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 93.4 m -83.87 124.56 31.1 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.989 0.423 . . . . 0.0 111.661 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.662 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 3.9 m-85 -115.5 154.42 29.36 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.883 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.577 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 48.8 ttp85 -138.16 114.83 10.57 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.8 t30 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.504 -178.164 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.305 0 CA-C-O 120.309 -0.162 . . . . 0.0 113.382 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.1 mt -95.3 123.99 55.05 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 117.014 0.407 . . . . 0.0 110.425 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.686 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.2 Cg_exo -57.22 132.46 51.28 Favored 'Trans proline' 0 CA--C 1.516 -0.411 0 C-N-CA 122.3 2.0 . . . . 0.0 112.063 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 90.0 m -74.3 -6.53 48.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.518 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.74 -28.83 9.38 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.78 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.695 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 94.8 mt-10 -77.38 136.4 38.42 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.593 0.711 . . . . 0.0 110.149 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.5 m -109.45 132.13 54.42 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.659 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 3.6 p -103.45 51.36 0.79 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.048 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.61 HG13 ' HD2' ' A' ' 25' ' ' LYS . 40.5 t -65.86 -41.89 90.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.957 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -124.1 -49.5 1.83 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.524 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 27.7 pt -112.8 150.83 43.39 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.69 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -66.41 147.71 83.12 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.648 2.232 . . . . 0.0 111.636 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.695 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 8.8 m -69.94 149.53 47.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.338 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.9 mm -70.55 -41.57 78.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.149 0.499 . . . . 0.0 110.152 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.802 ' HA ' HD13 ' A' ' 18' ' ' ILE . 70.2 m -70.76 -3.51 19.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.024 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 75.3 m -63.02 -35.84 81.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.926 0.393 . . . . 0.0 110.337 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.64 -22.61 64.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.732 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.802 HD13 ' HA ' ' A' ' 15' ' ' SER . 2.6 mp -79.59 -34.07 15.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.4 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.82 -16.76 0.19 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.18 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 34.8 m -65.12 131.28 46.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.549 0.69 . . . . 0.0 111.244 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.43 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 2.6 m -104.49 127.19 52.14 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.13 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.7 t -72.37 128.67 36.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.45 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 23' ' ' LYS . 12.4 ptpt -158.19 127.58 5.79 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m 58.82 33.77 23.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.115 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.61 ' HD2' HG13 ' A' ' 9' ' ' VAL . 51.6 mtmt 69.57 17.67 7.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.567 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.703 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 17.5 t -135.4 129.41 49.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.043 0.449 . . . . 0.0 110.053 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 84.9 m -86.81 122.88 31.3 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.921 0.391 . . . . 0.0 111.044 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.703 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 3.5 m-85 -114.39 153.37 29.98 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.939 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.487 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 41.6 ttp85 -137.02 114.31 10.84 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.7 t30 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.602 -178.257 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.465 0 N-CA-C 114.178 0.431 . . . . 0.0 114.178 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -94.43 121.95 62.25 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 117.569 0.685 . . . . 0.0 110.883 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 50.3 Cg_exo -56.29 131.42 45.69 Favored 'Trans proline' 0 CA--C 1.518 -0.307 0 C-N-CA 122.523 2.149 . . . . 0.0 112.717 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.781 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 70.1 m -71.62 -11.26 60.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.467 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.65 -31.19 8.4 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.063 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -75.45 140.17 42.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.5 0.667 . . . . 0.0 110.322 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 m -106.73 130.47 54.44 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.144 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -96.75 49.29 1.08 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.117 0.484 . . . . 0.0 110.752 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.592 HG22 ' HB2' ' A' ' 25' ' ' LYS . 22.0 t -80.29 -59.9 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.405 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -91.83 -36.29 13.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.418 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.463 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.4 tt -149.31 140.96 14.65 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.854 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.463 ' HD2' HG13 ' A' ' 11' ' ' ILE . 37.9 Cg_exo -57.58 147.69 77.66 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.346 2.03 . . . . 0.0 112.0 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.7 m -64.84 148.73 50.78 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.1 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 mm -74.68 -40.16 47.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.354 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 18' ' ' ILE . 55.9 p -70.99 0.87 6.49 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.796 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 16.1 m -60.91 -35.61 77.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.252 0.549 . . . . 0.0 110.614 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.33 -29.71 70.97 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 15' ' ' SER . 38.7 pt -92.42 7.41 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.05 -25.0 2.68 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 119.214 -1.47 . . . . 0.0 114.536 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.796 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 69.9 m -68.25 142.68 55.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.5 0.667 . . . . 0.0 111.842 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 3.4 p -129.86 133.85 47.16 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.963 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 t -70.38 124.08 23.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.866 0.365 . . . . 0.0 111.317 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -148.56 121.28 8.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.857 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.684 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 11.2 m 55.22 47.23 22.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.684 ' HG3' ' O ' ' A' ' 24' ' ' SER . 0.0 OUTLIER 57.9 15.66 3.21 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.206 1.402 . . . . 0.0 112.754 -178.582 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.6 t -130.55 130.06 64.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.035 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 99.6 m -83.56 128.01 34.19 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 122.08 -0.388 . . . . 0.0 110.681 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.669 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 4.2 m-85 -113.98 154.08 28.23 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.95 0.405 . . . . 0.0 110.222 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.781 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 29.8 ttm180 -132.22 103.94 6.5 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.674 -178.353 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 120.447 -0.085 . . . . 0.0 113.257 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.5 mt -94.5 122.19 61.6 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.864 0.332 . . . . 0.0 110.433 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.625 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 52.2 Cg_exo -55.06 133.05 55.92 Favored 'Trans proline' 0 CA--C 1.519 -0.247 0 C-N-CA 122.478 2.119 . . . . 0.0 112.448 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 71.0 m -76.64 -2.46 32.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.463 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.17 -31.54 6.26 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 48.5 mt-10 -65.47 141.73 58.39 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.551 0.691 . . . . 0.0 111.07 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -117.57 125.61 51.11 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.603 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.8 p -96.94 45.52 1.05 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.391 0.615 . . . . 0.0 110.864 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.646 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 36.5 t -67.66 -52.94 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.655 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -114.82 -48.08 2.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.256 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 27.5 pt -108.28 143.71 27.97 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.127 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.08 164.31 34.68 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.645 2.23 . . . . 0.0 112.487 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.602 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 1.5 m -58.53 130.01 44.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.34 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.5 tt -86.63 -32.02 6.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.7 m -86.06 21.75 1.91 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.341 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.602 ' OG ' ' HB2' ' A' ' 13' ' ' CYS . 68.9 m -54.41 -36.19 63.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.98 0.419 . . . . 0.0 111.092 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.77 -25.84 67.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.526 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.464 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 5.9 mm -86.92 38.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.145 0.497 . . . . 0.0 110.63 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.05 30.61 74.1 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.775 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 98.8 m -106.72 146.66 30.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.88 0.371 . . . . 0.0 110.359 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.3 t -148.43 141.07 24.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.342 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.3 t -67.64 125.31 25.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.092 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -144.68 115.67 7.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.886 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.6 m 57.13 41.68 26.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.186 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.646 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 1.2 tptt 72.26 7.61 5.73 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.059 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.745 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.2 t -130.44 131.1 65.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 43.2 m -79.34 128.62 33.56 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.745 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 11.5 m-85 -121.43 155.84 34.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.102 0.477 . . . . 0.0 110.812 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.694 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 38.8 ttp180 -131.71 112.83 12.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.2 p30 . . . . . 0 N--CA 1.473 0.691 0 O-C-N 124.145 0.903 . . . . 0.0 111.993 -178.228 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 CA-C-O 120.256 -0.191 . . . . 0.0 113.403 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.2 mm -96.55 124.31 51.23 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 117.15 0.475 . . . . 0.0 110.469 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.651 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.4 Cg_exo -56.54 131.7 47.27 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 122.41 2.073 . . . . 0.0 112.493 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 91.7 m -71.87 -8.47 54.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.338 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.01 -30.85 8.34 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.696 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.64 137.53 40.79 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.682 0.753 . . . . 0.0 110.548 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -110.25 129.47 55.72 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.52 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 p -97.79 47.51 1.01 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.177 0.513 . . . . 0.0 110.254 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.051 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 44.1 t -66.92 -52.38 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.071 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -105.45 -49.55 3.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.5 pt -125.69 148.37 61.78 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.72 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.12 150.42 88.68 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.592 2.195 . . . . 0.0 112.738 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.9 m -67.27 150.48 48.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.606 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.4 pt -77.68 -38.38 25.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.618 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.416 ' HB3' HD11 ' A' ' 18' ' ' ILE . 13.8 m -79.11 12.15 2.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.849 0.357 . . . . 0.0 111.706 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.594 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 52.6 p -66.77 -44.92 80.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.163 0.506 . . . . 0.0 110.745 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.68 -26.19 65.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.553 HG13 HH22 ' A' ' 29' ' ' ARG . 18.8 pt -93.6 10.85 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.2 -31.04 2.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 119.191 -1.48 . . . . 0.0 115.138 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.594 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 56.0 m -68.68 130.73 43.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.805 0.803 . . . . 0.0 111.48 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.454 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 3.7 m -111.39 125.47 53.9 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.182 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 25.9 t -71.24 126.91 30.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.523 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 21' ' ' SER . 12.5 ptpt -157.86 128.92 6.55 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m 58.78 34.62 23.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.052 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 1.051 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 46.9 mmtm 69.68 15.47 8.09 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.82 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.684 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 20.2 t -135.19 130.82 51.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.431 . . . . 0.0 110.351 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 98.1 m -85.48 122.6 29.84 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.852 0.358 . . . . 0.0 110.621 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.684 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 6.0 m-85 -111.95 154.23 25.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.481 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.6 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 52.0 ttm-85 -131.4 111.45 11.84 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.964 -179.409 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.488 0 N-CA-C 113.917 0.327 . . . . 0.0 113.917 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.3 mm -96.36 125.79 46.28 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 117.329 0.565 . . . . 0.0 110.719 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 51.7 Cg_exo -56.9 131.97 48.79 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.428 2.086 . . . . 0.0 112.426 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.667 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 59.8 m -70.78 -10.3 59.2 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.483 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.91 -32.64 7.28 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.039 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.662 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 99.2 mt-10 -80.33 139.65 36.5 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.51 0.671 . . . . 0.0 110.207 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 5.4 m -109.75 135.42 50.69 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.892 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -101.77 50.45 0.85 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.447 0.642 . . . . 0.0 109.742 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.522 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 31.2 t -62.66 -50.12 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.727 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -125.4 -41.55 2.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.49 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.454 HG13 ' HD2' ' A' ' 12' ' ' PRO . 10.9 tt -117.21 134.95 23.01 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.294 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.454 ' HD2' HG13 ' A' ' 11' ' ' ILE . 11.7 Cg_endo -59.16 148.86 83.81 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.629 2.22 . . . . 0.0 112.493 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.662 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 22.4 m -63.83 138.05 58.31 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.526 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.3 pt -77.22 -36.85 24.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.623 ' O ' HG12 ' A' ' 18' ' ' ILE . 19.4 m -83.12 16.75 2.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.946 0.403 . . . . 0.0 111.389 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.893 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 23.6 p -64.94 -27.72 69.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.937 0.398 . . . . 0.0 110.897 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.82 -21.56 29.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 15' ' ' SER . 23.7 pt -76.83 -6.41 8.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.872 0.367 . . . . 0.0 111.126 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.5 33.4 1.32 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.374 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.893 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 83.6 m -99.81 139.87 34.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.971 0.415 . . . . 0.0 110.717 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 21.7 t -119.21 137.5 53.6 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.565 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 51.5 t -73.49 122.04 21.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.943 0.402 . . . . 0.0 110.919 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -142.55 122.04 13.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.12 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m 57.03 36.82 28.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.576 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 16.0 mttp 68.03 21.21 8.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.588 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 42.5 t -137.73 131.02 42.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 93.0 m -83.56 126.8 33.19 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 122.039 -0.413 . . . . 0.0 110.784 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.683 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 3.8 m-85 -115.7 154.88 28.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.084 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.667 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 61.6 ttt-85 -137.59 112.43 8.95 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.6 t30 . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.738 -178.387 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.41 0 CA-C-O 120.145 -0.253 . . . . 0.0 113.649 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.7 mt -95.23 123.86 55.59 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 117.33 0.565 . . . . 0.0 110.683 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.668 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.6 Cg_exo -56.57 131.18 44.13 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 122.363 2.042 . . . . 0.0 112.486 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.815 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 57.3 m -72.96 -9.24 58.51 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.367 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.63 -33.08 6.32 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.785 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.44 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 49.9 mt-10 -74.68 140.83 44.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.6 0.714 . . . . 0.0 110.634 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -111.96 129.49 56.17 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.684 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -91.47 52.72 2.13 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.369 0.604 . . . . 0.0 110.202 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.611 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 48.1 t -67.13 -59.52 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.694 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 55.1 m95 -93.91 -51.04 5.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.07 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pp -131.14 161.64 60.5 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.069 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.42 146.24 61.69 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.797 2.331 . . . . 0.0 112.089 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 11.9 m -66.12 144.53 56.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.283 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.741 HD13 ' H ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -74.82 -27.79 20.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.021 0.439 . . . . 0.0 110.343 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.68 ' O ' HG12 ' A' ' 18' ' ' ILE . 10.1 p -67.46 -11.17 57.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.816 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.621 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 19.3 m -53.26 -32.46 48.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 111.469 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.15 71.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.68 HG12 ' O ' ' A' ' 15' ' ' SER . 27.0 pt -89.74 5.45 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.54 -20.22 4.41 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.656 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.621 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 72.4 m -66.17 148.24 52.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.232 0.539 . . . . 0.0 111.05 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 p -143.45 133.06 23.65 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.49 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.9 t -64.32 123.65 19.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.93 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -144.72 115.61 7.82 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.5 m 56.7 38.81 29.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.179 0.514 . . . . 0.0 110.471 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.611 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 5.5 mptp? 70.26 13.27 7.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.092 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.652 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 20.1 t -129.71 129.24 66.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.5 m -83.48 124.83 31.1 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 122.001 -0.437 . . . . 0.0 111.067 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.668 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 6.0 m-85 -114.99 150.57 35.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.997 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.815 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 60.3 ttt180 -129.59 111.78 13.06 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 121.339 0.59 . . . . 0.0 110.139 -179.064 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.51 0 N-CA-C 114.261 0.464 . . . . 0.0 114.261 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mm -95.43 123.31 56.98 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 117.57 0.685 . . . . 0.0 110.758 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.673 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 52.6 Cg_exo -57.39 130.11 37.46 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 122.505 2.137 . . . . 0.0 112.655 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.88 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 56.8 m -73.54 -8.26 55.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.273 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.55 -30.76 7.88 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.641 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.684 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 94.5 mt-10 -75.08 138.64 42.26 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.471 0.653 . . . . 0.0 110.037 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -113.55 131.45 56.08 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.784 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.1 p -94.78 45.3 1.11 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.594 0.712 . . . . 0.0 109.865 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.704 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 48.2 t -70.88 -55.0 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.888 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -103.91 -44.89 4.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.015 0.436 . . . . 0.0 110.909 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.551 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.2 tt -133.63 138.98 32.31 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.196 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HD2' HG13 ' A' ' 11' ' ' ILE . 9.5 Cg_endo -54.14 146.65 47.98 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.914 2.409 . . . . 0.0 112.744 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.684 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 5.4 m -67.86 144.74 55.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.745 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.9 tt -75.41 -34.98 31.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.154 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.77 ' HA ' HD13 ' A' ' 18' ' ' ILE . 66.3 m -71.16 -3.51 20.48 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.67 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.611 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 74.1 m -60.99 -35.18 76.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.756 0.313 . . . . 0.0 110.52 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.28 -28.54 69.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.176 0.512 . . . . 0.0 110.771 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.77 HD13 ' HA ' ' A' ' 15' ' ' SER . 2.8 mp -72.8 -26.6 23.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.247 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.424 ' HA3' ' NE ' ' A' ' 29' ' ' ARG . . . 148.21 -9.99 1.14 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.053 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 59.3 m -66.52 133.19 49.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.251 0.548 . . . . 0.0 110.663 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 13.8 m -110.41 136.58 49.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.959 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.9 t -74.47 117.31 16.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.793 0.33 . . . . 0.0 110.644 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.618 ' HD3' ' CE1' ' A' ' 28' ' ' TYR . 13.4 tttt -135.79 117.83 15.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.1 m 57.05 35.55 26.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.346 0.594 . . . . 0.0 109.963 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.704 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 59.1 mttm 68.21 20.41 8.85 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.668 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.576 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.2 t -129.85 125.94 61.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 85.3 m -85.25 122.64 29.72 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.016 0.436 . . . . 0.0 111.701 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 2.9 m-85 -113.36 151.05 31.77 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.68 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.88 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER -127.3 106.09 8.98 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.44 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.5 t30 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.093 -178.599 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.419 0 CA-C-O 120.184 -0.231 . . . . 0.0 113.659 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.2 mt -92.25 121.05 67.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 117.177 0.488 . . . . 0.0 110.667 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.661 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 50.6 Cg_exo -55.98 129.16 33.43 Favored 'Trans proline' 0 CA--C 1.52 -0.222 0 C-N-CA 122.486 2.124 . . . . 0.0 112.782 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.828 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 79.5 m -74.11 -1.98 22.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.496 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.33 -30.92 5.69 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 83.3 mt-10 -61.53 138.29 58.28 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.471 0.653 . . . . 0.0 110.357 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 m -117.48 125.6 51.17 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.592 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.2 p -93.54 46.8 1.21 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.652 0.739 . . . . 0.0 110.322 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.414 HG22 ' HE2' ' A' ' 25' ' ' LYS . 49.5 t -74.66 -38.96 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.703 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -130.06 -50.63 1.12 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.966 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.827 ' H ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -103.63 144.07 27.93 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.854 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.86 164.29 36.0 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.641 2.227 . . . . 0.0 112.422 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 16' ' ' SER . 3.5 m -54.79 125.88 21.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.483 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.0 pt -76.88 -38.39 28.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.496 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 10.5 m -90.77 32.9 0.95 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.104 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.496 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 2.4 p -60.59 -47.27 86.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.849 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.94 -22.44 66.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.046 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.5 mm -75.94 -26.89 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.584 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.56 -6.77 2.19 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.307 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 15' ' ' SER . 56.5 m -77.08 134.06 38.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.389 0.614 . . . . 0.0 111.275 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 18.3 m -127.57 136.31 51.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.652 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.7 t -68.81 127.19 32.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.895 0.378 . . . . 0.0 111.601 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -149.91 120.45 7.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.709 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m 58.33 36.7 25.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.854 0.359 . . . . 0.0 110.604 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HE2' HG22 ' A' ' 9' ' ' VAL . 59.8 mtpt 69.4 15.06 8.44 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.404 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.43 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 38.2 t -131.92 130.05 61.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.565 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 68.8 m -84.2 124.36 31.09 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 122.151 -0.343 . . . . 0.0 110.762 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.661 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 3.2 m-85 -112.34 153.76 26.75 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.626 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.828 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.6 ttm180 -128.85 108.92 10.83 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 121.381 0.61 . . . . 0.0 109.975 -178.79 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.436 0 N-CA-C 113.835 0.294 . . . . 0.0 113.835 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.4 mt -94.39 123.53 58.28 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 117.357 0.579 . . . . 0.0 110.699 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.646 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 50.6 Cg_exo -56.12 131.97 49.09 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.431 2.088 . . . . 0.0 112.397 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 74.2 m -71.88 -8.31 53.59 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.75 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.05 -32.53 6.78 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.98 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.648 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 99.7 mt-10 -79.99 140.92 36.4 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.471 0.653 . . . . 0.0 110.011 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.8 m -111.91 135.11 52.97 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.707 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -98.57 51.01 0.99 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.483 0.658 . . . . 0.0 109.719 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.541 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 44.3 t -63.96 -49.69 80.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.639 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -116.23 -48.61 2.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.719 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.707 ' H ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -117.92 153.14 50.94 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.64 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -66.71 146.02 77.39 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.557 2.172 . . . . 0.0 111.653 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.648 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 6.2 m -67.81 148.27 51.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.346 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.2 mm -74.0 -37.59 47.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.285 0.564 . . . . 0.0 110.006 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.7 ' HA ' HD13 ' A' ' 18' ' ' ILE . 65.1 p -63.96 -12.37 36.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.061 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.772 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 13.0 m -56.59 -38.37 71.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.665 0.269 . . . . 0.0 111.094 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.34 -24.15 67.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.826 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.7 HD13 ' HA ' ' A' ' 15' ' ' SER . 3.2 mp -79.73 -39.59 20.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.4 0.619 . . . . 0.0 110.224 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . 157.68 36.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.534 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.772 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 77.2 m -112.36 142.14 45.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.035 0.445 . . . . 0.0 110.573 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 m -119.53 133.45 55.67 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.013 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.4 t -70.54 121.86 18.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.349 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.1 tttp -140.09 117.14 11.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.241 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m 55.99 39.27 30.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.924 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 18.1 mttp 70.21 15.56 7.49 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.011 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.618 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.8 t -132.59 128.97 58.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 87.8 m -83.73 128.23 34.38 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.989 -0.445 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.646 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 5.9 m-85 -117.67 155.49 29.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.248 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.701 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 30.6 ttm180 -135.98 109.12 7.73 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.3 t30 . . . . . 0 C--N 1.327 -0.406 0 CA-C-O 121.507 0.67 . . . . 0.0 109.902 -178.58 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.449 0 N-CA-C 113.885 0.314 . . . . 0.0 113.885 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm -96.51 123.22 55.11 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 117.546 0.673 . . . . 0.0 110.723 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.668 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 50.7 Cg_exo -56.52 132.2 50.37 Favored 'Trans proline' 0 CA--C 1.517 -0.367 0 C-N-CA 122.474 2.116 . . . . 0.0 112.611 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.761 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 60.7 m -73.99 -10.89 60.1 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.272 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.0 -32.71 6.79 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.93 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -73.03 139.53 46.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.525 0.679 . . . . 0.0 110.516 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.5 m -107.48 130.35 54.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.873 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.3 p -100.54 47.84 0.92 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.166 0.508 . . . . 0.0 110.501 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.644 HG22 ' HB3' ' A' ' 25' ' ' LYS . 42.8 t -73.59 -48.85 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.77 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -101.02 -49.5 4.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.031 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.63 153.36 81.5 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.653 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -66.75 147.3 80.97 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.7 2.266 . . . . 0.0 111.813 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.2 m -66.94 149.28 50.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.512 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.5 mt -72.03 -35.62 54.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.375 0.607 . . . . 0.0 109.836 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.7 p -69.23 -3.25 13.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.477 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 31.3 m -56.5 -39.48 73.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.0 0.428 . . . . 0.0 110.679 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.74 -22.3 64.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.1 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.3 mm -78.71 -28.04 14.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.764 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 151.73 -16.42 0.83 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.836 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 16' ' ' SER . 76.0 m -67.88 139.74 56.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.372 0.606 . . . . 0.0 111.213 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.465 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 6.3 m -122.21 131.46 53.95 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.941 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.1 t -66.53 124.34 22.52 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.22 0.325 . . . . 0.0 110.334 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.465 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.6 mttm -142.64 115.57 8.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.099 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 53.8 m 55.37 38.38 30.23 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.441 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.644 ' HB3' HG22 ' A' ' 9' ' ' VAL . 8.3 mtmp? 74.95 13.89 3.28 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.727 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.644 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.3 t -133.44 128.72 55.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 90.6 m -83.1 125.55 31.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.849 0.357 . . . . 0.0 110.965 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.668 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 5.8 m-85 -115.55 151.37 35.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.819 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.761 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 27.7 ttm180 -130.95 110.41 11.24 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 121.457 0.646 . . . . 0.0 110.089 -178.756 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 114.038 0.375 . . . . 0.0 114.038 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.4 mm -100.46 123.78 45.03 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 117.339 0.569 . . . . 0.0 110.74 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.687 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.3 Cg_exo -55.47 133.38 57.74 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.539 2.16 . . . . 0.0 112.472 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 35.2 m -76.53 -5.79 49.09 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.511 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.11 -32.83 5.83 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.689 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.504 ' OE2' HG22 ' A' ' 14' ' ' ILE . 48.5 mt-10 -76.47 145.15 39.42 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.464 0.65 . . . . 0.0 110.734 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.3 m -119.02 132.57 56.06 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.049 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -89.77 58.08 4.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.639 0.733 . . . . 0.0 109.706 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.637 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 22.5 t -63.72 -48.67 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.319 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -130.7 -40.63 1.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.779 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 26.6 pt -116.88 155.18 49.48 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.032 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 11' ' ' ILE . 8.0 Cg_exo -70.67 145.82 52.9 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.837 2.358 . . . . 0.0 111.755 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.5 m -69.99 147.3 50.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.17 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.504 HG22 ' OE2' ' A' ' 6' ' ' GLU . 10.6 tp -71.82 -34.73 52.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.965 0.412 . . . . 0.0 110.352 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.667 ' HA ' HD13 ' A' ' 18' ' ' ILE . 14.3 m -66.72 -14.83 63.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.251 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.714 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 70.2 m -59.67 -32.79 70.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.717 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.96 -25.47 66.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.667 HD13 ' HA ' ' A' ' 15' ' ' SER . 3.2 mp -81.3 -46.7 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.304 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.53 34.05 0.02 OUTLIER Glycine 0 C--N 1.319 -0.414 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.086 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.714 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 72.3 m -108.59 143.31 37.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.12 0.486 . . . . 0.0 110.683 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 12.3 p -121.91 137.26 54.86 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.518 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -71.25 115.16 10.08 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -133.76 115.83 15.01 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.8 m 57.34 37.61 28.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.043 0.449 . . . . 0.0 110.695 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.637 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 14.5 ttmm 71.9 12.07 6.16 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.53 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.699 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 18.1 t -127.94 129.81 69.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 97.3 m -82.11 124.79 30.17 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 122.051 -0.405 . . . . 0.0 111.062 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.699 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 5.4 m-85 -116.51 151.12 36.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.799 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.563 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 31.7 ttp85 -128.89 118.19 22.27 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.45 ' OD1' ' HG2' ' A' ' 29' ' ' ARG . 5.0 p-10 . . . . . 0 N--CA 1.469 0.504 0 O-C-N 123.954 0.784 . . . . 0.0 111.783 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.396 0 CA-C-O 120.177 -0.235 . . . . 0.0 113.484 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.9 mt -94.2 121.96 62.63 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 117.224 0.512 . . . . 0.0 110.551 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.694 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.3 Cg_exo -56.14 129.9 37.34 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.39 2.06 . . . . 0.0 112.64 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.812 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 76.5 m -74.09 -4.86 38.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.236 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.09 -27.39 8.37 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.487 ' OE1' ' HB2' ' A' ' 15' ' ' SER . 32.3 mt-10 -68.0 138.97 56.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.523 0.677 . . . . 0.0 110.873 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -111.74 125.17 53.7 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.441 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.1 p -98.68 43.79 1.05 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.288 0.566 . . . . 0.0 110.215 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.059 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 38.9 t -73.12 -51.18 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.112 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.642 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 3.8 m-90 -97.28 -51.02 4.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.156 0.503 . . . . 0.0 110.902 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.1 pt -130.95 156.12 80.54 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.688 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.35 146.7 81.44 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.642 2.228 . . . . 0.0 111.916 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 6' ' ' GLU . 24.1 m -66.97 146.44 54.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.72 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.817 HD13 ' H ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -75.31 -35.04 32.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.006 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.487 ' HB2' ' OE1' ' A' ' 6' ' ' GLU . 11.1 m -76.38 5.1 7.66 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.447 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 36.1 m -58.8 -41.02 85.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 110.611 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.51 -24.98 67.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.227 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.0 mt -76.18 -25.72 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.951 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.13 -13.71 0.73 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.057 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 56.6 m -71.67 139.03 49.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.362 0.601 . . . . 0.0 111.289 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.491 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 7.7 m -125.0 130.76 53.01 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.729 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.0 t -65.19 120.78 13.36 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.245 0.341 . . . . 0.0 110.395 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.7 mttm -141.44 115.94 9.56 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.1 m 56.2 39.59 30.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 111.026 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 1.059 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 46.4 mmtm 71.63 12.43 6.4 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.167 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.637 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.4 t -130.89 128.22 62.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 86.5 m -83.62 122.9 29.2 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.965 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.694 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 4.5 m-85 -111.5 151.09 29.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.907 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.812 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.0 ttm180 -128.45 112.06 13.96 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.393 0.616 . . . . 0.0 110.071 -179.06 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.36 0 CA-C-O 120.337 -0.146 . . . . 0.0 113.436 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -98.86 128.37 32.62 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 117.114 0.457 . . . . 0.0 110.618 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.68 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 47.9 Cg_exo -58.37 130.89 39.75 Favored 'Trans proline' 0 CA--C 1.517 -0.36 0 C-N-CA 122.312 2.008 . . . . 0.0 112.155 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.734 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 52.8 m -73.59 -6.29 45.66 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.69 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.5 -31.84 7.09 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.647 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.637 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 98.8 mt-10 -77.76 138.91 39.27 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.457 0.646 . . . . 0.0 109.839 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 m -117.42 134.78 54.45 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.914 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -96.17 46.35 1.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.229 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.925 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 39.9 t -66.4 -42.53 90.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.84 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -127.35 -46.73 1.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.339 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.7 tp -117.33 136.72 23.55 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.761 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.85 148.62 91.69 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.296 1.997 . . . . 0.0 111.826 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.637 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 4.3 m -69.15 147.08 51.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.951 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.428 ' H ' HD12 ' A' ' 14' ' ' ILE . 4.4 mp -77.18 -37.67 26.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.581 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.84 ' HA ' HD13 ' A' ' 18' ' ' ILE . 5.1 t -68.02 -7.4 28.75 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.364 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.579 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 69.2 m -59.27 -37.72 78.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.755 0.312 . . . . 0.0 110.928 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.21 -25.49 67.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.178 0.513 . . . . 0.0 111.098 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.84 HD13 ' HA ' ' A' ' 15' ' ' SER . 2.9 mp -76.24 -25.47 16.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.617 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.15 -16.5 0.79 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.874 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.579 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 57.5 m -66.18 138.98 58.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.405 0.622 . . . . 0.0 111.489 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 p -121.71 135.21 54.95 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.101 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.7 t -66.43 123.31 19.64 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.984 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -138.17 113.81 9.71 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 m 56.27 38.78 30.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.432 0.634 . . . . 0.0 110.303 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.925 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 72.6 mttt 68.33 20.0 8.81 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.164 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.667 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.6 t -132.08 127.24 57.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 89.0 m -84.94 123.18 30.22 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.109 0.481 . . . . 0.0 111.777 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.68 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 2.9 m-85 -116.05 150.88 36.57 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.816 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.734 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 44.7 ttt-85 -135.34 121.03 19.51 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.324 -178.191 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 113.875 0.31 . . . . 0.0 113.875 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.8 mm -95.63 125.18 50.27 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 117.352 0.576 . . . . 0.0 110.661 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 52.9 Cg_exo -57.14 131.24 44.01 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 C-N-CA 122.424 2.082 . . . . 0.0 112.494 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.83 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 69.9 m -72.89 -10.42 59.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.333 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.27 -33.05 6.78 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.867 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -75.07 141.18 43.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.519 0.676 . . . . 0.0 110.251 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 m -116.07 130.55 56.86 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.417 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.25 48.38 1.16 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.041 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.933 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 39.2 t -65.3 -40.82 89.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.545 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -132.82 -47.12 0.87 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.336 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.5 tp -110.84 134.91 20.83 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.91 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -63.95 147.47 91.93 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.334 2.022 . . . . 0.0 111.643 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.2 m -63.96 145.48 55.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.408 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mp -75.31 -43.88 42.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.967 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.74 ' O ' HG12 ' A' ' 18' ' ' ILE . 8.3 m -76.32 15.43 0.59 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.064 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.759 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 18.6 p -63.89 -39.01 93.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.233 0.54 . . . . 0.0 110.595 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.99 -28.06 67.39 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 15' ' ' SER . 11.4 pt -78.65 -3.62 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.99 -17.94 3.83 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.006 -1.093 . . . . 0.0 113.36 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.759 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 57.3 m -66.6 131.62 46.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.467 0.651 . . . . 0.0 111.314 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 15.2 m -117.5 137.0 52.84 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.932 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -72.82 120.28 18.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.964 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.625 ' HD3' ' CE1' ' A' ' 28' ' ' TYR . 6.9 tttt -139.53 119.57 13.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.1 m 57.84 35.76 25.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.26 0.552 . . . . 0.0 109.923 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.933 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 73.2 mttt 66.61 23.51 10.32 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.562 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.606 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 24.6 t -134.73 127.23 48.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.544 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 94.0 m -83.85 123.1 29.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.983 0.421 . . . . 0.0 111.449 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.669 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 3.9 m-85 -113.78 152.45 30.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.674 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.83 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 57.8 ttt180 -130.48 110.72 11.67 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.58 -178.771 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.358 0 CA-C-O 120.32 -0.156 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.3 124.19 50.01 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 117.068 0.434 . . . . 0.0 110.334 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.652 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 50.7 Cg_exo -56.31 132.18 50.3 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.418 2.079 . . . . 0.0 112.491 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 80.5 m -72.61 -10.46 59.82 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.21 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.03 -32.03 7.57 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.849 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.694 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 97.3 mt-10 -78.25 138.24 38.52 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.592 0.71 . . . . 0.0 110.455 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 m -107.94 134.33 51.01 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.151 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.532 ' O ' ' HD2' ' A' ' 25' ' ' LYS . 1.7 p -101.0 37.88 1.66 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.237 0.542 . . . . 0.0 110.117 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.637 ' HB ' ' CE3' ' A' ' 10' ' ' TRP . 39.5 t -64.35 -52.4 56.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.999 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.637 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 3.8 m-90 -96.71 -55.55 2.86 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.175 0.512 . . . . 0.0 110.434 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 23.4 pt -125.96 156.59 71.41 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.301 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.85 147.31 89.39 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.55 2.167 . . . . 0.0 111.997 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.694 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 27.6 m -65.1 142.35 58.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.701 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.2 pt -77.05 -35.65 23.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.98 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.49 ' HB3' HD12 ' A' ' 18' ' ' ILE . 50.4 m -79.75 12.17 2.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.834 0.349 . . . . 0.0 111.606 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.887 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 19.4 p -60.95 -36.01 78.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.768 0.318 . . . . 0.0 110.964 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.6 -23.25 62.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.473 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 15' ' ' SER . 60.9 mt -70.86 -25.8 26.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.652 0.739 . . . . 0.0 110.289 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.95 31.84 0.29 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.661 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.887 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 60.0 m -103.34 137.46 41.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.192 0.52 . . . . 0.0 110.765 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.487 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 11.2 m -119.48 134.09 55.38 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.053 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.1 t -67.74 120.08 13.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.19 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.4 mttm -139.72 115.58 10.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 t 58.35 36.64 25.66 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.36 0.6 . . . . 0.0 109.854 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.532 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 28.6 mmtp 68.49 19.79 8.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.797 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.666 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 22.6 t -132.91 128.05 56.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 90.8 m -83.61 121.87 27.83 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.89 0.376 . . . . 0.0 111.357 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.666 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 5.0 m-85 -112.38 152.58 28.45 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.025 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.603 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 49.4 ttp85 -133.84 113.59 12.42 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 121.301 0.572 . . . . 0.0 109.952 -179.147 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 N-CA-C 113.808 0.283 . . . . 0.0 113.808 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.29 124.0 52.87 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 117.36 0.58 . . . . 0.0 110.759 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.673 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.6 Cg_exo -57.34 130.67 40.42 Favored 'Trans proline' 0 CA--C 1.516 -0.38 0 C-N-CA 122.415 2.076 . . . . 0.0 112.471 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.784 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 72.6 m -72.94 -9.7 59.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.319 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.28 -32.89 6.64 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.582 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -73.09 140.61 47.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.503 0.668 . . . . 0.0 110.507 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -114.47 130.77 56.75 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.842 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.8 48.78 1.38 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.378 0.608 . . . . 0.0 110.126 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.585 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 45.1 t -64.69 -57.25 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.924 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 59.2 m95 -102.8 -47.82 4.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.091 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.84 158.88 69.06 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.25 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -68.21 147.14 72.03 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.795 2.33 . . . . 0.0 111.997 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.6 m -64.82 151.97 44.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.93 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 13.9 tt -75.8 -38.48 37.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.426 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 m -76.6 9.75 2.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.741 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 22.9 p -59.19 -49.25 78.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.896 0.379 . . . . 0.0 110.906 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.7 -22.54 67.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.471 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.8 mt -75.07 -24.52 17.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.614 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.75 -14.99 0.92 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.208 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 36.4 m -74.15 132.6 42.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.461 0.648 . . . . 0.0 111.592 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 14.6 m -115.18 136.63 52.91 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.959 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 51.7 t -70.61 120.16 15.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.836 0.351 . . . . 0.0 110.564 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -139.73 118.52 12.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.966 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.8 m 56.64 36.68 28.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.141 0.495 . . . . 0.0 110.334 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.585 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER 69.52 17.63 7.93 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.956 -179.423 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.618 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 24.7 t -132.82 129.44 58.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 89.1 m -83.7 122.27 28.4 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.042 0.449 . . . . 0.0 111.336 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.673 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 4.4 m-85 -112.8 152.21 29.45 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.608 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.784 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 66.2 ttt180 -130.87 111.68 12.32 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.707 -178.886 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.43 0 N-CA-C 113.882 0.313 . . . . 0.0 113.882 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.5 mm -96.68 126.58 42.63 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 117.307 0.554 . . . . 0.0 110.864 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.654 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 51.6 Cg_exo -57.33 130.45 39.33 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.403 2.069 . . . . 0.0 112.366 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.666 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 34.8 m -72.25 -8.42 54.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.558 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.1 -30.97 8.19 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.189 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -74.59 142.21 44.66 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.511 0.672 . . . . 0.0 110.672 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 m -109.59 128.81 55.48 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.01 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -94.38 48.12 1.22 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.11 0.481 . . . . 0.0 110.713 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.21 -57.3 5.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.493 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -98.64 -37.22 9.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.724 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.573 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.0 tt -146.21 138.96 14.06 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.339 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HD2' HG13 ' A' ' 11' ' ' ILE . 8.3 Cg_endo -53.59 144.57 51.81 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.88 2.386 . . . . 0.0 112.779 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.2 m -65.4 147.35 53.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.832 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mm -73.04 -38.76 56.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.115 0.484 . . . . 0.0 110.303 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.567 ' O ' HG12 ' A' ' 18' ' ' ILE . 6.8 m -68.7 -4.55 16.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.227 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.696 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 15.6 m -58.1 -35.33 71.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.105 0.479 . . . . 0.0 110.638 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.69 -32.62 74.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.573 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.567 HG12 ' O ' ' A' ' 15' ' ' SER . 27.1 pt -86.74 5.9 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.78 -18.52 4.55 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 119.634 -1.27 . . . . 0.0 114.538 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.696 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 83.6 m -67.71 139.68 56.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.618 0.709 . . . . 0.0 111.803 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.0 m -125.1 135.38 52.63 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.747 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.3 t -69.74 125.08 25.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.093 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -146.6 119.42 8.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.132 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.608 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 10.8 m 56.85 39.61 29.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.967 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 24' ' ' SER . 8.7 ptpt 70.98 9.19 6.73 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.446 1.098 . . . . 0.0 112.038 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 t -128.39 130.43 69.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.209 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 91.5 m -83.72 127.2 33.61 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 122.189 -0.319 . . . . 0.0 110.738 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 2.9 m-85 -115.37 153.2 31.44 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.666 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 62.4 ttt-85 -136.09 115.49 12.67 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.724 -178.771 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.342 0 CA-C-O 120.369 -0.128 . . . . 0.0 113.294 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.4 mm -96.37 125.64 46.83 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 117.026 0.413 . . . . 0.0 110.384 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.654 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.6 Cg_exo -57.15 132.64 52.54 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.353 2.035 . . . . 0.0 112.358 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 72.5 m -72.11 -7.84 51.26 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.562 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.33 -31.38 8.1 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.246 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -79.69 141.04 36.79 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.693 0.759 . . . . 0.0 111.038 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 m -107.74 129.55 55.03 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.0 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -99.92 51.03 0.91 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.56 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.57 -45.53 77.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.803 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -117.57 -48.56 2.59 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.952 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.6 pt -117.85 151.26 48.49 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.837 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.3 146.11 68.15 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.664 2.243 . . . . 0.0 111.661 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 10.0 m -66.55 148.41 51.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.488 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -71.92 -43.11 68.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.298 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.4 p -68.03 -3.13 9.17 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.866 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 18.3 m -57.99 -40.81 81.62 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.708 0.289 . . . . 0.0 110.609 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.02 67.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.607 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.8 mt -76.74 -37.14 27.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.408 0.623 . . . . 0.0 110.284 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . 155.42 33.36 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.704 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.866 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 83.9 m -109.92 138.67 45.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.17 0.509 . . . . 0.0 110.605 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.8 m -118.97 117.74 29.62 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.923 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 32.8 t -62.9 137.79 58.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.848 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -166.83 128.92 1.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.096 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.64 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 9.4 t 57.29 41.9 25.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 24' ' ' SER . 0.9 OUTLIER 62.6 16.06 8.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.777 1.231 . . . . 0.0 112.413 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.662 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.3 t -134.29 130.76 54.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.147 0.498 . . . . 0.0 110.995 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 89.5 m -84.14 128.1 34.34 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.102 178.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.662 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 6.6 m-85 -119.01 153.75 34.18 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.794 0.331 . . . . 0.0 110.173 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.615 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 29.5 ttm180 -134.61 114.8 13.14 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.654 -178.708 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.406 0 CA-C-O 120.174 -0.237 . . . . 0.0 113.678 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.2 mm -96.49 124.46 50.85 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 117.31 0.555 . . . . 0.0 110.585 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.67 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.4 Cg_exo -56.98 130.39 39.54 Favored 'Trans proline' 0 CA--C 1.516 -0.392 0 C-N-CA 122.405 2.07 . . . . 0.0 112.51 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.795 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 76.0 m -73.46 -8.49 56.12 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.4 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.33 -28.44 8.95 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.588 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.714 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 94.4 mt-10 -74.69 137.3 42.05 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.535 0.683 . . . . 0.0 109.957 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.2 m -108.92 131.8 54.67 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.681 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.0 p -99.41 45.02 1.0 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.581 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.621 ' HB ' ' CE3' ' A' ' 10' ' ' TRP . 21.6 t -76.3 -52.1 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.145 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.621 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 5.1 m-90 -93.74 -49.23 5.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.305 0.574 . . . . 0.0 110.935 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.0 pt -136.23 159.41 70.94 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.018 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -63.74 146.88 92.56 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.392 2.062 . . . . 0.0 111.637 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.714 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 36.5 m -66.33 149.86 49.73 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.797 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.453 ' H ' HD12 ' A' ' 14' ' ' ILE . 4.2 mp -72.69 -41.05 62.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.969 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -73.14 5.44 3.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 31.4 m -60.5 -41.66 94.77 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.945 0.402 . . . . 0.0 110.512 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.78 -25.8 67.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.281 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.5 mt -74.91 -25.36 18.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.009 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.18 -8.86 1.09 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.101 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 40.7 m -73.92 136.04 43.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.339 0.59 . . . . 0.0 111.147 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.497 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 5.7 m -118.71 131.09 56.14 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.681 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.1 t -64.91 121.52 14.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.275 0.36 . . . . 0.0 110.227 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.5 mttm -141.08 113.0 7.75 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.548 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 48.8 m 54.31 45.76 26.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.305 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 24' ' ' SER . 1.2 pttm 71.33 4.87 5.23 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.838 1.255 . . . . 0.0 112.518 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.62 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.1 t -125.35 127.91 72.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 120.856 0.36 . . . . 0.0 110.324 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 91.8 m -83.95 120.93 26.7 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.815 0.34 . . . . 0.0 110.827 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.67 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 5.0 m-85 -109.42 151.78 26.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.143 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.795 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.6 ttm180 -130.31 113.65 14.65 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 . . . . . 0 C--N 1.328 -0.36 0 CA-C-O 121.317 0.58 . . . . 0.0 110.159 -179.149 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.401 0 N-CA-C 113.828 0.291 . . . . 0.0 113.828 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 51.2 mm -95.85 126.9 43.15 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 117.266 0.533 . . . . 0.0 110.709 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.662 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.6 Cg_exo -57.09 132.73 53.24 Favored 'Trans proline' 0 CA--C 1.518 -0.323 0 C-N-CA 122.48 2.12 . . . . 0.0 112.458 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 74.4 m -74.11 -9.12 58.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.281 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.36 -31.58 7.89 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.637 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.684 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 95.0 mt-10 -76.6 139.64 40.72 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.456 0.646 . . . . 0.0 110.094 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.1 m -114.95 133.55 55.92 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.001 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -97.73 51.22 1.06 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.816 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.851 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 36.8 t -62.84 -40.0 87.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.03 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -128.82 -49.48 1.24 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.088 0.471 . . . . 0.0 110.383 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.744 ' H ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -114.23 153.29 46.42 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.408 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -65.78 147.8 85.91 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.559 2.173 . . . . 0.0 111.648 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.684 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 8.3 m -69.44 150.12 47.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.417 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 mm -70.03 -41.41 79.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.274 0.559 . . . . 0.0 109.892 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.801 ' HA ' HD13 ' A' ' 18' ' ' ILE . 68.0 m -69.17 -6.76 30.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.878 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 74.2 m -62.67 -35.43 79.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.927 0.394 . . . . 0.0 110.287 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.2 -24.32 65.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.698 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.801 HD13 ' HA ' ' A' ' 15' ' ' SER . 2.7 mp -78.7 -34.23 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.395 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.48 -14.25 0.18 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.311 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 46.3 m -66.35 133.02 49.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.492 0.663 . . . . 0.0 111.414 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 13.4 m -107.29 135.38 48.89 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.16 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.0 t -73.31 118.86 16.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 0.0 110.723 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -132.16 118.4 19.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 p 49.97 42.2 24.17 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.643 0.735 . . . . 0.0 111.087 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.851 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 74.4 mttt 67.87 20.97 9.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.544 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.624 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.6 t -133.39 126.18 51.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 93.4 m -83.87 124.56 31.1 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.989 0.423 . . . . 0.0 111.661 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.662 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 3.9 m-85 -115.5 154.42 29.36 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.883 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.577 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 48.8 ttp85 -138.16 114.83 10.57 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.8 t30 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.504 -178.164 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.305 0 CA-C-O 120.309 -0.162 . . . . 0.0 113.382 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.1 mt -95.3 123.99 55.05 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 117.014 0.407 . . . . 0.0 110.425 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.686 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.2 Cg_exo -57.22 132.46 51.28 Favored 'Trans proline' 0 CA--C 1.516 -0.411 0 C-N-CA 122.3 2.0 . . . . 0.0 112.063 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 90.0 m -74.3 -6.53 48.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.518 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.74 -28.83 9.38 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.78 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.695 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 94.8 mt-10 -77.38 136.4 38.42 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.593 0.711 . . . . 0.0 110.149 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.5 m -109.45 132.13 54.42 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.659 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 3.6 p -103.45 51.36 0.79 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.048 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.61 HG13 ' HD2' ' A' ' 25' ' ' LYS . 40.5 t -65.86 -41.89 90.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.957 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -124.1 -49.5 1.83 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.524 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 27.7 pt -112.8 150.83 43.39 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.69 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -66.41 147.71 83.12 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.648 2.232 . . . . 0.0 111.636 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.695 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 8.8 m -69.94 149.53 47.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.338 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.9 mm -70.55 -41.57 78.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.149 0.499 . . . . 0.0 110.152 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.802 ' HA ' HD13 ' A' ' 18' ' ' ILE . 70.2 m -70.76 -3.51 19.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.024 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 75.3 m -63.02 -35.84 81.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.926 0.393 . . . . 0.0 110.337 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.64 -22.61 64.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.732 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.802 HD13 ' HA ' ' A' ' 15' ' ' SER . 2.6 mp -79.59 -34.07 15.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.4 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.82 -16.76 0.19 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.18 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 34.8 m -65.12 131.28 46.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.549 0.69 . . . . 0.0 111.244 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.43 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 2.6 m -104.49 127.19 52.14 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.13 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.7 t -72.37 128.67 36.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.45 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 23' ' ' LYS . 12.4 ptpt -158.19 127.58 5.79 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m 58.82 33.77 23.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.115 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.61 ' HD2' HG13 ' A' ' 9' ' ' VAL . 51.6 mtmt 69.57 17.67 7.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.567 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.703 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 17.5 t -135.4 129.41 49.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.043 0.449 . . . . 0.0 110.053 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 84.9 m -86.81 122.88 31.3 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.921 0.391 . . . . 0.0 111.044 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.703 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 3.5 m-85 -114.39 153.37 29.98 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.939 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.487 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 41.6 ttp85 -137.02 114.31 10.84 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.7 t30 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.602 -178.257 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.465 0 N-CA-C 114.178 0.431 . . . . 0.0 114.178 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -94.43 121.95 62.25 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 117.569 0.685 . . . . 0.0 110.883 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 50.3 Cg_exo -56.29 131.42 45.69 Favored 'Trans proline' 0 CA--C 1.518 -0.307 0 C-N-CA 122.523 2.149 . . . . 0.0 112.717 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.781 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 70.1 m -71.62 -11.26 60.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.467 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.65 -31.19 8.4 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.063 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -75.45 140.17 42.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.5 0.667 . . . . 0.0 110.322 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 m -106.73 130.47 54.44 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.144 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -96.75 49.29 1.08 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.117 0.484 . . . . 0.0 110.752 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.592 HG22 ' HB2' ' A' ' 25' ' ' LYS . 22.0 t -80.29 -59.9 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.405 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -91.83 -36.29 13.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.418 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.463 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.4 tt -149.31 140.96 14.65 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.854 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.463 ' HD2' HG13 ' A' ' 11' ' ' ILE . 37.9 Cg_exo -57.58 147.69 77.66 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.346 2.03 . . . . 0.0 112.0 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.7 m -64.84 148.73 50.78 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.1 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 mm -74.68 -40.16 47.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.354 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 18' ' ' ILE . 55.9 p -70.99 0.87 6.49 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.796 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 16.1 m -60.91 -35.61 77.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.252 0.549 . . . . 0.0 110.614 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.33 -29.71 70.97 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 15' ' ' SER . 38.7 pt -92.42 7.41 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.05 -25.0 2.68 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 119.214 -1.47 . . . . 0.0 114.536 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.796 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 69.9 m -68.25 142.68 55.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.5 0.667 . . . . 0.0 111.842 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 3.4 p -129.86 133.85 47.16 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.963 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 t -70.38 124.08 23.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.866 0.365 . . . . 0.0 111.317 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -148.56 121.28 8.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.857 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.684 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 11.2 m 55.22 47.23 22.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.684 ' HG3' ' O ' ' A' ' 24' ' ' SER . 0.0 OUTLIER 57.9 15.66 3.21 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.206 1.402 . . . . 0.0 112.754 -178.582 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.6 t -130.55 130.06 64.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.035 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 99.6 m -83.56 128.01 34.19 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 122.08 -0.388 . . . . 0.0 110.681 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.669 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 4.2 m-85 -113.98 154.08 28.23 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.95 0.405 . . . . 0.0 110.222 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.781 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 29.8 ttm180 -132.22 103.94 6.5 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.674 -178.353 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 120.447 -0.085 . . . . 0.0 113.257 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.5 mt -94.5 122.19 61.6 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.864 0.332 . . . . 0.0 110.433 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.625 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 52.2 Cg_exo -55.06 133.05 55.92 Favored 'Trans proline' 0 CA--C 1.519 -0.247 0 C-N-CA 122.478 2.119 . . . . 0.0 112.448 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 71.0 m -76.64 -2.46 32.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.463 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.17 -31.54 6.26 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 48.5 mt-10 -65.47 141.73 58.39 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.551 0.691 . . . . 0.0 111.07 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -117.57 125.61 51.11 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.603 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.8 p -96.94 45.52 1.05 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.391 0.615 . . . . 0.0 110.864 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.646 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 36.5 t -67.66 -52.94 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.655 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -114.82 -48.08 2.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.256 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 27.5 pt -108.28 143.71 27.97 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.127 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.08 164.31 34.68 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.645 2.23 . . . . 0.0 112.487 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.602 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 1.5 m -58.53 130.01 44.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.34 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.5 tt -86.63 -32.02 6.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.7 m -86.06 21.75 1.91 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.341 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.602 ' OG ' ' HB2' ' A' ' 13' ' ' CYS . 68.9 m -54.41 -36.19 63.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.98 0.419 . . . . 0.0 111.092 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.77 -25.84 67.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.526 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.464 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 5.9 mm -86.92 38.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.145 0.497 . . . . 0.0 110.63 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.05 30.61 74.1 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.775 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 98.8 m -106.72 146.66 30.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.88 0.371 . . . . 0.0 110.359 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.3 t -148.43 141.07 24.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.342 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.3 t -67.64 125.31 25.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.092 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -144.68 115.67 7.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.886 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.6 m 57.13 41.68 26.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.186 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.646 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 1.2 tptt 72.26 7.61 5.73 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.059 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.745 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.2 t -130.44 131.1 65.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 43.2 m -79.34 128.62 33.56 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.745 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 11.5 m-85 -121.43 155.84 34.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.102 0.477 . . . . 0.0 110.812 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.694 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 38.8 ttp180 -131.71 112.83 12.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.2 p30 . . . . . 0 N--CA 1.473 0.691 0 O-C-N 124.145 0.903 . . . . 0.0 111.993 -178.228 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 CA-C-O 120.256 -0.191 . . . . 0.0 113.403 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.2 mm -96.55 124.31 51.23 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 117.15 0.475 . . . . 0.0 110.469 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.651 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.4 Cg_exo -56.54 131.7 47.27 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 122.41 2.073 . . . . 0.0 112.493 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 91.7 m -71.87 -8.47 54.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.338 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.01 -30.85 8.34 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.696 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.64 137.53 40.79 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.682 0.753 . . . . 0.0 110.548 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -110.25 129.47 55.72 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.52 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 p -97.79 47.51 1.01 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.177 0.513 . . . . 0.0 110.254 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.051 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 44.1 t -66.92 -52.38 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.071 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -105.45 -49.55 3.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.5 pt -125.69 148.37 61.78 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.72 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.12 150.42 88.68 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.592 2.195 . . . . 0.0 112.738 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.9 m -67.27 150.48 48.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.606 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.4 pt -77.68 -38.38 25.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.618 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.416 ' HB3' HD11 ' A' ' 18' ' ' ILE . 13.8 m -79.11 12.15 2.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.849 0.357 . . . . 0.0 111.706 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.594 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 52.6 p -66.77 -44.92 80.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.163 0.506 . . . . 0.0 110.745 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.68 -26.19 65.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.553 HG13 HH22 ' A' ' 29' ' ' ARG . 18.8 pt -93.6 10.85 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.2 -31.04 2.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 119.191 -1.48 . . . . 0.0 115.138 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.594 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 56.0 m -68.68 130.73 43.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.805 0.803 . . . . 0.0 111.48 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.454 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 3.7 m -111.39 125.47 53.9 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.182 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 25.9 t -71.24 126.91 30.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.523 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 21' ' ' SER . 12.5 ptpt -157.86 128.92 6.55 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m 58.78 34.62 23.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.052 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 1.051 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 46.9 mmtm 69.68 15.47 8.09 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.82 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.684 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 20.2 t -135.19 130.82 51.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.431 . . . . 0.0 110.351 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 98.1 m -85.48 122.6 29.84 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.852 0.358 . . . . 0.0 110.621 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.684 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 6.0 m-85 -111.95 154.23 25.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.481 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.6 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 52.0 ttm-85 -131.4 111.45 11.84 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.964 -179.409 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.488 0 N-CA-C 113.917 0.327 . . . . 0.0 113.917 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.3 mm -96.36 125.79 46.28 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 117.329 0.565 . . . . 0.0 110.719 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 51.7 Cg_exo -56.9 131.97 48.79 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.428 2.086 . . . . 0.0 112.426 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.667 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 59.8 m -70.78 -10.3 59.2 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.483 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.91 -32.64 7.28 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.039 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.662 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 99.2 mt-10 -80.33 139.65 36.5 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.51 0.671 . . . . 0.0 110.207 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 5.4 m -109.75 135.42 50.69 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.892 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -101.77 50.45 0.85 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.447 0.642 . . . . 0.0 109.742 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.522 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 31.2 t -62.66 -50.12 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.727 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -125.4 -41.55 2.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.49 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.454 HG13 ' HD2' ' A' ' 12' ' ' PRO . 10.9 tt -117.21 134.95 23.01 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.294 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.454 ' HD2' HG13 ' A' ' 11' ' ' ILE . 11.7 Cg_endo -59.16 148.86 83.81 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.629 2.22 . . . . 0.0 112.493 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.662 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 22.4 m -63.83 138.05 58.31 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.526 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.3 pt -77.22 -36.85 24.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.623 ' O ' HG12 ' A' ' 18' ' ' ILE . 19.4 m -83.12 16.75 2.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.946 0.403 . . . . 0.0 111.389 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.893 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 23.6 p -64.94 -27.72 69.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.937 0.398 . . . . 0.0 110.897 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.82 -21.56 29.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 15' ' ' SER . 23.7 pt -76.83 -6.41 8.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.872 0.367 . . . . 0.0 111.126 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.5 33.4 1.32 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.374 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.893 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 83.6 m -99.81 139.87 34.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.971 0.415 . . . . 0.0 110.717 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 21.7 t -119.21 137.5 53.6 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.565 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 51.5 t -73.49 122.04 21.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.943 0.402 . . . . 0.0 110.919 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -142.55 122.04 13.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.12 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m 57.03 36.82 28.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.576 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 16.0 mttp 68.03 21.21 8.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.588 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 42.5 t -137.73 131.02 42.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 93.0 m -83.56 126.8 33.19 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 122.039 -0.413 . . . . 0.0 110.784 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.683 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 3.8 m-85 -115.7 154.88 28.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.084 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.667 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 61.6 ttt-85 -137.59 112.43 8.95 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.6 t30 . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.738 -178.387 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.41 0 CA-C-O 120.145 -0.253 . . . . 0.0 113.649 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.7 mt -95.23 123.86 55.59 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 117.33 0.565 . . . . 0.0 110.683 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.668 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.6 Cg_exo -56.57 131.18 44.13 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 122.363 2.042 . . . . 0.0 112.486 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.815 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 57.3 m -72.96 -9.24 58.51 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.367 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.63 -33.08 6.32 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.785 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.44 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 49.9 mt-10 -74.68 140.83 44.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.6 0.714 . . . . 0.0 110.634 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -111.96 129.49 56.17 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.684 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -91.47 52.72 2.13 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.369 0.604 . . . . 0.0 110.202 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.611 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 48.1 t -67.13 -59.52 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.694 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 55.1 m95 -93.91 -51.04 5.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.07 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pp -131.14 161.64 60.5 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.069 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.42 146.24 61.69 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.797 2.331 . . . . 0.0 112.089 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 11.9 m -66.12 144.53 56.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.283 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.741 HD13 ' H ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -74.82 -27.79 20.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.021 0.439 . . . . 0.0 110.343 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.68 ' O ' HG12 ' A' ' 18' ' ' ILE . 10.1 p -67.46 -11.17 57.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.816 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.621 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 19.3 m -53.26 -32.46 48.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 111.469 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.15 71.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.68 HG12 ' O ' ' A' ' 15' ' ' SER . 27.0 pt -89.74 5.45 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.54 -20.22 4.41 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.656 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.621 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 72.4 m -66.17 148.24 52.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.232 0.539 . . . . 0.0 111.05 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 p -143.45 133.06 23.65 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.49 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.9 t -64.32 123.65 19.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.93 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -144.72 115.61 7.82 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.5 m 56.7 38.81 29.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.179 0.514 . . . . 0.0 110.471 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.611 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 5.5 mptp? 70.26 13.27 7.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.092 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.652 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 20.1 t -129.71 129.24 66.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.5 m -83.48 124.83 31.1 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 122.001 -0.437 . . . . 0.0 111.067 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.668 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 6.0 m-85 -114.99 150.57 35.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.997 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.815 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 60.3 ttt180 -129.59 111.78 13.06 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 121.339 0.59 . . . . 0.0 110.139 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.51 0 N-CA-C 114.261 0.464 . . . . 0.0 114.261 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mm -95.43 123.31 56.98 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 117.57 0.685 . . . . 0.0 110.758 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.673 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 52.6 Cg_exo -57.39 130.11 37.46 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 122.505 2.137 . . . . 0.0 112.655 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.88 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 56.8 m -73.54 -8.26 55.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.273 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.55 -30.76 7.88 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.641 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.684 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 94.5 mt-10 -75.08 138.64 42.26 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.471 0.653 . . . . 0.0 110.037 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -113.55 131.45 56.08 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.784 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.1 p -94.78 45.3 1.11 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.594 0.712 . . . . 0.0 109.865 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.704 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 48.2 t -70.88 -55.0 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.888 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -103.91 -44.89 4.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.015 0.436 . . . . 0.0 110.909 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.551 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.2 tt -133.63 138.98 32.31 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.196 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HD2' HG13 ' A' ' 11' ' ' ILE . 9.5 Cg_endo -54.14 146.65 47.98 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.914 2.409 . . . . 0.0 112.744 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.684 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 5.4 m -67.86 144.74 55.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.745 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.9 tt -75.41 -34.98 31.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.154 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.77 ' HA ' HD13 ' A' ' 18' ' ' ILE . 66.3 m -71.16 -3.51 20.48 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.67 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.611 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 74.1 m -60.99 -35.18 76.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.756 0.313 . . . . 0.0 110.52 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.28 -28.54 69.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.176 0.512 . . . . 0.0 110.771 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.77 HD13 ' HA ' ' A' ' 15' ' ' SER . 2.8 mp -72.8 -26.6 23.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.247 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.424 ' HA3' ' NE ' ' A' ' 29' ' ' ARG . . . 148.21 -9.99 1.14 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.053 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 59.3 m -66.52 133.19 49.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.251 0.548 . . . . 0.0 110.663 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 13.8 m -110.41 136.58 49.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.959 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.9 t -74.47 117.31 16.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.793 0.33 . . . . 0.0 110.644 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.618 ' HD3' ' CE1' ' A' ' 28' ' ' TYR . 13.4 tttt -135.79 117.83 15.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.1 m 57.05 35.55 26.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.346 0.594 . . . . 0.0 109.963 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.704 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 59.1 mttm 68.21 20.41 8.85 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.668 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.576 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.2 t -129.85 125.94 61.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 85.3 m -85.25 122.64 29.72 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.016 0.436 . . . . 0.0 111.701 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 2.9 m-85 -113.36 151.05 31.77 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.68 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.88 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER -127.3 106.09 8.98 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.5 t30 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.093 -178.599 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.419 0 CA-C-O 120.184 -0.231 . . . . 0.0 113.659 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.2 mt -92.25 121.05 67.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 117.177 0.488 . . . . 0.0 110.667 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.661 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 50.6 Cg_exo -55.98 129.16 33.43 Favored 'Trans proline' 0 CA--C 1.52 -0.222 0 C-N-CA 122.486 2.124 . . . . 0.0 112.782 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.828 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 79.5 m -74.11 -1.98 22.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.496 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.33 -30.92 5.69 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 83.3 mt-10 -61.53 138.29 58.28 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.471 0.653 . . . . 0.0 110.357 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 m -117.48 125.6 51.17 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.592 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.2 p -93.54 46.8 1.21 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.652 0.739 . . . . 0.0 110.322 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.414 HG22 ' HE2' ' A' ' 25' ' ' LYS . 49.5 t -74.66 -38.96 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.703 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -130.06 -50.63 1.12 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.966 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.827 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -103.63 144.07 27.93 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.854 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.86 164.29 36.0 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.641 2.227 . . . . 0.0 112.422 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 16' ' ' SER . 3.5 m -54.79 125.88 21.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.483 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.0 pt -76.88 -38.39 28.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.496 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 10.5 m -90.77 32.9 0.95 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.104 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.496 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 2.4 p -60.59 -47.27 86.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.849 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.94 -22.44 66.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.046 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.5 mm -75.94 -26.89 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.584 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.56 -6.77 2.19 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.307 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 15' ' ' SER . 56.5 m -77.08 134.06 38.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.389 0.614 . . . . 0.0 111.275 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 18.3 m -127.57 136.31 51.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.652 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.7 t -68.81 127.19 32.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.895 0.378 . . . . 0.0 111.601 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -149.91 120.45 7.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.709 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m 58.33 36.7 25.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.854 0.359 . . . . 0.0 110.604 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HE2' HG22 ' A' ' 9' ' ' VAL . 59.8 mtpt 69.4 15.06 8.44 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.404 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.43 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 38.2 t -131.92 130.05 61.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.565 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 68.8 m -84.2 124.36 31.09 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 122.151 -0.343 . . . . 0.0 110.762 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.661 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 3.2 m-85 -112.34 153.76 26.75 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.626 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.828 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.6 ttm180 -128.85 108.92 10.83 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 121.381 0.61 . . . . 0.0 109.975 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.436 0 N-CA-C 113.835 0.294 . . . . 0.0 113.835 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.4 mt -94.39 123.53 58.28 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 117.357 0.579 . . . . 0.0 110.699 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.646 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 50.6 Cg_exo -56.12 131.97 49.09 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.431 2.088 . . . . 0.0 112.397 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 74.2 m -71.88 -8.31 53.59 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.75 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.05 -32.53 6.78 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.98 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.648 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 99.7 mt-10 -79.99 140.92 36.4 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.471 0.653 . . . . 0.0 110.011 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.8 m -111.91 135.11 52.97 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.707 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -98.57 51.01 0.99 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.483 0.658 . . . . 0.0 109.719 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.541 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 44.3 t -63.96 -49.69 80.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.639 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -116.23 -48.61 2.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.719 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.707 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -117.92 153.14 50.94 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.64 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -66.71 146.02 77.39 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.557 2.172 . . . . 0.0 111.653 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.648 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 6.2 m -67.81 148.27 51.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.346 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.2 mm -74.0 -37.59 47.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.285 0.564 . . . . 0.0 110.006 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.7 ' HA ' HD13 ' A' ' 18' ' ' ILE . 65.1 p -63.96 -12.37 36.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.061 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.772 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 13.0 m -56.59 -38.37 71.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.665 0.269 . . . . 0.0 111.094 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.34 -24.15 67.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.826 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.7 HD13 ' HA ' ' A' ' 15' ' ' SER . 3.2 mp -79.73 -39.59 20.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.4 0.619 . . . . 0.0 110.224 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . 157.68 36.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.534 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.772 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 77.2 m -112.36 142.14 45.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.035 0.445 . . . . 0.0 110.573 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 m -119.53 133.45 55.67 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.013 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.4 t -70.54 121.86 18.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.349 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.1 tttp -140.09 117.14 11.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.241 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m 55.99 39.27 30.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.924 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 18.1 mttp 70.21 15.56 7.49 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.011 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.618 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.8 t -132.59 128.97 58.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 87.8 m -83.73 128.23 34.38 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.989 -0.445 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.646 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 5.9 m-85 -117.67 155.49 29.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.248 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.701 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 30.6 ttm180 -135.98 109.12 7.73 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.3 t30 . . . . . 0 C--N 1.327 -0.406 0 CA-C-O 121.507 0.67 . . . . 0.0 109.902 -178.58 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.449 0 N-CA-C 113.885 0.314 . . . . 0.0 113.885 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm -96.51 123.22 55.11 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 117.546 0.673 . . . . 0.0 110.723 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.668 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 50.7 Cg_exo -56.52 132.2 50.37 Favored 'Trans proline' 0 CA--C 1.517 -0.367 0 C-N-CA 122.474 2.116 . . . . 0.0 112.611 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.761 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 60.7 m -73.99 -10.89 60.1 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.272 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.0 -32.71 6.79 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.93 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -73.03 139.53 46.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.525 0.679 . . . . 0.0 110.516 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.5 m -107.48 130.35 54.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.873 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.3 p -100.54 47.84 0.92 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.166 0.508 . . . . 0.0 110.501 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.644 HG22 ' HB3' ' A' ' 25' ' ' LYS . 42.8 t -73.59 -48.85 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.77 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -101.02 -49.5 4.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.031 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.63 153.36 81.5 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.653 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -66.75 147.3 80.97 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.7 2.266 . . . . 0.0 111.813 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.2 m -66.94 149.28 50.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.512 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.5 mt -72.03 -35.62 54.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.375 0.607 . . . . 0.0 109.836 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.7 p -69.23 -3.25 13.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.477 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 31.3 m -56.5 -39.48 73.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.0 0.428 . . . . 0.0 110.679 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.74 -22.3 64.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.1 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.3 mm -78.71 -28.04 14.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.764 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 151.73 -16.42 0.83 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.836 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 16' ' ' SER . 76.0 m -67.88 139.74 56.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.372 0.606 . . . . 0.0 111.213 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.465 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 6.3 m -122.21 131.46 53.95 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.941 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.1 t -66.53 124.34 22.52 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.22 0.325 . . . . 0.0 110.334 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.465 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.6 mttm -142.64 115.57 8.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.099 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 53.8 m 55.37 38.38 30.23 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.441 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.644 ' HB3' HG22 ' A' ' 9' ' ' VAL . 8.3 mtmp? 74.95 13.89 3.28 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.727 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.644 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.3 t -133.44 128.72 55.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 90.6 m -83.1 125.55 31.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.849 0.357 . . . . 0.0 110.965 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.668 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 5.8 m-85 -115.55 151.37 35.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.819 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.761 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 27.7 ttm180 -130.95 110.41 11.24 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 121.457 0.646 . . . . 0.0 110.089 -178.756 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 114.038 0.375 . . . . 0.0 114.038 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.4 mm -100.46 123.78 45.03 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 117.339 0.569 . . . . 0.0 110.74 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.687 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.3 Cg_exo -55.47 133.38 57.74 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.539 2.16 . . . . 0.0 112.472 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 35.2 m -76.53 -5.79 49.09 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.511 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.11 -32.83 5.83 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.689 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.504 ' OE2' HG22 ' A' ' 14' ' ' ILE . 48.5 mt-10 -76.47 145.15 39.42 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.464 0.65 . . . . 0.0 110.734 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.3 m -119.02 132.57 56.06 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.049 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -89.77 58.08 4.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.639 0.733 . . . . 0.0 109.706 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.637 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 22.5 t -63.72 -48.67 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.319 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -130.7 -40.63 1.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.779 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 26.6 pt -116.88 155.18 49.48 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.032 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 11' ' ' ILE . 8.0 Cg_exo -70.67 145.82 52.9 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.837 2.358 . . . . 0.0 111.755 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.5 m -69.99 147.3 50.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.17 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.504 HG22 ' OE2' ' A' ' 6' ' ' GLU . 10.6 tp -71.82 -34.73 52.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.965 0.412 . . . . 0.0 110.352 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.667 ' HA ' HD13 ' A' ' 18' ' ' ILE . 14.3 m -66.72 -14.83 63.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.251 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.714 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 70.2 m -59.67 -32.79 70.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.717 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.96 -25.47 66.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.667 HD13 ' HA ' ' A' ' 15' ' ' SER . 3.2 mp -81.3 -46.7 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.304 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.53 34.05 0.02 OUTLIER Glycine 0 C--N 1.319 -0.414 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.086 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.714 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 72.3 m -108.59 143.31 37.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.12 0.486 . . . . 0.0 110.683 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 12.3 p -121.91 137.26 54.86 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.518 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -71.25 115.16 10.08 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -133.76 115.83 15.01 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.8 m 57.34 37.61 28.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.043 0.449 . . . . 0.0 110.695 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.637 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 14.5 ttmm 71.9 12.07 6.16 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.53 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.699 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 18.1 t -127.94 129.81 69.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 97.3 m -82.11 124.79 30.17 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 122.051 -0.405 . . . . 0.0 111.062 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.699 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 5.4 m-85 -116.51 151.12 36.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.799 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.563 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 31.7 ttp85 -128.89 118.19 22.27 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.45 ' OD1' ' HG2' ' A' ' 29' ' ' ARG . 5.0 p-10 . . . . . 0 N--CA 1.469 0.504 0 O-C-N 123.954 0.784 . . . . 0.0 111.783 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.396 0 CA-C-O 120.177 -0.235 . . . . 0.0 113.484 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.9 mt -94.2 121.96 62.63 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 117.224 0.512 . . . . 0.0 110.551 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.694 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.3 Cg_exo -56.14 129.9 37.34 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.39 2.06 . . . . 0.0 112.64 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.812 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 76.5 m -74.09 -4.86 38.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.236 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.09 -27.39 8.37 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.487 ' OE1' ' HB2' ' A' ' 15' ' ' SER . 32.3 mt-10 -68.0 138.97 56.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.523 0.677 . . . . 0.0 110.873 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -111.74 125.17 53.7 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.441 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.1 p -98.68 43.79 1.05 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.288 0.566 . . . . 0.0 110.215 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.059 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 38.9 t -73.12 -51.18 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.112 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.642 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 3.8 m-90 -97.28 -51.02 4.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.156 0.503 . . . . 0.0 110.902 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.1 pt -130.95 156.12 80.54 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.688 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.35 146.7 81.44 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.642 2.228 . . . . 0.0 111.916 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 6' ' ' GLU . 24.1 m -66.97 146.44 54.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.72 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.817 HD13 ' H ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -75.31 -35.04 32.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.006 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.487 ' HB2' ' OE1' ' A' ' 6' ' ' GLU . 11.1 m -76.38 5.1 7.66 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.447 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 36.1 m -58.8 -41.02 85.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 110.611 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.51 -24.98 67.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.227 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.0 mt -76.18 -25.72 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.951 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.13 -13.71 0.73 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.057 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 56.6 m -71.67 139.03 49.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.362 0.601 . . . . 0.0 111.289 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.491 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 7.7 m -125.0 130.76 53.01 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.729 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.0 t -65.19 120.78 13.36 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.245 0.341 . . . . 0.0 110.395 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.7 mttm -141.44 115.94 9.56 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.1 m 56.2 39.59 30.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 111.026 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 1.059 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 46.4 mmtm 71.63 12.43 6.4 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.167 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.637 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.4 t -130.89 128.22 62.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 86.5 m -83.62 122.9 29.2 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.965 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.694 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 4.5 m-85 -111.5 151.09 29.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.907 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.812 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.0 ttm180 -128.45 112.06 13.96 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.393 0.616 . . . . 0.0 110.071 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.36 0 CA-C-O 120.337 -0.146 . . . . 0.0 113.436 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -98.86 128.37 32.62 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 117.114 0.457 . . . . 0.0 110.618 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.68 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 47.9 Cg_exo -58.37 130.89 39.75 Favored 'Trans proline' 0 CA--C 1.517 -0.36 0 C-N-CA 122.312 2.008 . . . . 0.0 112.155 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.734 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 52.8 m -73.59 -6.29 45.66 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.69 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.5 -31.84 7.09 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.647 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.637 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 98.8 mt-10 -77.76 138.91 39.27 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.457 0.646 . . . . 0.0 109.839 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 m -117.42 134.78 54.45 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.914 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -96.17 46.35 1.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.229 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.925 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 39.9 t -66.4 -42.53 90.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.84 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -127.35 -46.73 1.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.339 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.7 tp -117.33 136.72 23.55 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.761 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.85 148.62 91.69 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.296 1.997 . . . . 0.0 111.826 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.637 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 4.3 m -69.15 147.08 51.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.951 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.428 ' H ' HD12 ' A' ' 14' ' ' ILE . 4.4 mp -77.18 -37.67 26.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.581 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.84 ' HA ' HD13 ' A' ' 18' ' ' ILE . 5.1 t -68.02 -7.4 28.75 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.364 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.579 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 69.2 m -59.27 -37.72 78.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.755 0.312 . . . . 0.0 110.928 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.21 -25.49 67.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.178 0.513 . . . . 0.0 111.098 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.84 HD13 ' HA ' ' A' ' 15' ' ' SER . 2.9 mp -76.24 -25.47 16.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.617 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.15 -16.5 0.79 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.874 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.579 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 57.5 m -66.18 138.98 58.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.405 0.622 . . . . 0.0 111.489 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 p -121.71 135.21 54.95 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.101 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.7 t -66.43 123.31 19.64 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.984 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -138.17 113.81 9.71 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 m 56.27 38.78 30.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.432 0.634 . . . . 0.0 110.303 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.925 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 72.6 mttt 68.33 20.0 8.81 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.164 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.667 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.6 t -132.08 127.24 57.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 89.0 m -84.94 123.18 30.22 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.109 0.481 . . . . 0.0 111.777 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.68 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 2.9 m-85 -116.05 150.88 36.57 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.816 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.734 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 44.7 ttt-85 -135.34 121.03 19.51 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.324 -178.191 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 113.875 0.31 . . . . 0.0 113.875 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.8 mm -95.63 125.18 50.27 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 117.352 0.576 . . . . 0.0 110.661 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 52.9 Cg_exo -57.14 131.24 44.01 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 C-N-CA 122.424 2.082 . . . . 0.0 112.494 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.83 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 69.9 m -72.89 -10.42 59.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.333 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.27 -33.05 6.78 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.867 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -75.07 141.18 43.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.519 0.676 . . . . 0.0 110.251 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 m -116.07 130.55 56.86 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.417 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.25 48.38 1.16 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.041 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.933 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 39.2 t -65.3 -40.82 89.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.545 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -132.82 -47.12 0.87 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.336 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.5 tp -110.84 134.91 20.83 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.91 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -63.95 147.47 91.93 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.334 2.022 . . . . 0.0 111.643 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.2 m -63.96 145.48 55.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.408 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mp -75.31 -43.88 42.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.967 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.74 ' O ' HG12 ' A' ' 18' ' ' ILE . 8.3 m -76.32 15.43 0.59 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.064 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.759 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 18.6 p -63.89 -39.01 93.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.233 0.54 . . . . 0.0 110.595 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.99 -28.06 67.39 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 15' ' ' SER . 11.4 pt -78.65 -3.62 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.99 -17.94 3.83 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.006 -1.093 . . . . 0.0 113.36 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.759 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 57.3 m -66.6 131.62 46.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.467 0.651 . . . . 0.0 111.314 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 15.2 m -117.5 137.0 52.84 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.932 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -72.82 120.28 18.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.964 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.625 ' HD3' ' CE1' ' A' ' 28' ' ' TYR . 6.9 tttt -139.53 119.57 13.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.1 m 57.84 35.76 25.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.26 0.552 . . . . 0.0 109.923 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.933 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 73.2 mttt 66.61 23.51 10.32 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.562 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.606 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 24.6 t -134.73 127.23 48.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.544 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 94.0 m -83.85 123.1 29.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.983 0.421 . . . . 0.0 111.449 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.669 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 3.9 m-85 -113.78 152.45 30.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.674 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.83 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 57.8 ttt180 -130.48 110.72 11.67 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.0 m120 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.58 -178.771 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.358 0 CA-C-O 120.32 -0.156 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.3 124.19 50.01 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 117.068 0.434 . . . . 0.0 110.334 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.652 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 50.7 Cg_exo -56.31 132.18 50.3 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.418 2.079 . . . . 0.0 112.491 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 80.5 m -72.61 -10.46 59.82 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.21 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.03 -32.03 7.57 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.849 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.694 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 97.3 mt-10 -78.25 138.24 38.52 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.592 0.71 . . . . 0.0 110.455 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 m -107.94 134.33 51.01 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.151 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.532 ' O ' ' HD2' ' A' ' 25' ' ' LYS . 1.7 p -101.0 37.88 1.66 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.237 0.542 . . . . 0.0 110.117 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.637 ' HB ' ' CE3' ' A' ' 10' ' ' TRP . 39.5 t -64.35 -52.4 56.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.999 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.637 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 3.8 m-90 -96.71 -55.55 2.86 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.175 0.512 . . . . 0.0 110.434 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 23.4 pt -125.96 156.59 71.41 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.301 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.85 147.31 89.39 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.55 2.167 . . . . 0.0 111.997 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.694 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 27.6 m -65.1 142.35 58.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.701 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.2 pt -77.05 -35.65 23.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.98 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.49 ' HB3' HD12 ' A' ' 18' ' ' ILE . 50.4 m -79.75 12.17 2.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.834 0.349 . . . . 0.0 111.606 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.887 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 19.4 p -60.95 -36.01 78.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.768 0.318 . . . . 0.0 110.964 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.6 -23.25 62.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.473 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 15' ' ' SER . 60.9 mt -70.86 -25.8 26.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.652 0.739 . . . . 0.0 110.289 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.95 31.84 0.29 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.661 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.887 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 60.0 m -103.34 137.46 41.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.192 0.52 . . . . 0.0 110.765 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.487 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 11.2 m -119.48 134.09 55.38 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.053 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.1 t -67.74 120.08 13.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.19 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.4 mttm -139.72 115.58 10.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 t 58.35 36.64 25.66 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.36 0.6 . . . . 0.0 109.854 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.532 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 28.6 mmtp 68.49 19.79 8.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.797 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.666 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 22.6 t -132.91 128.05 56.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 90.8 m -83.61 121.87 27.83 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.89 0.376 . . . . 0.0 111.357 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.666 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 5.0 m-85 -112.38 152.58 28.45 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.025 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.603 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 49.4 ttp85 -133.84 113.59 12.42 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 121.301 0.572 . . . . 0.0 109.952 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 N-CA-C 113.808 0.283 . . . . 0.0 113.808 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.29 124.0 52.87 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 117.36 0.58 . . . . 0.0 110.759 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.673 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.6 Cg_exo -57.34 130.67 40.42 Favored 'Trans proline' 0 CA--C 1.516 -0.38 0 C-N-CA 122.415 2.076 . . . . 0.0 112.471 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.784 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 72.6 m -72.94 -9.7 59.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.319 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.28 -32.89 6.64 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.582 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -73.09 140.61 47.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.503 0.668 . . . . 0.0 110.507 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -114.47 130.77 56.75 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.842 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.8 48.78 1.38 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.378 0.608 . . . . 0.0 110.126 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.585 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 45.1 t -64.69 -57.25 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.924 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 59.2 m95 -102.8 -47.82 4.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.091 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.84 158.88 69.06 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.25 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -68.21 147.14 72.03 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.795 2.33 . . . . 0.0 111.997 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.6 m -64.82 151.97 44.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.93 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 13.9 tt -75.8 -38.48 37.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.426 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 m -76.6 9.75 2.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.741 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 22.9 p -59.19 -49.25 78.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.896 0.379 . . . . 0.0 110.906 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.7 -22.54 67.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.471 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.8 mt -75.07 -24.52 17.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.614 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.75 -14.99 0.92 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.208 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 36.4 m -74.15 132.6 42.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.461 0.648 . . . . 0.0 111.592 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 14.6 m -115.18 136.63 52.91 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.959 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 51.7 t -70.61 120.16 15.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.836 0.351 . . . . 0.0 110.564 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -139.73 118.52 12.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.966 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.8 m 56.64 36.68 28.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.141 0.495 . . . . 0.0 110.334 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.585 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER 69.52 17.63 7.93 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.956 -179.423 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.618 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 24.7 t -132.82 129.44 58.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 89.1 m -83.7 122.27 28.4 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.042 0.449 . . . . 0.0 111.336 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.673 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 4.4 m-85 -112.8 152.21 29.45 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.608 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.784 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 66.2 ttt180 -130.87 111.68 12.32 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.9 m120 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.707 -178.886 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.43 0 N-CA-C 113.882 0.313 . . . . 0.0 113.882 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.5 mm -96.68 126.58 42.63 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 117.307 0.554 . . . . 0.0 110.864 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.654 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 51.6 Cg_exo -57.33 130.45 39.33 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.403 2.069 . . . . 0.0 112.366 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.666 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 34.8 m -72.25 -8.42 54.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.558 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.1 -30.97 8.19 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.189 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -74.59 142.21 44.66 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.511 0.672 . . . . 0.0 110.672 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 m -109.59 128.81 55.48 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.01 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -94.38 48.12 1.22 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.11 0.481 . . . . 0.0 110.713 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.21 -57.3 5.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.493 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -98.64 -37.22 9.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.724 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.573 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.0 tt -146.21 138.96 14.06 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.339 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HD2' HG13 ' A' ' 11' ' ' ILE . 8.3 Cg_endo -53.59 144.57 51.81 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.88 2.386 . . . . 0.0 112.779 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.2 m -65.4 147.35 53.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.832 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mm -73.04 -38.76 56.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.115 0.484 . . . . 0.0 110.303 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.567 ' O ' HG12 ' A' ' 18' ' ' ILE . 6.8 m -68.7 -4.55 16.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.227 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.696 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 15.6 m -58.1 -35.33 71.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.105 0.479 . . . . 0.0 110.638 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.69 -32.62 74.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.573 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.567 HG12 ' O ' ' A' ' 15' ' ' SER . 27.1 pt -86.74 5.9 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.78 -18.52 4.55 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 119.634 -1.27 . . . . 0.0 114.538 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.696 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 83.6 m -67.71 139.68 56.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.618 0.709 . . . . 0.0 111.803 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.0 m -125.1 135.38 52.63 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.747 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.3 t -69.74 125.08 25.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.093 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -146.6 119.42 8.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.132 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.608 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 10.8 m 56.85 39.61 29.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.967 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 24' ' ' SER . 8.7 ptpt 70.98 9.19 6.73 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.446 1.098 . . . . 0.0 112.038 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 t -128.39 130.43 69.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.209 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 91.5 m -83.72 127.2 33.61 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 122.189 -0.319 . . . . 0.0 110.738 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 2.9 m-85 -115.37 153.2 31.44 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.666 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 62.4 ttt-85 -136.09 115.49 12.67 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.724 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.342 0 CA-C-O 120.369 -0.128 . . . . 0.0 113.294 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.4 mm -96.37 125.64 46.83 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 117.026 0.413 . . . . 0.0 110.384 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.654 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.6 Cg_exo -57.15 132.64 52.54 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.353 2.035 . . . . 0.0 112.358 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 72.5 m -72.11 -7.84 51.26 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.562 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.33 -31.38 8.1 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.246 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -79.69 141.04 36.79 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.693 0.759 . . . . 0.0 111.038 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 m -107.74 129.55 55.03 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.0 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -99.92 51.03 0.91 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.56 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.57 -45.53 77.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.803 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -117.57 -48.56 2.59 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.952 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.6 pt -117.85 151.26 48.49 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.837 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.3 146.11 68.15 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.664 2.243 . . . . 0.0 111.661 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 10.0 m -66.55 148.41 51.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.488 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -71.92 -43.11 68.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.298 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.4 p -68.03 -3.13 9.17 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.866 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 18.3 m -57.99 -40.81 81.62 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.708 0.289 . . . . 0.0 110.609 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.02 67.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.607 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.8 mt -76.74 -37.14 27.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.408 0.623 . . . . 0.0 110.284 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . 155.42 33.36 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.704 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.866 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 83.9 m -109.92 138.67 45.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.17 0.509 . . . . 0.0 110.605 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.8 m -118.97 117.74 29.62 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.923 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 32.8 t -62.9 137.79 58.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.848 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -166.83 128.92 1.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.096 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.64 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 9.4 t 57.29 41.9 25.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 24' ' ' SER . 0.9 OUTLIER 62.6 16.06 8.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.777 1.231 . . . . 0.0 112.413 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.662 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.3 t -134.29 130.76 54.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.147 0.498 . . . . 0.0 110.995 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 89.5 m -84.14 128.1 34.34 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.102 178.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.662 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 6.6 m-85 -119.01 153.75 34.18 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.794 0.331 . . . . 0.0 110.173 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.615 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 29.5 ttm180 -134.61 114.8 13.14 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.654 -178.708 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.406 0 CA-C-O 120.174 -0.237 . . . . 0.0 113.678 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.2 mm -96.49 124.46 50.85 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 117.31 0.555 . . . . 0.0 110.585 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.67 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.4 Cg_exo -56.98 130.39 39.54 Favored 'Trans proline' 0 CA--C 1.516 -0.392 0 C-N-CA 122.405 2.07 . . . . 0.0 112.51 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.795 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 76.0 m -73.46 -8.49 56.12 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.4 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.33 -28.44 8.95 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.588 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.714 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 94.4 mt-10 -74.69 137.3 42.05 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.535 0.683 . . . . 0.0 109.957 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.2 m -108.92 131.8 54.67 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.681 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.0 p -99.41 45.02 1.0 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.581 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.621 ' HB ' ' CE3' ' A' ' 10' ' ' TRP . 21.6 t -76.3 -52.1 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.145 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.621 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 5.1 m-90 -93.74 -49.23 5.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.305 0.574 . . . . 0.0 110.935 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.0 pt -136.23 159.41 70.94 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.018 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -63.74 146.88 92.56 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.392 2.062 . . . . 0.0 111.637 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.714 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 36.5 m -66.33 149.86 49.73 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.797 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.453 ' H ' HD12 ' A' ' 14' ' ' ILE . 4.2 mp -72.69 -41.05 62.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.969 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -73.14 5.44 3.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 31.4 m -60.5 -41.66 94.77 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.945 0.402 . . . . 0.0 110.512 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.78 -25.8 67.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.281 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.5 mt -74.91 -25.36 18.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.009 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.18 -8.86 1.09 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.101 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 40.7 m -73.92 136.04 43.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.339 0.59 . . . . 0.0 111.147 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.497 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 5.7 m -118.71 131.09 56.14 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.681 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.1 t -64.91 121.52 14.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.275 0.36 . . . . 0.0 110.227 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.5 mttm -141.08 113.0 7.75 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.548 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 48.8 m 54.31 45.76 26.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.305 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 24' ' ' SER . 1.2 pttm 71.33 4.87 5.23 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.838 1.255 . . . . 0.0 112.518 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.62 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.1 t -125.35 127.91 72.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 120.856 0.36 . . . . 0.0 110.324 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 91.8 m -83.95 120.93 26.7 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.815 0.34 . . . . 0.0 110.827 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.67 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 5.0 m-85 -109.42 151.78 26.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.143 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.795 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.6 ttm180 -130.31 113.65 14.65 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-O 121.317 0.58 . . . . 0.0 110.159 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.401 0 N-CA-C 113.828 0.291 . . . . 0.0 113.828 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 51.2 mm -95.85 126.9 43.15 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 117.266 0.533 . . . . 0.0 110.709 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.662 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.6 Cg_exo -57.09 132.73 53.24 Favored 'Trans proline' 0 CA--C 1.518 -0.323 0 C-N-CA 122.48 2.12 . . . . 0.0 112.458 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 74.4 m -74.11 -9.12 58.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.281 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.36 -31.58 7.89 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.637 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.684 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 95.0 mt-10 -76.6 139.64 40.72 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.456 0.646 . . . . 0.0 110.094 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.1 m -114.95 133.55 55.92 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.001 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -97.73 51.22 1.06 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.816 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.851 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 36.8 t -62.84 -40.0 87.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.03 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -128.82 -49.48 1.24 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.088 0.471 . . . . 0.0 110.383 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.744 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -114.23 153.29 46.42 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.408 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -65.78 147.8 85.91 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.559 2.173 . . . . 0.0 111.648 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.684 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 8.3 m -69.44 150.12 47.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.417 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 mm -70.03 -41.41 79.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.274 0.559 . . . . 0.0 109.892 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.801 ' HA ' HD13 ' A' ' 18' ' ' ILE . 68.0 m -69.17 -6.76 30.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.878 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 74.2 m -62.67 -35.43 79.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.927 0.394 . . . . 0.0 110.287 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.2 -24.32 65.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.698 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.801 HD13 ' HA ' ' A' ' 15' ' ' SER . 2.7 mp -78.7 -34.23 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.395 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.48 -14.25 0.18 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.311 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 46.3 m -66.35 133.02 49.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.492 0.663 . . . . 0.0 111.414 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 13.4 m -107.29 135.38 48.89 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.16 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.0 t -73.31 118.86 16.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 0.0 110.723 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -132.16 118.4 19.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 p 49.97 42.2 24.17 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.643 0.735 . . . . 0.0 111.087 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.851 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 74.4 mttt 67.87 20.97 9.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.544 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.624 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.6 t -133.39 126.18 51.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 93.4 m -83.87 124.56 31.1 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.989 0.423 . . . . 0.0 111.661 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.662 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 3.9 m-85 -115.5 154.42 29.36 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.883 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.577 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 48.8 ttp85 -138.16 114.83 10.57 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.8 t30 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.504 -178.164 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.305 0 CA-C-O 120.309 -0.162 . . . . 0.0 113.382 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.1 mt -95.3 123.99 55.05 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 117.014 0.407 . . . . 0.0 110.425 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.686 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.2 Cg_exo -57.22 132.46 51.28 Favored 'Trans proline' 0 CA--C 1.516 -0.411 0 C-N-CA 122.3 2.0 . . . . 0.0 112.063 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 90.0 m -74.3 -6.53 48.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.518 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.74 -28.83 9.38 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.78 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.695 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 94.8 mt-10 -77.38 136.4 38.42 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.593 0.711 . . . . 0.0 110.149 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.5 m -109.45 132.13 54.42 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.659 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 3.6 p -103.45 51.36 0.79 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.048 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.61 HG13 ' HD2' ' A' ' 25' ' ' LYS . 40.5 t -65.86 -41.89 90.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.957 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -124.1 -49.5 1.83 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.524 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 27.7 pt -112.8 150.83 43.39 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.69 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -66.41 147.71 83.12 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.648 2.232 . . . . 0.0 111.636 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.695 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 8.8 m -69.94 149.53 47.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.338 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.9 mm -70.55 -41.57 78.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.149 0.499 . . . . 0.0 110.152 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.802 ' HA ' HD13 ' A' ' 18' ' ' ILE . 70.2 m -70.76 -3.51 19.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.024 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 75.3 m -63.02 -35.84 81.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.926 0.393 . . . . 0.0 110.337 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.64 -22.61 64.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.732 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.802 HD13 ' HA ' ' A' ' 15' ' ' SER . 2.6 mp -79.59 -34.07 15.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.4 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.82 -16.76 0.19 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.18 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 34.8 m -65.12 131.28 46.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.549 0.69 . . . . 0.0 111.244 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.43 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 2.6 m -104.49 127.19 52.14 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.13 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.7 t -72.37 128.67 36.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.45 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.433 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 12.4 ptpt -158.19 127.58 5.79 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m 58.82 33.77 23.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.115 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.61 ' HD2' HG13 ' A' ' 9' ' ' VAL . 51.6 mtmt 69.57 17.67 7.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.567 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.703 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 17.5 t -135.4 129.41 49.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.043 0.449 . . . . 0.0 110.053 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 84.9 m -86.81 122.88 31.3 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.921 0.391 . . . . 0.0 111.044 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.703 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 3.5 m-85 -114.39 153.37 29.98 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.939 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.487 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 41.6 ttp85 -137.02 114.31 10.84 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.7 t30 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.602 -178.257 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.465 0 N-CA-C 114.178 0.431 . . . . 0.0 114.178 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -94.43 121.95 62.25 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 117.569 0.685 . . . . 0.0 110.883 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 50.3 Cg_exo -56.29 131.42 45.69 Favored 'Trans proline' 0 CA--C 1.518 -0.307 0 C-N-CA 122.523 2.149 . . . . 0.0 112.717 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.781 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 70.1 m -71.62 -11.26 60.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.467 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.65 -31.19 8.4 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.063 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -75.45 140.17 42.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.5 0.667 . . . . 0.0 110.322 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 m -106.73 130.47 54.44 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.144 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -96.75 49.29 1.08 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.117 0.484 . . . . 0.0 110.752 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.592 HG22 ' HB2' ' A' ' 25' ' ' LYS . 22.0 t -80.29 -59.9 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.405 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -91.83 -36.29 13.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.418 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.463 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.4 tt -149.31 140.96 14.65 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.854 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.463 ' HD2' HG13 ' A' ' 11' ' ' ILE . 37.9 Cg_exo -57.58 147.69 77.66 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.346 2.03 . . . . 0.0 112.0 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.7 m -64.84 148.73 50.78 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.1 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 mm -74.68 -40.16 47.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.354 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 18' ' ' ILE . 55.9 p -70.99 0.87 6.49 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.796 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 16.1 m -60.91 -35.61 77.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.252 0.549 . . . . 0.0 110.614 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.33 -29.71 70.97 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 15' ' ' SER . 38.7 pt -92.42 7.41 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.05 -25.0 2.68 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 119.214 -1.47 . . . . 0.0 114.536 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.796 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 69.9 m -68.25 142.68 55.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.5 0.667 . . . . 0.0 111.842 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 3.4 p -129.86 133.85 47.16 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.963 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 t -70.38 124.08 23.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.866 0.365 . . . . 0.0 111.317 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -148.56 121.28 8.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.857 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.684 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 11.2 m 55.22 47.23 22.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.684 ' HG3' ' O ' ' A' ' 24' ' ' SER . 0.0 OUTLIER 57.9 15.66 3.21 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.206 1.402 . . . . 0.0 112.754 -178.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.6 t -130.55 130.06 64.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.035 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 99.6 m -83.56 128.01 34.19 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 122.08 -0.388 . . . . 0.0 110.681 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.669 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 4.2 m-85 -113.98 154.08 28.23 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.95 0.405 . . . . 0.0 110.222 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.781 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 29.8 ttm180 -132.22 103.94 6.5 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.674 -178.353 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 120.447 -0.085 . . . . 0.0 113.257 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.5 mt -94.5 122.19 61.6 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.864 0.332 . . . . 0.0 110.433 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.625 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 52.2 Cg_exo -55.06 133.05 55.92 Favored 'Trans proline' 0 CA--C 1.519 -0.247 0 C-N-CA 122.478 2.119 . . . . 0.0 112.448 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 71.0 m -76.64 -2.46 32.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.463 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.17 -31.54 6.26 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 48.5 mt-10 -65.47 141.73 58.39 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.551 0.691 . . . . 0.0 111.07 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -117.57 125.61 51.11 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.603 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.8 p -96.94 45.52 1.05 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.391 0.615 . . . . 0.0 110.864 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.646 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 36.5 t -67.66 -52.94 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.655 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -114.82 -48.08 2.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.256 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 27.5 pt -108.28 143.71 27.97 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.127 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.08 164.31 34.68 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.645 2.23 . . . . 0.0 112.487 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.602 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 1.5 m -58.53 130.01 44.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.34 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.5 tt -86.63 -32.02 6.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.7 m -86.06 21.75 1.91 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.341 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.602 ' OG ' ' HB2' ' A' ' 13' ' ' CYS . 68.9 m -54.41 -36.19 63.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.98 0.419 . . . . 0.0 111.092 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.77 -25.84 67.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.526 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.464 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 5.9 mm -86.92 38.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.145 0.497 . . . . 0.0 110.63 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.05 30.61 74.1 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.775 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 98.8 m -106.72 146.66 30.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.88 0.371 . . . . 0.0 110.359 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.3 t -148.43 141.07 24.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.342 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.3 t -67.64 125.31 25.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.092 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -144.68 115.67 7.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.886 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.6 m 57.13 41.68 26.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.186 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.646 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 1.2 tptt 72.26 7.61 5.73 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.059 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.745 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.2 t -130.44 131.1 65.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 43.2 m -79.34 128.62 33.56 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.745 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 11.5 m-85 -121.43 155.84 34.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.102 0.477 . . . . 0.0 110.812 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.694 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 38.8 ttp180 -131.71 112.83 12.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.2 p30 . . . . . 0 N--CA 1.473 0.691 0 O-C-N 124.145 0.903 . . . . 0.0 111.993 -178.228 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 CA-C-O 120.256 -0.191 . . . . 0.0 113.403 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.2 mm -96.55 124.31 51.23 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 117.15 0.475 . . . . 0.0 110.469 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.651 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.4 Cg_exo -56.54 131.7 47.27 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 122.41 2.073 . . . . 0.0 112.493 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 91.7 m -71.87 -8.47 54.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.338 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.01 -30.85 8.34 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.696 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.64 137.53 40.79 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.682 0.753 . . . . 0.0 110.548 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -110.25 129.47 55.72 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.52 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 p -97.79 47.51 1.01 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.177 0.513 . . . . 0.0 110.254 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.051 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 44.1 t -66.92 -52.38 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.071 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -105.45 -49.55 3.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.5 pt -125.69 148.37 61.78 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.72 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.12 150.42 88.68 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.592 2.195 . . . . 0.0 112.738 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.9 m -67.27 150.48 48.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.606 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.4 pt -77.68 -38.38 25.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.618 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.416 ' HB3' HD11 ' A' ' 18' ' ' ILE . 13.8 m -79.11 12.15 2.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.849 0.357 . . . . 0.0 111.706 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.594 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 52.6 p -66.77 -44.92 80.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.163 0.506 . . . . 0.0 110.745 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.68 -26.19 65.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.553 HG13 HH22 ' A' ' 29' ' ' ARG . 18.8 pt -93.6 10.85 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.2 -31.04 2.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 119.191 -1.48 . . . . 0.0 115.138 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.594 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 56.0 m -68.68 130.73 43.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.805 0.803 . . . . 0.0 111.48 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.454 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 3.7 m -111.39 125.47 53.9 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.182 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 25.9 t -71.24 126.91 30.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.523 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 21' ' ' SER . 12.5 ptpt -157.86 128.92 6.55 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m 58.78 34.62 23.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.052 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 1.051 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 46.9 mmtm 69.68 15.47 8.09 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.82 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.684 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 20.2 t -135.19 130.82 51.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.431 . . . . 0.0 110.351 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 98.1 m -85.48 122.6 29.84 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.852 0.358 . . . . 0.0 110.621 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.684 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 6.0 m-85 -111.95 154.23 25.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.481 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.6 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 52.0 ttm-85 -131.4 111.45 11.84 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.964 -179.409 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.488 0 N-CA-C 113.917 0.327 . . . . 0.0 113.917 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.3 mm -96.36 125.79 46.28 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 117.329 0.565 . . . . 0.0 110.719 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 51.7 Cg_exo -56.9 131.97 48.79 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.428 2.086 . . . . 0.0 112.426 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.667 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 59.8 m -70.78 -10.3 59.2 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.483 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.91 -32.64 7.28 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.039 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.662 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 99.2 mt-10 -80.33 139.65 36.5 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.51 0.671 . . . . 0.0 110.207 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 5.4 m -109.75 135.42 50.69 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.892 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -101.77 50.45 0.85 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.447 0.642 . . . . 0.0 109.742 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.522 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 31.2 t -62.66 -50.12 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.727 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -125.4 -41.55 2.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.49 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.454 HG13 ' HD2' ' A' ' 12' ' ' PRO . 10.9 tt -117.21 134.95 23.01 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.294 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.454 ' HD2' HG13 ' A' ' 11' ' ' ILE . 11.7 Cg_endo -59.16 148.86 83.81 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.629 2.22 . . . . 0.0 112.493 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.662 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 22.4 m -63.83 138.05 58.31 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.526 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.3 pt -77.22 -36.85 24.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.623 ' O ' HG12 ' A' ' 18' ' ' ILE . 19.4 m -83.12 16.75 2.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.946 0.403 . . . . 0.0 111.389 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.893 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 23.6 p -64.94 -27.72 69.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.937 0.398 . . . . 0.0 110.897 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.82 -21.56 29.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 15' ' ' SER . 23.7 pt -76.83 -6.41 8.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.872 0.367 . . . . 0.0 111.126 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.5 33.4 1.32 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.374 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.893 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 83.6 m -99.81 139.87 34.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.971 0.415 . . . . 0.0 110.717 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 21.7 t -119.21 137.5 53.6 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.565 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 51.5 t -73.49 122.04 21.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.943 0.402 . . . . 0.0 110.919 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -142.55 122.04 13.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.12 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m 57.03 36.82 28.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.576 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 16.0 mttp 68.03 21.21 8.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.588 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 42.5 t -137.73 131.02 42.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 93.0 m -83.56 126.8 33.19 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 122.039 -0.413 . . . . 0.0 110.784 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.683 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 3.8 m-85 -115.7 154.88 28.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.084 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.667 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 61.6 ttt-85 -137.59 112.43 8.95 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.6 t30 . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.738 -178.387 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.41 0 CA-C-O 120.145 -0.253 . . . . 0.0 113.649 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.7 mt -95.23 123.86 55.59 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 117.33 0.565 . . . . 0.0 110.683 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.668 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.6 Cg_exo -56.57 131.18 44.13 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 122.363 2.042 . . . . 0.0 112.486 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.815 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 57.3 m -72.96 -9.24 58.51 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.367 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.63 -33.08 6.32 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.785 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.44 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 49.9 mt-10 -74.68 140.83 44.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.6 0.714 . . . . 0.0 110.634 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -111.96 129.49 56.17 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.684 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -91.47 52.72 2.13 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.369 0.604 . . . . 0.0 110.202 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.611 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 48.1 t -67.13 -59.52 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.694 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 55.1 m95 -93.91 -51.04 5.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.07 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pp -131.14 161.64 60.5 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.069 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.42 146.24 61.69 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.797 2.331 . . . . 0.0 112.089 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 11.9 m -66.12 144.53 56.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.283 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.741 HD13 ' H ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -74.82 -27.79 20.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.021 0.439 . . . . 0.0 110.343 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.68 ' O ' HG12 ' A' ' 18' ' ' ILE . 10.1 p -67.46 -11.17 57.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.816 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.621 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 19.3 m -53.26 -32.46 48.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 111.469 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.94 -31.15 71.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.68 HG12 ' O ' ' A' ' 15' ' ' SER . 27.0 pt -89.74 5.45 4.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.54 -20.22 4.41 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.656 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.621 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 72.4 m -66.17 148.24 52.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.232 0.539 . . . . 0.0 111.05 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 p -143.45 133.06 23.65 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.49 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.9 t -64.32 123.65 19.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.93 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -144.72 115.61 7.82 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.5 m 56.7 38.81 29.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.179 0.514 . . . . 0.0 110.471 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.611 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 5.5 mptp? 70.26 13.27 7.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.092 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.652 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 20.1 t -129.71 129.24 66.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.5 m -83.48 124.83 31.1 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 122.001 -0.437 . . . . 0.0 111.067 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.668 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 6.0 m-85 -114.99 150.57 35.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.997 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.815 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 60.3 ttt180 -129.59 111.78 13.06 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 121.339 0.59 . . . . 0.0 110.139 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.51 0 N-CA-C 114.261 0.464 . . . . 0.0 114.261 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mm -95.43 123.31 56.98 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 117.57 0.685 . . . . 0.0 110.758 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.673 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 52.6 Cg_exo -57.39 130.11 37.46 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 122.505 2.137 . . . . 0.0 112.655 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.88 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 56.8 m -73.54 -8.26 55.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.273 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.55 -30.76 7.88 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.641 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.684 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 94.5 mt-10 -75.08 138.64 42.26 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.471 0.653 . . . . 0.0 110.037 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -113.55 131.45 56.08 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.784 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.1 p -94.78 45.3 1.11 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.594 0.712 . . . . 0.0 109.865 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.704 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 48.2 t -70.88 -55.0 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.888 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -103.91 -44.89 4.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.015 0.436 . . . . 0.0 110.909 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.551 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.2 tt -133.63 138.98 32.31 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.196 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HD2' HG13 ' A' ' 11' ' ' ILE . 9.5 Cg_endo -54.14 146.65 47.98 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.914 2.409 . . . . 0.0 112.744 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.684 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 5.4 m -67.86 144.74 55.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.745 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.9 tt -75.41 -34.98 31.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.154 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.77 ' HA ' HD13 ' A' ' 18' ' ' ILE . 66.3 m -71.16 -3.51 20.48 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.67 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.611 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 74.1 m -60.99 -35.18 76.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.756 0.313 . . . . 0.0 110.52 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.28 -28.54 69.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.176 0.512 . . . . 0.0 110.771 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.77 HD13 ' HA ' ' A' ' 15' ' ' SER . 2.8 mp -72.8 -26.6 23.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.247 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.424 ' HA3' ' NE ' ' A' ' 29' ' ' ARG . . . 148.21 -9.99 1.14 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.053 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 59.3 m -66.52 133.19 49.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.251 0.548 . . . . 0.0 110.663 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 13.8 m -110.41 136.58 49.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.959 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.9 t -74.47 117.31 16.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.793 0.33 . . . . 0.0 110.644 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.618 ' HD3' ' CE1' ' A' ' 28' ' ' TYR . 13.4 tttt -135.79 117.83 15.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.1 m 57.05 35.55 26.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.346 0.594 . . . . 0.0 109.963 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.704 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 59.1 mttm 68.21 20.41 8.85 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.668 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.576 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.2 t -129.85 125.94 61.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 85.3 m -85.25 122.64 29.72 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.016 0.436 . . . . 0.0 111.701 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 2.9 m-85 -113.36 151.05 31.77 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.68 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.88 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER -127.3 106.09 8.98 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.5 t30 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.093 -178.599 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.419 0 CA-C-O 120.184 -0.231 . . . . 0.0 113.659 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.2 mt -92.25 121.05 67.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 117.177 0.488 . . . . 0.0 110.667 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.661 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 50.6 Cg_exo -55.98 129.16 33.43 Favored 'Trans proline' 0 CA--C 1.52 -0.222 0 C-N-CA 122.486 2.124 . . . . 0.0 112.782 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.828 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 79.5 m -74.11 -1.98 22.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.496 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.33 -30.92 5.69 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 83.3 mt-10 -61.53 138.29 58.28 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.471 0.653 . . . . 0.0 110.357 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 m -117.48 125.6 51.17 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.592 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.2 p -93.54 46.8 1.21 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.652 0.739 . . . . 0.0 110.322 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.414 HG22 ' HE2' ' A' ' 25' ' ' LYS . 49.5 t -74.66 -38.96 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.703 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -130.06 -50.63 1.12 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.966 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.827 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -103.63 144.07 27.93 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.854 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.86 164.29 36.0 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.641 2.227 . . . . 0.0 112.422 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 16' ' ' SER . 3.5 m -54.79 125.88 21.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.483 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.0 pt -76.88 -38.39 28.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.496 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 10.5 m -90.77 32.9 0.95 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.104 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.496 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 2.4 p -60.59 -47.27 86.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.849 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.94 -22.44 66.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.046 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.5 mm -75.94 -26.89 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.584 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.56 -6.77 2.19 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.307 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 15' ' ' SER . 56.5 m -77.08 134.06 38.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.389 0.614 . . . . 0.0 111.275 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 18.3 m -127.57 136.31 51.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.652 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.7 t -68.81 127.19 32.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.895 0.378 . . . . 0.0 111.601 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -149.91 120.45 7.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.709 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m 58.33 36.7 25.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.854 0.359 . . . . 0.0 110.604 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HE2' HG22 ' A' ' 9' ' ' VAL . 59.8 mtpt 69.4 15.06 8.44 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.404 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.43 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 38.2 t -131.92 130.05 61.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.565 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 68.8 m -84.2 124.36 31.09 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 122.151 -0.343 . . . . 0.0 110.762 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.661 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 3.2 m-85 -112.34 153.76 26.75 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.626 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.828 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.6 ttm180 -128.85 108.92 10.83 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 121.381 0.61 . . . . 0.0 109.975 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.436 0 N-CA-C 113.835 0.294 . . . . 0.0 113.835 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.4 mt -94.39 123.53 58.28 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 117.357 0.579 . . . . 0.0 110.699 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.646 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 50.6 Cg_exo -56.12 131.97 49.09 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.431 2.088 . . . . 0.0 112.397 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 74.2 m -71.88 -8.31 53.59 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.75 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.05 -32.53 6.78 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.98 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.648 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 99.7 mt-10 -79.99 140.92 36.4 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.471 0.653 . . . . 0.0 110.011 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.8 m -111.91 135.11 52.97 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.707 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -98.57 51.01 0.99 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.483 0.658 . . . . 0.0 109.719 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.541 ' HA ' ' HG2' ' A' ' 25' ' ' LYS . 44.3 t -63.96 -49.69 80.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.639 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -116.23 -48.61 2.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.719 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.707 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -117.92 153.14 50.94 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.64 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -66.71 146.02 77.39 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.557 2.172 . . . . 0.0 111.653 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.648 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 6.2 m -67.81 148.27 51.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.346 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.2 mm -74.0 -37.59 47.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.285 0.564 . . . . 0.0 110.006 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.7 ' HA ' HD13 ' A' ' 18' ' ' ILE . 65.1 p -63.96 -12.37 36.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.061 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.772 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 13.0 m -56.59 -38.37 71.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.665 0.269 . . . . 0.0 111.094 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.34 -24.15 67.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.826 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.7 HD13 ' HA ' ' A' ' 15' ' ' SER . 3.2 mp -79.73 -39.59 20.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.4 0.619 . . . . 0.0 110.224 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . 157.68 36.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.534 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.772 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 77.2 m -112.36 142.14 45.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.035 0.445 . . . . 0.0 110.573 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 m -119.53 133.45 55.67 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.013 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.4 t -70.54 121.86 18.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.349 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.1 tttp -140.09 117.14 11.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.241 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m 55.99 39.27 30.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.924 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 9' ' ' VAL . 18.1 mttp 70.21 15.56 7.49 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.011 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.618 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.8 t -132.59 128.97 58.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 87.8 m -83.73 128.23 34.38 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.989 -0.445 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.646 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 5.9 m-85 -117.67 155.49 29.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.248 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.701 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 30.6 ttm180 -135.98 109.12 7.73 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.3 t30 . . . . . 0 C--N 1.327 -0.406 0 CA-C-O 121.507 0.67 . . . . 0.0 109.902 -178.58 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.449 0 N-CA-C 113.885 0.314 . . . . 0.0 113.885 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm -96.51 123.22 55.11 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 117.546 0.673 . . . . 0.0 110.723 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.668 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 50.7 Cg_exo -56.52 132.2 50.37 Favored 'Trans proline' 0 CA--C 1.517 -0.367 0 C-N-CA 122.474 2.116 . . . . 0.0 112.611 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.761 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 60.7 m -73.99 -10.89 60.1 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.272 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.0 -32.71 6.79 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.93 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -73.03 139.53 46.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.525 0.679 . . . . 0.0 110.516 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.5 m -107.48 130.35 54.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.873 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.3 p -100.54 47.84 0.92 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.166 0.508 . . . . 0.0 110.501 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.644 HG22 ' HB3' ' A' ' 25' ' ' LYS . 42.8 t -73.59 -48.85 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.77 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -101.02 -49.5 4.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.031 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.63 153.36 81.5 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.653 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -66.75 147.3 80.97 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.7 2.266 . . . . 0.0 111.813 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.2 m -66.94 149.28 50.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.512 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.5 mt -72.03 -35.62 54.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.375 0.607 . . . . 0.0 109.836 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.7 p -69.23 -3.25 13.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.477 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 31.3 m -56.5 -39.48 73.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.0 0.428 . . . . 0.0 110.679 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.74 -22.3 64.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.1 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.3 mm -78.71 -28.04 14.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.764 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 151.73 -16.42 0.83 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.836 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 16' ' ' SER . 76.0 m -67.88 139.74 56.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.372 0.606 . . . . 0.0 111.213 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.465 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 6.3 m -122.21 131.46 53.95 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.941 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.1 t -66.53 124.34 22.52 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.22 0.325 . . . . 0.0 110.334 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.465 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.6 mttm -142.64 115.57 8.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.099 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 53.8 m 55.37 38.38 30.23 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.441 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.644 ' HB3' HG22 ' A' ' 9' ' ' VAL . 8.3 mtmp? 74.95 13.89 3.28 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.727 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.644 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.3 t -133.44 128.72 55.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 90.6 m -83.1 125.55 31.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.849 0.357 . . . . 0.0 110.965 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.668 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 5.8 m-85 -115.55 151.37 35.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.819 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.761 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 27.7 ttm180 -130.95 110.41 11.24 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 121.457 0.646 . . . . 0.0 110.089 -178.756 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 114.038 0.375 . . . . 0.0 114.038 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.4 mm -100.46 123.78 45.03 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 117.339 0.569 . . . . 0.0 110.74 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.687 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.3 Cg_exo -55.47 133.38 57.74 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.539 2.16 . . . . 0.0 112.472 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 35.2 m -76.53 -5.79 49.09 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.511 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.11 -32.83 5.83 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.689 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.504 ' OE2' HG22 ' A' ' 14' ' ' ILE . 48.5 mt-10 -76.47 145.15 39.42 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.464 0.65 . . . . 0.0 110.734 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.3 m -119.02 132.57 56.06 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.049 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -89.77 58.08 4.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.639 0.733 . . . . 0.0 109.706 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.637 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 22.5 t -63.72 -48.67 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.319 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -130.7 -40.63 1.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.779 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 26.6 pt -116.88 155.18 49.48 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.032 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 11' ' ' ILE . 8.0 Cg_exo -70.67 145.82 52.9 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.837 2.358 . . . . 0.0 111.755 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.5 m -69.99 147.3 50.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.17 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.504 HG22 ' OE2' ' A' ' 6' ' ' GLU . 10.6 tp -71.82 -34.73 52.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.965 0.412 . . . . 0.0 110.352 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.667 ' HA ' HD13 ' A' ' 18' ' ' ILE . 14.3 m -66.72 -14.83 63.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.251 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.714 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 70.2 m -59.67 -32.79 70.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.717 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.96 -25.47 66.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.667 HD13 ' HA ' ' A' ' 15' ' ' SER . 3.2 mp -81.3 -46.7 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.304 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.53 34.05 0.02 OUTLIER Glycine 0 C--N 1.319 -0.414 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.086 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.714 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 72.3 m -108.59 143.31 37.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.12 0.486 . . . . 0.0 110.683 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 12.3 p -121.91 137.26 54.86 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.518 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -71.25 115.16 10.08 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -133.76 115.83 15.01 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.8 m 57.34 37.61 28.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.043 0.449 . . . . 0.0 110.695 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.637 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 14.5 ttmm 71.9 12.07 6.16 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.53 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.699 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 18.1 t -127.94 129.81 69.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 97.3 m -82.11 124.79 30.17 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 122.051 -0.405 . . . . 0.0 111.062 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.699 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 5.4 m-85 -116.51 151.12 36.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.799 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.563 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 31.7 ttp85 -128.89 118.19 22.27 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.45 ' OD1' ' HG2' ' A' ' 29' ' ' ARG . 5.0 p-10 . . . . . 0 N--CA 1.469 0.504 0 O-C-N 123.954 0.784 . . . . 0.0 111.783 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.396 0 CA-C-O 120.177 -0.235 . . . . 0.0 113.484 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.9 mt -94.2 121.96 62.63 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 117.224 0.512 . . . . 0.0 110.551 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.694 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.3 Cg_exo -56.14 129.9 37.34 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.39 2.06 . . . . 0.0 112.64 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.812 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 76.5 m -74.09 -4.86 38.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.236 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.09 -27.39 8.37 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.487 ' OE1' ' HB2' ' A' ' 15' ' ' SER . 32.3 mt-10 -68.0 138.97 56.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.523 0.677 . . . . 0.0 110.873 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -111.74 125.17 53.7 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.441 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.1 p -98.68 43.79 1.05 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.288 0.566 . . . . 0.0 110.215 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.059 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 38.9 t -73.12 -51.18 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.112 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.642 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 3.8 m-90 -97.28 -51.02 4.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.156 0.503 . . . . 0.0 110.902 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.1 pt -130.95 156.12 80.54 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.688 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.35 146.7 81.44 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.642 2.228 . . . . 0.0 111.916 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 6' ' ' GLU . 24.1 m -66.97 146.44 54.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.72 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.817 HD13 ' H ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -75.31 -35.04 32.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.006 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.487 ' HB2' ' OE1' ' A' ' 6' ' ' GLU . 11.1 m -76.38 5.1 7.66 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.447 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 36.1 m -58.8 -41.02 85.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 110.611 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.51 -24.98 67.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.227 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.0 mt -76.18 -25.72 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.951 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.13 -13.71 0.73 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.057 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 56.6 m -71.67 139.03 49.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.362 0.601 . . . . 0.0 111.289 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.491 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 7.7 m -125.0 130.76 53.01 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.729 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.0 t -65.19 120.78 13.36 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.245 0.341 . . . . 0.0 110.395 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.7 mttm -141.44 115.94 9.56 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.1 m 56.2 39.59 30.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 111.026 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 1.059 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 46.4 mmtm 71.63 12.43 6.4 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.167 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.637 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.4 t -130.89 128.22 62.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 86.5 m -83.62 122.9 29.2 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.965 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.694 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 4.5 m-85 -111.5 151.09 29.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.907 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.812 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.0 ttm180 -128.45 112.06 13.96 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.393 0.616 . . . . 0.0 110.071 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.36 0 CA-C-O 120.337 -0.146 . . . . 0.0 113.436 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -98.86 128.37 32.62 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 117.114 0.457 . . . . 0.0 110.618 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.68 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 47.9 Cg_exo -58.37 130.89 39.75 Favored 'Trans proline' 0 CA--C 1.517 -0.36 0 C-N-CA 122.312 2.008 . . . . 0.0 112.155 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.734 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 52.8 m -73.59 -6.29 45.66 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.69 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.5 -31.84 7.09 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.647 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.637 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 98.8 mt-10 -77.76 138.91 39.27 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.457 0.646 . . . . 0.0 109.839 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 m -117.42 134.78 54.45 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.914 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -96.17 46.35 1.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.229 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.925 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 39.9 t -66.4 -42.53 90.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.84 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -127.35 -46.73 1.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.339 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.7 tp -117.33 136.72 23.55 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.761 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.85 148.62 91.69 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.296 1.997 . . . . 0.0 111.826 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.637 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 4.3 m -69.15 147.08 51.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.951 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.428 ' H ' HD12 ' A' ' 14' ' ' ILE . 4.4 mp -77.18 -37.67 26.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.581 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.84 ' HA ' HD13 ' A' ' 18' ' ' ILE . 5.1 t -68.02 -7.4 28.75 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.364 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.579 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 69.2 m -59.27 -37.72 78.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.755 0.312 . . . . 0.0 110.928 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.21 -25.49 67.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.178 0.513 . . . . 0.0 111.098 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.84 HD13 ' HA ' ' A' ' 15' ' ' SER . 2.9 mp -76.24 -25.47 16.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.617 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.15 -16.5 0.79 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.874 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.579 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 57.5 m -66.18 138.98 58.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.405 0.622 . . . . 0.0 111.489 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 p -121.71 135.21 54.95 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.101 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.7 t -66.43 123.31 19.64 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.984 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -138.17 113.81 9.71 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 m 56.27 38.78 30.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.432 0.634 . . . . 0.0 110.303 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.925 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 72.6 mttt 68.33 20.0 8.81 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.164 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.667 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.6 t -132.08 127.24 57.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 89.0 m -84.94 123.18 30.22 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.109 0.481 . . . . 0.0 111.777 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.68 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 2.9 m-85 -116.05 150.88 36.57 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.816 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.734 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 44.7 ttt-85 -135.34 121.03 19.51 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.324 -178.191 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 113.875 0.31 . . . . 0.0 113.875 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.8 mm -95.63 125.18 50.27 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 117.352 0.576 . . . . 0.0 110.661 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 52.9 Cg_exo -57.14 131.24 44.01 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 C-N-CA 122.424 2.082 . . . . 0.0 112.494 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.83 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 69.9 m -72.89 -10.42 59.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.333 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.27 -33.05 6.78 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.867 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -75.07 141.18 43.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.519 0.676 . . . . 0.0 110.251 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 m -116.07 130.55 56.86 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.417 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.25 48.38 1.16 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.041 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.933 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 39.2 t -65.3 -40.82 89.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.545 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -132.82 -47.12 0.87 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.336 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.5 tp -110.84 134.91 20.83 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.91 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -63.95 147.47 91.93 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.334 2.022 . . . . 0.0 111.643 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.2 m -63.96 145.48 55.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.408 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mp -75.31 -43.88 42.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.967 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.74 ' O ' HG12 ' A' ' 18' ' ' ILE . 8.3 m -76.32 15.43 0.59 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.064 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.759 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 18.6 p -63.89 -39.01 93.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.233 0.54 . . . . 0.0 110.595 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.99 -28.06 67.39 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 15' ' ' SER . 11.4 pt -78.65 -3.62 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.99 -17.94 3.83 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.006 -1.093 . . . . 0.0 113.36 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.759 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 57.3 m -66.6 131.62 46.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.467 0.651 . . . . 0.0 111.314 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 15.2 m -117.5 137.0 52.84 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.932 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -72.82 120.28 18.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.964 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.625 ' HD3' ' CE1' ' A' ' 28' ' ' TYR . 6.9 tttt -139.53 119.57 13.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.1 m 57.84 35.76 25.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.26 0.552 . . . . 0.0 109.923 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.933 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 73.2 mttt 66.61 23.51 10.32 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.562 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.606 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 24.6 t -134.73 127.23 48.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.544 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 94.0 m -83.85 123.1 29.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.983 0.421 . . . . 0.0 111.449 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.669 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 3.9 m-85 -113.78 152.45 30.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.674 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.83 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 57.8 ttt180 -130.48 110.72 11.67 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.0 m120 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.58 -178.771 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.358 0 CA-C-O 120.32 -0.156 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.3 124.19 50.01 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 117.068 0.434 . . . . 0.0 110.334 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.652 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 50.7 Cg_exo -56.31 132.18 50.3 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.418 2.079 . . . . 0.0 112.491 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 80.5 m -72.61 -10.46 59.82 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.21 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.03 -32.03 7.57 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.849 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.694 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 97.3 mt-10 -78.25 138.24 38.52 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.592 0.71 . . . . 0.0 110.455 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 m -107.94 134.33 51.01 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.151 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.532 ' O ' ' HD2' ' A' ' 25' ' ' LYS . 1.7 p -101.0 37.88 1.66 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.237 0.542 . . . . 0.0 110.117 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.637 ' HB ' ' CE3' ' A' ' 10' ' ' TRP . 39.5 t -64.35 -52.4 56.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.999 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.637 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 3.8 m-90 -96.71 -55.55 2.86 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.175 0.512 . . . . 0.0 110.434 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 23.4 pt -125.96 156.59 71.41 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.301 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.85 147.31 89.39 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.55 2.167 . . . . 0.0 111.997 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.694 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 27.6 m -65.1 142.35 58.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.701 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.2 pt -77.05 -35.65 23.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.98 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.49 ' HB3' HD12 ' A' ' 18' ' ' ILE . 50.4 m -79.75 12.17 2.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.834 0.349 . . . . 0.0 111.606 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.887 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 19.4 p -60.95 -36.01 78.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.768 0.318 . . . . 0.0 110.964 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.6 -23.25 62.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.473 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 15' ' ' SER . 60.9 mt -70.86 -25.8 26.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.652 0.739 . . . . 0.0 110.289 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.95 31.84 0.29 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.661 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.887 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 60.0 m -103.34 137.46 41.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.192 0.52 . . . . 0.0 110.765 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.487 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 11.2 m -119.48 134.09 55.38 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.053 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.1 t -67.74 120.08 13.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.19 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.4 mttm -139.72 115.58 10.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 t 58.35 36.64 25.66 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.36 0.6 . . . . 0.0 109.854 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.532 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 28.6 mmtp 68.49 19.79 8.66 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.797 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.666 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 22.6 t -132.91 128.05 56.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 90.8 m -83.61 121.87 27.83 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.89 0.376 . . . . 0.0 111.357 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.666 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 5.0 m-85 -112.38 152.58 28.45 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.025 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.603 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 49.4 ttp85 -133.84 113.59 12.42 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 121.301 0.572 . . . . 0.0 109.952 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 N-CA-C 113.808 0.283 . . . . 0.0 113.808 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.8 mm -96.29 124.0 52.87 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 117.36 0.58 . . . . 0.0 110.759 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.673 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.6 Cg_exo -57.34 130.67 40.42 Favored 'Trans proline' 0 CA--C 1.516 -0.38 0 C-N-CA 122.415 2.076 . . . . 0.0 112.471 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.784 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 72.6 m -72.94 -9.7 59.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.319 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.28 -32.89 6.64 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.582 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -73.09 140.61 47.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.503 0.668 . . . . 0.0 110.507 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -114.47 130.77 56.75 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.842 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.8 48.78 1.38 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.378 0.608 . . . . 0.0 110.126 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.585 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 45.1 t -64.69 -57.25 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.924 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 59.2 m95 -102.8 -47.82 4.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.091 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.84 158.88 69.06 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.25 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -68.21 147.14 72.03 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.795 2.33 . . . . 0.0 111.997 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.6 m -64.82 151.97 44.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.93 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 13.9 tt -75.8 -38.48 37.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.426 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 m -76.6 9.75 2.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.741 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 22.9 p -59.19 -49.25 78.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.896 0.379 . . . . 0.0 110.906 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.7 -22.54 67.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.471 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.8 mt -75.07 -24.52 17.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.614 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.75 -14.99 0.92 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.208 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 36.4 m -74.15 132.6 42.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.461 0.648 . . . . 0.0 111.592 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 14.6 m -115.18 136.63 52.91 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.959 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 51.7 t -70.61 120.16 15.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.836 0.351 . . . . 0.0 110.564 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -139.73 118.52 12.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.966 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.8 m 56.64 36.68 28.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.141 0.495 . . . . 0.0 110.334 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.585 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER 69.52 17.63 7.93 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.956 -179.423 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.618 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 24.7 t -132.82 129.44 58.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 89.1 m -83.7 122.27 28.4 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.042 0.449 . . . . 0.0 111.336 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.673 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 4.4 m-85 -112.8 152.21 29.45 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.608 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.784 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 66.2 ttt180 -130.87 111.68 12.32 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.9 m120 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.707 -178.886 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.43 0 N-CA-C 113.882 0.313 . . . . 0.0 113.882 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.5 mm -96.68 126.58 42.63 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 117.307 0.554 . . . . 0.0 110.864 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.654 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 51.6 Cg_exo -57.33 130.45 39.33 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.403 2.069 . . . . 0.0 112.366 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.666 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 34.8 m -72.25 -8.42 54.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.558 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.1 -30.97 8.19 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.189 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -74.59 142.21 44.66 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.511 0.672 . . . . 0.0 110.672 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 m -109.59 128.81 55.48 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.01 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -94.38 48.12 1.22 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.11 0.481 . . . . 0.0 110.713 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.21 -57.3 5.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.493 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -98.64 -37.22 9.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.724 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.573 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.0 tt -146.21 138.96 14.06 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.339 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HD2' HG13 ' A' ' 11' ' ' ILE . 8.3 Cg_endo -53.59 144.57 51.81 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.88 2.386 . . . . 0.0 112.779 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.2 m -65.4 147.35 53.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.832 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mm -73.04 -38.76 56.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.115 0.484 . . . . 0.0 110.303 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.567 ' O ' HG12 ' A' ' 18' ' ' ILE . 6.8 m -68.7 -4.55 16.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.227 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.696 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 15.6 m -58.1 -35.33 71.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.105 0.479 . . . . 0.0 110.638 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.69 -32.62 74.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.573 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.567 HG12 ' O ' ' A' ' 15' ' ' SER . 27.1 pt -86.74 5.9 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.78 -18.52 4.55 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 119.634 -1.27 . . . . 0.0 114.538 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.696 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 83.6 m -67.71 139.68 56.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.618 0.709 . . . . 0.0 111.803 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.0 m -125.1 135.38 52.63 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.747 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.3 t -69.74 125.08 25.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.093 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -146.6 119.42 8.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.132 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.608 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 10.8 m 56.85 39.61 29.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.967 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 24' ' ' SER . 8.7 ptpt 70.98 9.19 6.73 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.446 1.098 . . . . 0.0 112.038 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 t -128.39 130.43 69.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.209 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 91.5 m -83.72 127.2 33.61 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 122.189 -0.319 . . . . 0.0 110.738 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 2.9 m-85 -115.37 153.2 31.44 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.666 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 62.4 ttt-85 -136.09 115.49 12.67 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.724 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.342 0 CA-C-O 120.369 -0.128 . . . . 0.0 113.294 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.4 mm -96.37 125.64 46.83 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 117.026 0.413 . . . . 0.0 110.384 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.654 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.6 Cg_exo -57.15 132.64 52.54 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.353 2.035 . . . . 0.0 112.358 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 72.5 m -72.11 -7.84 51.26 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.562 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.33 -31.38 8.1 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.246 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -79.69 141.04 36.79 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.693 0.759 . . . . 0.0 111.038 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 m -107.74 129.55 55.03 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.0 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -99.92 51.03 0.91 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.56 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.57 -45.53 77.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.803 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -117.57 -48.56 2.59 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.952 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.6 pt -117.85 151.26 48.49 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.837 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.3 146.11 68.15 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.664 2.243 . . . . 0.0 111.661 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 10.0 m -66.55 148.41 51.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.488 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -71.92 -43.11 68.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.298 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.4 p -68.03 -3.13 9.17 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.866 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 18.3 m -57.99 -40.81 81.62 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.708 0.289 . . . . 0.0 110.609 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.02 67.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.607 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.8 mt -76.74 -37.14 27.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.408 0.623 . . . . 0.0 110.284 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 29' ' ' ARG . . . 155.42 33.36 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.704 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.866 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 83.9 m -109.92 138.67 45.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.17 0.509 . . . . 0.0 110.605 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.8 m -118.97 117.74 29.62 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.923 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 32.8 t -62.9 137.79 58.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.848 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -166.83 128.92 1.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.096 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.64 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 9.4 t 57.29 41.9 25.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 24' ' ' SER . 0.9 OUTLIER 62.6 16.06 8.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.777 1.231 . . . . 0.0 112.413 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.662 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.3 t -134.29 130.76 54.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.147 0.498 . . . . 0.0 110.995 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 89.5 m -84.14 128.1 34.34 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.102 178.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.662 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 6.6 m-85 -119.01 153.75 34.18 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.794 0.331 . . . . 0.0 110.173 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.615 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 29.5 ttm180 -134.61 114.8 13.14 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.654 -178.708 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.406 0 CA-C-O 120.174 -0.237 . . . . 0.0 113.678 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.2 mm -96.49 124.46 50.85 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 117.31 0.555 . . . . 0.0 110.585 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.67 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.4 Cg_exo -56.98 130.39 39.54 Favored 'Trans proline' 0 CA--C 1.516 -0.392 0 C-N-CA 122.405 2.07 . . . . 0.0 112.51 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.795 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 76.0 m -73.46 -8.49 56.12 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.4 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.33 -28.44 8.95 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.588 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.714 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 94.4 mt-10 -74.69 137.3 42.05 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.535 0.683 . . . . 0.0 109.957 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.2 m -108.92 131.8 54.67 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.681 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.0 p -99.41 45.02 1.0 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.581 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.621 ' HB ' ' CE3' ' A' ' 10' ' ' TRP . 21.6 t -76.3 -52.1 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.145 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.621 ' CE3' ' HB ' ' A' ' 9' ' ' VAL . 5.1 m-90 -93.74 -49.23 5.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.305 0.574 . . . . 0.0 110.935 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.0 pt -136.23 159.41 70.94 Favored Pre-proline 0 N--CA 1.447 -0.577 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.018 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -63.74 146.88 92.56 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.392 2.062 . . . . 0.0 111.637 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.714 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 36.5 m -66.33 149.86 49.73 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.797 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.453 ' H ' HD12 ' A' ' 14' ' ' ILE . 4.2 mp -72.69 -41.05 62.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.969 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -73.14 5.44 3.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 31.4 m -60.5 -41.66 94.77 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.945 0.402 . . . . 0.0 110.512 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.78 -25.8 67.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.281 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.5 mt -74.91 -25.36 18.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.009 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.18 -8.86 1.09 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.101 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 40.7 m -73.92 136.04 43.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.339 0.59 . . . . 0.0 111.147 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.497 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 5.7 m -118.71 131.09 56.14 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.681 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.1 t -64.91 121.52 14.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.275 0.36 . . . . 0.0 110.227 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HE2' ' HB2' ' A' ' 21' ' ' SER . 66.5 mttm -141.08 113.0 7.75 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.548 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 48.8 m 54.31 45.76 26.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.305 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 24' ' ' SER . 1.2 pttm 71.33 4.87 5.23 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.838 1.255 . . . . 0.0 112.518 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.62 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.1 t -125.35 127.91 72.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 120.856 0.36 . . . . 0.0 110.324 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 91.8 m -83.95 120.93 26.7 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.815 0.34 . . . . 0.0 110.827 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.67 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 5.0 m-85 -109.42 151.78 26.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.143 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.795 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.6 ttm180 -130.31 113.65 14.65 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-O 121.317 0.58 . . . . 0.0 110.159 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.401 0 N-CA-C 113.828 0.291 . . . . 0.0 113.828 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 51.2 mm -95.85 126.9 43.15 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 117.266 0.533 . . . . 0.0 110.709 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.662 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.6 Cg_exo -57.09 132.73 53.24 Favored 'Trans proline' 0 CA--C 1.518 -0.323 0 C-N-CA 122.48 2.12 . . . . 0.0 112.458 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 74.4 m -74.11 -9.12 58.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.281 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.36 -31.58 7.89 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.637 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.684 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 95.0 mt-10 -76.6 139.64 40.72 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.456 0.646 . . . . 0.0 110.094 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.1 m -114.95 133.55 55.92 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.001 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -97.73 51.22 1.06 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.816 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.851 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 36.8 t -62.84 -40.0 87.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.03 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -128.82 -49.48 1.24 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.088 0.471 . . . . 0.0 110.383 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.744 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -114.23 153.29 46.42 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.408 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -65.78 147.8 85.91 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.559 2.173 . . . . 0.0 111.648 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.684 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 8.3 m -69.44 150.12 47.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.417 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 mm -70.03 -41.41 79.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.274 0.559 . . . . 0.0 109.892 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.801 ' HA ' HD13 ' A' ' 18' ' ' ILE . 68.0 m -69.17 -6.76 30.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.878 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 74.2 m -62.67 -35.43 79.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.927 0.394 . . . . 0.0 110.287 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.2 -24.32 65.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.698 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.801 HD13 ' HA ' ' A' ' 15' ' ' SER . 2.7 mp -78.7 -34.23 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.395 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.48 -14.25 0.18 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.311 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 46.3 m -66.35 133.02 49.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.492 0.663 . . . . 0.0 111.414 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 13.4 m -107.29 135.38 48.89 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.16 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.0 t -73.31 118.86 16.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 0.0 110.723 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -132.16 118.4 19.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 p 49.97 42.2 24.17 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.643 0.735 . . . . 0.0 111.087 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.851 ' HD3' ' HA ' ' A' ' 9' ' ' VAL . 74.4 mttt 67.87 20.97 9.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.544 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.624 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.6 t -133.39 126.18 51.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 93.4 m -83.87 124.56 31.1 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.989 0.423 . . . . 0.0 111.661 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.662 ' CE2' ' HG3' ' A' ' 3' ' ' PRO . 3.9 m-85 -115.5 154.42 29.36 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.883 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.577 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 48.8 ttp85 -138.16 114.83 10.57 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.8 t30 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.504 -178.164 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.305 0 CA-C-O 120.309 -0.162 . . . . 0.0 113.382 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.1 mt -95.3 123.99 55.05 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 117.014 0.407 . . . . 0.0 110.425 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.686 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 52.2 Cg_exo -57.22 132.46 51.28 Favored 'Trans proline' 0 CA--C 1.516 -0.411 0 C-N-CA 122.3 2.0 . . . . 0.0 112.063 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 90.0 m -74.3 -6.53 48.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.518 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.74 -28.83 9.38 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.78 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.695 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 94.8 mt-10 -77.38 136.4 38.42 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 121.593 0.711 . . . . 0.0 110.149 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.5 m -109.45 132.13 54.42 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.659 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 3.6 p -103.45 51.36 0.79 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.048 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.61 HG13 ' HD2' ' A' ' 25' ' ' LYS . 40.5 t -65.86 -41.89 90.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.957 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -124.1 -49.5 1.83 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.524 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 27.7 pt -112.8 150.83 43.39 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.69 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -66.41 147.71 83.12 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.648 2.232 . . . . 0.0 111.636 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.695 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 8.8 m -69.94 149.53 47.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.338 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.9 mm -70.55 -41.57 78.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.149 0.499 . . . . 0.0 110.152 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.802 ' HA ' HD13 ' A' ' 18' ' ' ILE . 70.2 m -70.76 -3.51 19.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.024 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 75.3 m -63.02 -35.84 81.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.926 0.393 . . . . 0.0 110.337 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.64 -22.61 64.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.732 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.802 HD13 ' HA ' ' A' ' 15' ' ' SER . 2.6 mp -79.59 -34.07 15.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.4 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.82 -16.76 0.19 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.18 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 34.8 m -65.12 131.28 46.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.549 0.69 . . . . 0.0 111.244 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.43 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 2.6 m -104.49 127.19 52.14 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.13 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.7 t -72.37 128.67 36.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.45 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.433 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 12.4 ptpt -158.19 127.58 5.79 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m 58.82 33.77 23.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.115 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.61 ' HD2' HG13 ' A' ' 9' ' ' VAL . 51.6 mtmt 69.57 17.67 7.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.567 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.703 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 17.5 t -135.4 129.41 49.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.043 0.449 . . . . 0.0 110.053 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 84.9 m -86.81 122.88 31.3 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.921 0.391 . . . . 0.0 111.044 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.703 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 3.5 m-85 -114.39 153.37 29.98 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.939 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.487 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 41.6 ttp85 -137.02 114.31 10.84 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.7 t30 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.602 -178.257 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.465 0 N-CA-C 114.178 0.431 . . . . 0.0 114.178 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -94.43 121.95 62.25 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 117.569 0.685 . . . . 0.0 110.883 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 50.3 Cg_exo -56.29 131.42 45.69 Favored 'Trans proline' 0 CA--C 1.518 -0.307 0 C-N-CA 122.523 2.149 . . . . 0.0 112.717 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.781 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 70.1 m -71.62 -11.26 60.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.467 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.65 -31.19 8.4 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.063 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -75.45 140.17 42.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.5 0.667 . . . . 0.0 110.322 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 m -106.73 130.47 54.44 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.144 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -96.75 49.29 1.08 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.117 0.484 . . . . 0.0 110.752 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.592 HG22 ' HB2' ' A' ' 25' ' ' LYS . 22.0 t -80.29 -59.9 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.405 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -91.83 -36.29 13.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.418 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.463 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.4 tt -149.31 140.96 14.65 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.854 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.463 ' HD2' HG13 ' A' ' 11' ' ' ILE . 37.9 Cg_exo -57.58 147.69 77.66 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.346 2.03 . . . . 0.0 112.0 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.7 m -64.84 148.73 50.78 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.1 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 mm -74.68 -40.16 47.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.354 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 18' ' ' ILE . 55.9 p -70.99 0.87 6.49 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.796 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 16.1 m -60.91 -35.61 77.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.252 0.549 . . . . 0.0 110.614 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.33 -29.71 70.97 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 15' ' ' SER . 38.7 pt -92.42 7.41 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.05 -25.0 2.68 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 119.214 -1.47 . . . . 0.0 114.536 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.796 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 69.9 m -68.25 142.68 55.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.5 0.667 . . . . 0.0 111.842 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 3.4 p -129.86 133.85 47.16 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.963 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 t -70.38 124.08 23.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.866 0.365 . . . . 0.0 111.317 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -148.56 121.28 8.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.857 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.684 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 11.2 m 55.22 47.23 22.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.684 ' HG3' ' O ' ' A' ' 24' ' ' SER . 0.0 OUTLIER 57.9 15.66 3.21 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.206 1.402 . . . . 0.0 112.754 -178.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.6 t -130.55 130.06 64.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.035 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 99.6 m -83.56 128.01 34.19 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 122.08 -0.388 . . . . 0.0 110.681 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.669 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 4.2 m-85 -113.98 154.08 28.23 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.95 0.405 . . . . 0.0 110.222 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.781 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 29.8 ttm180 -132.22 103.94 6.5 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.674 -178.353 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 120.447 -0.085 . . . . 0.0 113.257 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.5 mt -94.5 122.19 61.6 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.864 0.332 . . . . 0.0 110.433 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.625 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 52.2 Cg_exo -55.06 133.05 55.92 Favored 'Trans proline' 0 CA--C 1.519 -0.247 0 C-N-CA 122.478 2.119 . . . . 0.0 112.448 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 71.0 m -76.64 -2.46 32.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.463 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.17 -31.54 6.26 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 48.5 mt-10 -65.47 141.73 58.39 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.551 0.691 . . . . 0.0 111.07 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -117.57 125.61 51.11 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.603 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.8 p -96.94 45.52 1.05 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.391 0.615 . . . . 0.0 110.864 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.646 ' HA ' ' HG3' ' A' ' 25' ' ' LYS . 36.5 t -67.66 -52.94 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.655 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -114.82 -48.08 2.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.256 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 27.5 pt -108.28 143.71 27.97 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.127 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.08 164.31 34.68 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.645 2.23 . . . . 0.0 112.487 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.602 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 1.5 m -58.53 130.01 44.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.34 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.5 tt -86.63 -32.02 6.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.7 m -86.06 21.75 1.91 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.341 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.602 ' OG ' ' HB2' ' A' ' 13' ' ' CYS . 68.9 m -54.41 -36.19 63.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.98 0.419 . . . . 0.0 111.092 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.77 -25.84 67.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.526 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.464 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 5.9 mm -86.92 38.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.145 0.497 . . . . 0.0 110.63 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.05 30.61 74.1 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.775 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 98.8 m -106.72 146.66 30.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.88 0.371 . . . . 0.0 110.359 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.3 t -148.43 141.07 24.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.342 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.3 t -67.64 125.31 25.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.092 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -144.68 115.67 7.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.886 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.6 m 57.13 41.68 26.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.186 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.646 ' HG3' ' HA ' ' A' ' 9' ' ' VAL . 1.2 tptt 72.26 7.61 5.73 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.059 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.745 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 21.2 t -130.44 131.1 65.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 43.2 m -79.34 128.62 33.56 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.745 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 11.5 m-85 -121.43 155.84 34.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.102 0.477 . . . . 0.0 110.812 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.694 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 38.8 ttp180 -131.71 112.83 12.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.2 p30 . . . . . 0 N--CA 1.473 0.691 0 O-C-N 124.145 0.903 . . . . 0.0 111.993 -178.228 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 CA-C-O 120.256 -0.191 . . . . 0.0 113.403 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.2 mm -96.55 124.31 51.23 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 117.15 0.475 . . . . 0.0 110.469 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.651 ' HG3' ' CE2' ' A' ' 28' ' ' TYR . 51.4 Cg_exo -56.54 131.7 47.27 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 122.41 2.073 . . . . 0.0 112.493 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 91.7 m -71.87 -8.47 54.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.338 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.01 -30.85 8.34 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.696 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.64 137.53 40.79 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.682 0.753 . . . . 0.0 110.548 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -110.25 129.47 55.72 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.52 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 p -97.79 47.51 1.01 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.177 0.513 . . . . 0.0 110.254 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.051 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 44.1 t -66.92 -52.38 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.071 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -105.45 -49.55 3.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.5 pt -125.69 148.37 61.78 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.72 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.12 150.42 88.68 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.592 2.195 . . . . 0.0 112.738 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.9 m -67.27 150.48 48.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.606 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.4 pt -77.68 -38.38 25.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.618 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.416 ' HB3' HD11 ' A' ' 18' ' ' ILE . 13.8 m -79.11 12.15 2.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.849 0.357 . . . . 0.0 111.706 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.594 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 52.6 p -66.77 -44.92 80.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.163 0.506 . . . . 0.0 110.745 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.68 -26.19 65.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.553 HG13 HH22 ' A' ' 29' ' ' ARG . 18.8 pt -93.6 10.85 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.2 -31.04 2.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 119.191 -1.48 . . . . 0.0 115.138 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.594 ' HB2' ' HA ' ' A' ' 16' ' ' SER . 56.0 m -68.68 130.73 43.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.805 0.803 . . . . 0.0 111.48 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.454 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 3.7 m -111.39 125.47 53.9 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.182 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 25.9 t -71.24 126.91 30.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.523 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 21' ' ' SER . 12.5 ptpt -157.86 128.92 6.55 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m 58.78 34.62 23.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.052 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 1.051 ' HD2' ' HA ' ' A' ' 9' ' ' VAL . 46.9 mmtm 69.68 15.47 8.09 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.82 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.684 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 20.2 t -135.19 130.82 51.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.431 . . . . 0.0 110.351 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 20' ' ' CYS . 98.1 m -85.48 122.6 29.84 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.852 0.358 . . . . 0.0 110.621 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.684 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 6.0 m-85 -111.95 154.23 25.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.481 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.6 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 52.0 ttm-85 -131.4 111.45 11.84 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.964 -179.409 . . . . . . . . 0 0 . 1 stop_ save_